Prof Francesco Muntoni

Photo

Personal Profile

Name: Francesco Muntoni Email: f.muntoni@ucl.ac.uk
Title: Prof Tel: 020 7905 2869
Department: ICH Developmental Neurosciences Prog Fax: 0207 905 2832
Position: Chair of Paediatric Neurology Address: 30 Guilford Street, , London, WC1N 1EH
Research Domain: Neuroscience, Populations & Lifelong Health Web Page: Personal Web Page

Profile

Research Description

I am a clinical paediatric neurologist with an interest in molecular aspects of neuromuscular disorders. I joined the Neuromuscular Unit at the Hammersmith in 1993, and became the Head of the Unit in 1996.

From a clinical perspective, this Neuromuscular Unit, named after Professor Victor Dubowitz, is the largest Paediatric Neuromuscular Unit in UK; it is recognised by the Muscular Dystrophy Campaign (the largest charity in this field); since 2001 the Unite was designated as a National reference centre by the Department of Health (NSCAG) for the work on clinical, pathological and genetic aspects related to congenital muscular dystrophies and myopathies. The Unit has its own diagnostic pathology laboratories, of which I am also responsible.

Regarding my contribution to research, an early original contributions was the discovery that the X-linked dilated cardiomyopathy (XLDCM) is secondary to a dystrophin gene abnormality (the same gene responsible for Duchenne muscular dystrophy). I have further characterised the molecular mechanisms responsible for this unusual phenotype since.

Another important area has been the establishment of international collaboration networks allowing the identification of a number of disease genes involved in neuromuscular disorders (12 novel genes in collaboration with external collaborators). My own group has also identified 2 novel loci for forms of congenital muscular dystrophy and three novel disease genes. One of these 2 genes (FKRP)  proved not only to be relevant for a rare form of congenital dystrophy, but also for a very common form of mild limb girdle muscular dystrophy. Allelic mutations in this gene are also found in severe variants of muscular dystrophy associated with structural brain involvement. We generated a knock-in animal model which phenotype faithfully recapitulates the human condition recapitulates and demonstrated that mutations in FKRP are responsible for a novel pathway involved in both muscular degeneration and for neuronal migration defects. Form a translational research perspective, I am interested in manipulation of splicing of genes involved in neuromuscular disorders. I am interested in the control of splicing of the SMN2 gene involved in spinal muscular atrophy, and have identified, in collaboration with Prof Eperon, a tailed antisense oligonucleotide which carry sequences that are involved in the recruitment of splicing proteins and induce a crucial exon inclusion in SMN2. A different approach, the use of antisense oligonucleotide to induce exon skipping in Duchenne muscular dystrophy, culminated in a Department of Health funded grant to establish a consortium for a phase I/II therapeutic trial of intramuscular antisense morpholino oligonucleotide in Duchenne muscular dystrophy that started in 2005 and was completed in 2008 (Muntoni PI). I subsequently obtained an MRC translational research grant to extend this study into a dose escalation, repeated intravenous morpholino antisense administration into young boys with Duchenne. This study started in February 2009 and is finished in March 2010. The results are very encouraging and have led to additional funding to perform additional studies both to target Duchenne individuals at later stage of disease progression, but also to assess the efficacy and safety of a new generation of antisense oligonucleotide, with the plan to perform a proof of concept study in 2013. These studies are supported by the GOSH Biomedical Research Centre and from the UCL MRC Neuromuscular Translational Research Centre, of which I am the Deputy Director.




Research Activities

Clinical trials

Genetics of brain disorders

Human neuromuscular diseases

Molecular genetics of childhood disease.

Molecular genetics of childhood inherited disorder

Motor Neuron and Neuromuscular Disorders

Neuromuscular and Neurodegenerative Disorders

Paediatric Neurology

The neurogenetics of neurodegenerative disease

peripheral nerve disease especially inherited neuropathies but also inflammatory neuropathies

Education Description

UCL Collaborators

Prof Andres Ruiz-Linares; Prof Adrian Thrasher; Prof Alan Thompson; Prof Tarek Yousry; Prof John Hardy; Prof Janet Darbyshire; Prof William Rosenberg; Dr Richard Orrell; Mr Hashim Ahmed; Prof Sebastian Brandner; Prof Elizabeth Fisher; Prof Michael Duchen; Dr Zarnie Khadjesari; Prof Michael Hanna; Prof Mary Reilly; Prof William Mckenna; Prof Elizabeth Murray; Prof Linda Greensmith; Prof Paul Wallace; Prof Nicholas Wood; Dr Shi-Yu Yang; Prof Martin Koltzenburg; Prof Irwin Nazareth; Dr Eddie Chung; Dr Ailbhe Mcdonald; Prof Perry Elliott; Prof Jenny Morgan

External Collaborators

Publications

    2015

    • Muntoni F, Cross JH (2015). Paediatric neurology: from molecular mechanisms to targeted treatments.. Lancet Neurol, 14(1), 16 - 18. doi:10.1016/S1474-4422(14)70304-7

    2014

    • Ferlini A, Flanigan KM, Lochmuller H, Muntoni F, 't Hoen PA, McNally E (2014). 204th ENMC International Workshop on Biomarkers in Duchenne Muscular Dystrophy 24-26 January 2014, Naarden, The Netherlands.. Neuromuscul Disord, , - . doi:10.1016/j.nmd.2014.09.004
    • Bönnemann CG, Wang CH, Quijano-Roy S, Deconinck N, Bertini E, Ferreiro A, Muntoni F, Sewry C, Béroud C, Mathews KD, Moore SA, Bellini J, Rutkowski A, North KN, Members of the International Standard of Care Committee for Congenital Muscular Dystrophies (2014). Diagnostic approach to the congenital muscular dystrophies.. Neuromuscul Disord, , - . doi:10.1016/j.nmd.2013.12.011
    • Di Foggia V, Zhang X, Licastro D, Gerli MF, Phadke R, Muntoni F, Mourikis P, Tajbakhsh S, Ellis M, Greaves LC, Taylor RW, Cossu G, Robson LG, Marino S (2014). Bmi1 enhances skeletal muscle regeneration through MT1-mediated oxidative stress protection in a mouse model of dystrophinopathy.. J Exp Med, , - . doi:10.1084/jem.20140317
    • Colombo I, Scoto M, Manzur AY, Robb SA, Maggi L, Gowda V, Cullup T, Yau M, Phadke R, Sewry C, Jungbluth H, Muntoni F (2014). Congenital myopathies: Natural history of a large pediatric cohort.. Neurology, , - . doi:10.1212/WNL.0000000000001110
    • Fridman V, Bundy B, Reilly MM, Pareyson D, Bacon C, Burns J, Day J, Feely S, Finkel RS, Grider T, Kirk CA, Herrmann DN, Laurá M, Li J, Lloyd T, Sumner CJ, Muntoni F, Piscosquito G, Ramchandren S, Shy R, Siskind CE, Yum SW, Moroni I, Pagliano E, Zuchner S, Scherer SS, Shy ME, on behalf of the Inherited Neuropathies Consortium (2014). CMT subtypes and disease burden in patients enrolled in the Inherited Neuropathies Consortium natural history study: a cross-sectional analysis.. J Neurol Neurosurg Psychiatry, , - . doi:10.1136/jnnp-2014-308826
    • Sframeli M, Sarkozy A, Astrea G, Scoto M, Feng L, Mein R, Yau M, Phadke R, Sewry C, Messina S, Robb S, Muntoni F (2014). Clinical and genetic spectrum in a large cohort of patients with a genetic diagnosis of congenital muscular dystrophies: Analysis of the UK diagnostic service 2001-2013. doi:10.1016/j.nmd.2014.06.283
    • Annoussamy M, Landy H, Ramsdell D, Nelken M, Muntoni F, Boennemann C, Bharucha D, Dowling JJ, Amburgey K, Lilien C, Ollivier G, Laporte J, Biancalana V, Schara U, Cuisset JM, D'Amico A, Deconinck N, Jeannet PY, Klein A, Fluss J, Mayer M, Seferian AM, Le Moing AG, Gidaro T, Hogrel JY, Mingozzi F, Buj-Bello A, Voit T, Servais L (2014). An international prospective, longitudinal study of the natural history and functional status of patients with myotubular myopathy. doi:10.1016/j.nmd.2014.06.053
    • Sframeli M, Sarkozy A, Longman C, Feng L, Robb S, Manzur AY, Mein R, Yau M, Barresi R, Phadke R, Sewry C, Muntoni F (2014). Alpha-dystroglycanopathy: Two new patients with GMPPB mutations and a mild limb-girdle phenotype. doi:10.1016/j.nmd.2014.06.404
    • Ramsey D, Scoto M, Mayhew A, Main M, Wilson I, Mazzone E, Montes J, Bushby K, Finkel R, Mercuri E, Muntoni F (2014). Developing the SMA REACH UK database: A combined effort to improve standards of care and translational research in Spinal Muscular Atrophy. doi:10.1016/j.nmd.2014.06.366
    • Butler JW, Main M, Muntoni F (2014). The impact of reduced ankle range of movement on the functional abilities of patients with Duchenne muscular dystrophy. doi:10.1016/j.nmd.2014.06.204
    • Zaharieva IT, Colombo I, Sframeli M, Sigurosson JH, Feng L, Phadke R, Sewry CA, Morgan JE, Muntoni F (2014). Whole exome sequencing in patients with congenital myopathies. doi:10.1016/j.nmd.2014.06.337
    • Ricotti V, Evans RB, Sinclair CDJ, Morrow JM, Butler JW, Janiczek RL, Hanna MG, Matthews PM, Yousry TA, Muntoni F, Thornton JS (2014). Upper limb muscle MRI fat-water quantification and clinical functional correlation in non-ambulant Duchenne muscular dystrophy. doi:10.1016/j.nmd.2014.06.158
    • Childs AM, Pysden K, Roper H, Chow G, Niks EH, Kriek M, Chinnery PF, Lewis-Smith D, Duchen M, Szabadkai G, Logan C, Sheridan E, Sewry C, Muntoni F (2014). Clinical and pathological features associated with mutations in MICU1. doi:10.1016/j.nmd.2014.06.187
    • Joseph S, Longman C, Muntoni F, Horrocks I (2014). Cases of normal to mildly elevated creatine kinase in muscle-eye-brain disease patients and delay in diagnosis. doi:10.1016/j.nmd.2014.06.405
    • Cortese A, Ellis M, Fratter C, Fox Z, Chambers D, Hodsdon P, Hargreaves I, Kinali M, Rahman S, Sewry C, Muntoni F, Poulton J, Phadke R (2014). What factors are associated with the prevalence of sub-sarcolemmal mitochondrial aggregates (SSMA) in paediatric skeletal muscle? Examining the use and limitations of SSMA as a diagnostic muscle biopsy marker. doi:10.1016/j.nmd.2014.06.247
    • Bishop CA, Ricotti V, Sinclair CDJ, Butler J, Evans RBM, Morrow JM, Hanna MG, Matthews PM, Yousry TA, Thornton JS, Muntoni F, Janiczek RL (2014). Semi-automated analysis of diaphragmatic motion during deep breathing using dynamic MRI in both healthy controls and non-ambulant Duchenne muscular dystrophy. doi:10.1016/j.nmd.2014.06.200
    • Anthony K, Arechavala-Gomeza V, Taylor LE, Vulin A, Kaminoh Y, Torelli S, Feng L, Janghra N, Bonne G, Beuvin M, Barresi R, Henderson M, Laval S, Lourbakos A, Campion G, Straub V, Voit T, Sewry CA, Morgan JE, Flanigan KM, Muntoni F (2014). Dystrophin quantification: Biological and translational research implications.. Neurology, , - . doi:10.1212/WNL.0000000000001025
    • Lynn S, Aartsma-Rus A, Bushby K, Furlong P, Goemans N, De Luca A, Mayhew A, McDonald C, Mercuri E, Muntoni F, Pohlschmidt M, Verschuuren J, Voit T, Vroom E, Wells DJ, Straub V (2014). Measuring clinical effectiveness of medicinal products for the treatment of Duchenne muscular dystrophy.. Neuromuscul Disord, , - . doi:10.1016/j.nmd.2014.09.003
    • Donkervoort S, Hu Y, Stojkovic T, Voermans N, Foley AR, Leach ME, Dastgir J, Bolduc V, Cullup T, de Becdelièvre A, Yang L, Su H, Meilleur K, Schindler AB, Kamsteeg EJ, Richard P, Butterfield R, Winder TL, Crawford T, Weiss RB, Muntoni F, Allamand V, Bönnemann CG (2014). Mosaicism for Dominant Collagen VI Mutations as a Cause for Intra-Familial Phenotypic Variability.. Hum Mutat, , - . doi:10.1002/humu.22691
    • Jonuschies J, Antoniou M, Waddington S, Boldrin L, Muntoni F, Thrasher A, Morgan J (2014). The Human Desmin Promoter Drives Robust Gene Expression for Skeletal Muscle Stem Cell-Mediated Gene Therapy.. Curr Gene Ther, , - .
    • Sewry CA, Phadke R, Zaharieva I, Feng L, Manzur A, Ravenscroft G, Laing N, Muntoni F (2014). Pathological markers that can help direct molecular diagnosis of nemaline myopathy.
    • Feng L, Matthews A, Scoto M, Chambers D, Manzur A, Muntoni F, Phadke R, Sewry C (2014). The expression of embryonic and foetal myosin heavy chain isoforms in human muscle are useful indicators of abnormality in muscle biopsies.
    • Cortese A, Ellis M, Chambers D, Rahman S, Hargreaves I, Fratter C, Sewry CA, Muntoni F, Poulton J, Phadke R (2014). The confounding effect of age in the use of subsarcolemmal mitochondrial aggregates (SSMA) as a diagnostic muscle biopsy marker in paediatric mitochondrial disease.
    • Chan SH, Reghan Foley A, Phadke R, Mathew AA, Pitt M, Sewry C, Muntoni F (2014). Limb girdle muscular dystrophy due to LAMA2 mutations: Diagnostic difficulties due to associated peripheral neuropathy.. Neuromuscul Disord, , - . doi:10.1016/j.nmd.2014.05.008
    • Yoon WW, Sedra F, Shah S, Wallis C, Muntoni F, Noordeen H (2014). Improvement of Pulmonary Function in Children With Early Onset Scoliosis Using Magnetic Growth Rods.. Spine (Phila Pa 1976), , - . doi:10.1097/BRS.0000000000000383
    • Logan CV, Sharpe JA, De Stefani D, Raffaello A, Rizzuto R, Duchen MR, Muntoni F, Sheridan E, Szabadkai G (2014). Genetic defects in mitochondrial calcium handling cause neuromuscular disease. EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 44, 47 - 47.
    • Foley AR, Pitceathly RD, He J, Kim J, Pearson NM, Muntoni F, Hanna MG (2014). Whole-genome sequencing and the clinician: a tale of two cities.. J Neurol Neurosurg Psychiatry, , - . doi:10.1136/jnnp-2013-306264
    • Kaye J, Hurles M, Griffin H, Grewal J, Bobrow M, Timpson N, Smee C, Bolton P, Durbin R, Dyke S, Fitzpatrick D, Kennedy K, Kent A, Muddyman D, Muntoni F, Raymond LF, Semple R, Spector T (2014). Managing clinically significant findings in research: the UK10K example.. Eur J Hum Genet, , - . doi:10.1038/ejhg.2013.290
    • Mora M, Angelini C, Bignami F, Bodin A, Crimi M, Di Donato J, Felice A, Jaeger C, Karcagi V, LeCam Y, Lynn S, Meznaric M, Moggio M, Monaco L, Politano L, de la Paz MP, Saker S, Schneiderat P, Ensini M, Garavaglia B, Gurwitz D, Johnson D, Muntoni F, Puymirat J, Reza M, Voit T, Baldo C, Bricarelli FD, Goldwurm S, Merla G, Pegoraro E, Renieri A, Zatloukal K, Filocamo M, Lochmüller H (2014). The EuroBioBank Network: 10 years of hands-on experience of collaborative, transnational biobanking for rare diseases.. Eur J Hum Genet, , - . doi:10.1038/ejhg.2014.272
    • Wein N, Vulin A, Simmons T, Heller KN, Rutherford A, Rodino-Kaplac LR, Johnson D, Weiss RB, Muntoni F, Flanigan KM (2014). Induction of the N-truncated dystrophin by out-of-frame exon 2 skipping restores muscle function in the Dup2 mouse, providing further support for a therapeutic pathway for 5 ' DMD mutations. doi:10.1016/j.nmd.2014.06.108
    • Lourbakos A, Hiller M, Kozaczynska K, Baptiste RJ, Reza M, Niks E, Koeks Z, de Klerk D, Wolterbeek R, Campion G, Nadarajah VD, Szigyarto CA-K, Calissano M, Muntoni F, Lochmueller H, Verschuuren JJGM, Goemans N, Tulinius M, de Kimpe S, Aartsma-Rus A, 't Hoen PAC, Spitali P (2014). MMP-9 serum levels increase over time in Duchenne muscular dystrophy patients and decrease upon treatment with drisapersen.
    • De Sanctis R, Pane M, Sivo S, Ricotti V, Baranello G, Frosini S, Mazzone E, Bianco F, Fanelli L, Main M, Corlatti A, D'Amico A, Colia G, Scalise R, Palermo C, Alfonsi C, Tritto G, Romeo DM, Graziano A, Battini R, Morandi L, Bertini E, Muntoni F, Mercuri E (2014). Suitability of North Star Ambulatory Assessment in young boys with Duchenne muscular dystrophy.. Neuromuscul Disord, , - . doi:10.1016/j.nmd.2014.09.015
    • van den Bergen JC, Hiller M, Böhringer S, Vijfhuizen L, Ginjaar I, Chaouch A, Bushby K, Straub V, Scoto M, Cirak S, Claustres M, Scotton C, Passarelli C, Lochmüller H, Muntoni F, Tuffery-Giraud S, Ferlini A, Aartsma-Rus A, Verschuuren J, 't Hoen PAC, Spitali P (2014). Validation of genetic modifiers for Duchenne muscular dystrophy: a multicentre study assessing SPP1 and LTBP4 variants. Journal of Neurology, Neurosurgery, and Psychiatry, , - .
    • Muntoni F, Spinty S, Roper H, Hughes I, Ricotti V, Bracchi A, Horne G, Tinsley J (2014). Utrophin modulators to treat Duchenne muscular dystrophy (DMD): Results from the Phase 1b safety and PK study in DMD boys dosed with SMT C1100. doi:10.1016/j.nmd.2014.06.116
    • Muntoni F (2014). Novel disease mechanisms in myopathies. doi:10.1016/j.nmd.2014.06.193
    • Byrne S, Bodi I, Sewry C, Goebel HH, Lidov H, Dionisi-Vici C, Rogers RC, Manchester D, Al-Owain M, Said E, Pilz D, Ryan M, Lourence CM, Manzur AY, Robb SA, Cullup T, Whyte T, Muntoni F, Gautel M, Jungbluth H (2014). The pathological spectrum of EPG5-related multisystem disorders. doi:10.1016/j.nmd.2014.06.141
    • Whyte T, Byrne S, Kho AL, Cullup T, Robb S, Sewry C, Bodi I, Hart N, Howard R, Gautel M, Muntoni F, Jungbluth H, Consortium UU (2014). A novel, EPG5-related vacuolar myopathy. doi:10.1016/j.nmd.2014.06.142
    • Whyte TG, Cirak S, Oprea I, Beales P, Osborn D, Busch K, Hurles M, Longman C, Quinlivan R, Sewry C, Jungbluth H, Muntoni F, Consortium2 UU (2014). Mutations in ECEL1 lead to distal arthrogryposis type 5D. doi:10.1016/j.nmd.2014.06.184
    • Meilleur KG, Jain MS, Hynan LS, Shieh CY, Kim E, Waite M, McGuire M, Fiorini C, Glanzman AM, Main M, Rose K, Duong T, Bendixen R, Linton MM, Arveson IC, Nichols C, Yang K, Fischbeck KH, Wagner KR, North K, Mankodi A, Grunseich C, Hartnett EJ, Smith M, Donkervoort S, Schindler A, Kokkinis A, Leach M, Foley AR, Collins J, Muntoni F, Rutkowski A, Bönnemann CG (2014). Results of a two-year pilot study of clinical outcome measures in collagen VI-related myopathy and LAMA2-related muscular dystrophy.. Neuromuscul Disord, , - . doi:10.1016/j.nmd.2014.09.010
    • De Palma S, Capitanio D, Vasso M, Braghetta P, Scotton C, Bonaldo P, Lochmüller H, Muntoni F, Ferlini A, Gelfi C (2014). Muscle proteomics reveals novel insights into the pathophysiological mechanisms of collagen VI myopathies.. J Proteome Res, , - . doi:10.1021/pr500675e
    • Voit T, Topaloglu H, Straub V, Muntoni F, Deconinck N, Campion G, De Kimpe SJ, Eagle M, Guglieri M, Hood S, Liefaard L, Lourbakos A, Morgan A, Nakielny J, Quarcoo N, Ricotti V, Rolfe K, Servais L, Wardell C, Wilson R, Wright P, Kraus JE (2014). Safety and efficacy of drisapersen for the treatment of Duchenne muscular dystrophy (DEMAND II): an exploratory, randomised, placebo-controlled phase 2 study.. Lancet Neurol, 13(10), 987 - 996. doi:10.1016/S1474-4422(14)70195-4
    • Thanopoulou I, Scoto M, Muntoni F, Martinez A (2014). A case of hyaline fibromatosis syndrome. JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, 12, 10 - 11.
    • Mazzone E, De Sanctis R, Fanelli L, Bianco F, Main M, van den Hauwe M, Ash M, de Vries R, Fagoaga Mata J, Schaefer K, D'Amico A, Colia G, Palermo C, Scoto M, Mayhew A, Eagle M, Servais L, Vigo M, Febrer A, Korinthenberg R, Jeukens M, de Viesser M, Totoescu A, Voit T, Bushby K, Muntoni F, Goemans N, Bertini E, Pane M, Mercuri E (2014). Hammersmith Functional Motor Scale and Motor Function Measure-20 in non ambulant SMA patients.. Neuromuscul Disord, , - . doi:10.1016/j.nmd.2014.01.003
    • Asgarian Z, Meng J, Ferrer V, Muntoni F, Morgan J, Danos O, Councell J (2014). A comparison of the factors influencing the transfer of full-length dystrophin cDNA via a recombinogenic lentivirus system.
    • Illingworth MA, Main M, Pitt M, Feng L, Sewry CA, Gunny R, Vorstman E, Beeson D, Manzur A, Muntoni F, Robb SA (2014). RYR1-related congenital myopathy with fatigable weakness, responding to pyridostigimine.. Neuromuscul Disord, , - . doi:10.1016/j.nmd.2014.05.003
    • Ayoglu B, Chaouch A, Lochmüller H, Politano L, Bertini E, Spitali P, Hiller M, Niks E, Gualandi F, Pontén F, Bushby K, Aartsma-Rus A, Schwartz E, Le Priol Y, Straub V, Uhlén M, Cirak S, 't Hoen PA, Muntoni F, Ferlini A, Schwenk JM, Nilsson P, Al-Khalili Szigyarto C (2014). Affinity proteomics within rare diseases: a BIO-NMD study for blood biomarkers of muscular dystrophies.. EMBO Mol Med, , - . doi:10.15252/emmm.201303724
    • Meng J, Chun S, Asfahani R, Lochmueller H, Muntoni F, Morgan J (2014). Human Skeletal Muscle-derived CD133(+) Cells Form Functional Satellite Cells After Intramuscular Transplantation in Immunodeficient Host Mice. MOLECULAR THERAPY, 22(5), 1008 - 1017. doi:10.1038/mt.2014.26
    • Rossor AM, Oates EC, Salter HK, Liu Y, Murphy SM, Schule R, Gonzalez MA, Scoto M, Phadke R, Sewry CA, Houlden H, Jordanova A, Tournev I, Chamova T, Litvinenko I, Zuchner S, Herrmann DN, Blake J, Sowden JE, Acsadi G, Rodriguez ML, Menezes MP, Clarke NF, Auer Grumbach M, Bullock SL, Muntoni F, Reilly MM, North KN (2014). Phenotypic and molecular insights into spinal muscular atrophy due to mutations in BICD2.. Brain, , - . doi:10.1093/brain/awu356

    2013

    • Garralda ME, McConachie H, Le Couteur A, Sriranjan S, Chakrabarti I, Cirak S, Guglieri M, Bushby K, Muntoni F (2013). Emotional impact of genetic trials in progressive paediatric disorders: a dose-ranging exon-skipping trial in Duchenne muscular dystrophy.. Child Care Health Dev, 39(3), 449 - 455. doi:10.1111/j.1365-2214.2012.01387.x
    • Cirak S, Foley AR, Herrmann R, Willer T, Yau S, Stevens E, Torelli S, Brodd L, Kamynina A, Vondracek P, Roper H, Longman C, Korinthenberg R, Marrosu G, Nürnberg P, UK10K Consortium , Michele DE, Plagnol V, Hurles M, Moore SA, Sewry CA, Campbell KP, Voit T, Muntoni F (2013). ISPD gene mutations are a common cause of congenital and limb-girdle muscular dystrophies.. Brain, 136(Pt 1), 269 - 281. doi:10.1093/brain/aws312
    • Ellis JA, Vroom E, Muntoni F (2013). 195th ENMC International Workshop: Newborn screening for Duchenne muscular dystrophy 14-16th December, 2012, Naarden, The Netherlands.. Neuromuscul Disord, , - . doi:10.1016/j.nmd.2013.05.008
    • Pitceathly RD, Rahman S, Wedatilake Y, Polke JM, Cirak S, Foley AR, Sailer A, Hurles ME, Stalker J, Hargreaves I, Woodward CE, Sweeney MG, Muntoni F, Houlden H, UK10K Consortium , Taanman JW, Hanna MG (2013). NDUFA4 Mutations Underlie Dysfunction of a Cytochrome c Oxidase Subunit Linked to Human Neurological Disease.. Cell Rep, , - . doi:10.1016/j.celrep.2013.05.005
    • Sanmaneechai O, Finkel R, Burns J, Muntoni F, Scherer S, Reilly M, Shy M (2013). Natural History Baseline of Hereditary Motor Sensory Peripheral Neuropathies That Caused by Mutations in the Myelin Protein Zero.
    • Sanmaneechai O, Laubenthal K, Shy R, Finkel R, Burns J, Muntoni F, Reilly M, Shy M (2013). The Charcot-Marie-Tooth (CMT) Infant Scale: A Pilot Study Testing the Ability of the Scale To Monitor Disease Progression in Infant and Children Younger Than Three Years Old.
    • Logan CV, Szabadkai G, Sharpe JA, Parry DA, Torelli S, Childs AM, Kriek M, Phadke R, Johnson CA, Roberts NY, Bonthron DT, Pysden KA, Whyte T, Munteanu I, Foley AR, Wheway G, Szymanska K, Natarajan S, Abdelhamed ZA, Morgan JE, Roper H, Santen GW, Niks EH, van der Pol WL, Lindhout D, Raffaello A, De Stefani D, den Dunnen JT, Sun Y, Ginjaar I, Sewry CA, Hurles M, Rizzuto R, UK10K Consortium , Duchen MR, Muntoni F, Sheridan E (2013). Loss-of-function mutations in MICU1 cause a brain and muscle disorder linked to primary alterations in mitochondrial calcium signaling.. Nat Genet, , - . doi:10.1038/ng.2851
    • Foley AR, Menezes MP, Pandraud A, Gonzalez MA, Al-Odaib A, Abrams AJ, Sugano K, Yonezawa A, Manzur AY, Burns J, Hughes I, McCullagh BG, Jungbluth H, Lim MJ, Lin JP, Megarbane A, Urtizberea JA, Shah AH, Antony J, Webster R, Broomfield A, Ng J, Mathew AA, O'Byrne JJ, Forman E, Scoto M, Prasad M, O'Brien K, Olpin S, Oppenheim M, Hargreaves I, Land JM, Wang MX, Carpenter K, Horvath R, Straub V, Lek M, Gold W, Farrell MO, Brandner S, Phadke R, Matsubara K, McGarvey ML, Scherer SS, Baxter PS, King MD, Clayton P, Rahman S, Reilly MM, Ouvrier RA, Christodoulou J, Züchner S, Muntoni F, Houlden H (2013). Treatable childhood neuronopathy caused by mutations in riboflavin transporter RFVT2.. Brain, , - . doi:10.1093/brain/awt315
    • Zaharieva IT, Calissano M, Scoto M, Preston M, Cirak S, Feng L, Collins J, Kole R, Guglieri M, Straub V, Bushby K, Ferlini A, Morgan JE, Muntoni F (2013). Dystromirs as serum biomarkers for monitoring the disease severity in duchenne muscular dystrophy.. PLoS One, 8(11), e80263 - . doi:10.1371/journal.pone.0080263
    • Scoto M, Cullup T, Cirak S, Yau S, Manzur AY, Feng L, Jacques TS, Anderson G, Abbs S, Sewry C, Jungbluth H, Muntoni F (2013). Nebulin (NEB) mutations in a childhood onset distal myopathy with rods and cores uncovered by next generation sequencing. EUROPEAN JOURNAL OF HUMAN GENETICS, 21(11), 1249 - 1252. doi:10.1038/ejhg.2013.31
    • Paco S, Kalko SG, Jou C, Rodríguez MA, Corbera J, Muntoni F, Feng L, Rivas E, Torner F, Gualandi F, Gomez-Foix AM, Ferrer A, Ortez C, Nascimento A, Colomer J, Jimenez-Mallebrera C (2013). Gene Expression Profiling Identifies Molecular Pathways Associated with Collagen VI Deficiency and Provides Novel Therapeutic Targets.. PLoS One, 8(10), e77430 - . doi:10.1371/journal.pone.0077430
    • Reza M, Laval SH, Counsell J, Muntoni F, Morgan J, Lochmuller H (2013). Optimised dystrophin mini-constructs for gene delivery. doi:10.1016/j.nmd.2013.06.691
    • Anthony K, Ricotti V, Guglieri M, Servais L, Voit T, Bushby K, Straub V, Morgan J, Muntoni F (2013). Assessing T cell-mediated immune response to dystrophin in the natural history of Duchenne muscular dystrophy. doi:10.1016/j.nmd.2013.06.705
    • Scoto M, Rossor A, Harms MB, Calissano M, Cirak S, Foley AR, Sewry C, Hafezparast M, Robb S, Manzur AY, Baloh RH, Reilly MM, Muntoni F (2013). Wide phenotypic spectrum of SMA with lower limbs predominance due to mutations in the tail domain of DYNC1H1 gene: A case series. doi:10.1016/j.nmd.2013.06.478
    • Ricotti V, Ridout DA, Mercuri E, Quinlivan R, Robb SA, Manzur AY, Muntoni F (2013). DYSTROPHINOPATHY: FUNCTIONAL EVALUATION AND ORGAN INVOLVMENT. doi:10.1016/j.nmd.2013.06.406
    • Oates EC, Rosser AM, Hafezparast M, Lek M, Scoto M, Greensmith L, Auer-Grumbach M, Schule R, Herrmann DN, Clarke NF, MacArthur DG, Zuechner S, Muntoni F, Reilly MM, North KN (2013). Mutations in a new dynein/dynactin adaptor gene cause Dominant Congenital Spinal Muscular Atrophy (DCSMA) and Hereditary Spastic Paraplegia (HSP). doi:10.1016/j.nmd.2013.06.560
    • Ricotti V, Scoto M, Mandy W, Entwistle K, Robb A, Pane M, Mercuri E, Skuse D, Muntoni F (2013). Neuropsychiatric comorbidities in Duchenne Muscular Dystrophy. doi:10.1016/j.nmd.2013.06.418
    • Feng L, Scoto M, Chambers D, Phadke R, Muntoni F, Sewry CA (2013). The presence of developmental and fetal/neonatal myosin in neonatal human muscle. doi:10.1016/j.nmd.2013.06.546
    • Scoto M, Cirak S, Whyte T, Foley AR, Pitt M, Polke J, Hurles ME, Manzur AY, Reilly MM, Muntoni F, Consortium UU (2013). An unusual double trouble of coexisting distal myopathy and distal motor neuropathy uncovered by exome sequencing. doi:10.1016/j.nmd.2013.06.435
    • Foley AR, Quijano-Roy S, Collins J, Straub V, McCallum M, Deconinck N, Mercuri E, Pane M, D'Amico A, Bertini E, North K, Ryan MM, Auh S, Muntoni F, Boennemann CG (2013). Natural history of pulmonary function in collagen VI-related myopathies: An international study. doi:10.1016/j.nmd.2013.06.386
    • Pitceathly RD, Taanman JW, Rahman S, Meunier B, Sadowski M, Cirak S, Hargreaves I, Land JM, Nanji T, Polke JM, Woodward CE, Sweeney MG, Solanki S, Foley AR, Hurles ME, Stalker J, Blake J, Holton JL, Phadke R, Muntoni F, Reilly MM, Hanna MG (2013). COX10 Mutations Resulting in Complex Multisystem Mitochondrial Disease That Remains Stable Into Adulthood. JAMA Neurol., , - . doi:10.1001/jamaneurol.2013.3242
    • Jaffer F, Reilly MM, Quinlivan R, Muntoni F, Turner C, Parton M, Lunn M, Hilton-Jones D, Korkodilos M, Hanna MG (2013). Emergency neuromuscular admissions are avoidable: a regional audit of unplanned hospital admissions of neuromuscular patients 2009-2011: final results and recommendations.. J Neurol Neurosurg Psychiatry, 84(11), e2 - . doi:10.1136/jnnp-2013-306573.7
    • Pitceathly RDS, Rahman S, Wedatilake Y, Polke JM, Cirak S, Foley AR, Sailer A, Hurles ME, Stalker J, Hargreaves I, Woodward CE, Sweeney MG, Muntoni F, Houlden H, Taanman J-W, Hanna MG (2013). NDUFA4 mutations underlie dysfunction of a cytochrome C oxidase subunit linked to human neurological disease. Cell Reports, 4(2), 402 - 402. doi:10.1016/j.celrep.2013.06.032
    • Stevens E, Torelli S, Feng L, Phadke R, Sewry CA, Muntoni F, Walter MC, Schneiderat P, Eddaoudi A (2013). Flow Cytometry for the Analysis of α-Dystroglycan Glycosylation in Fibroblasts from Patients with Dystroglycanopathies. PLoS ONE, 8(7), - . doi:10.1371/journal.pone.0068958
    • Rossor AM, Scoto M, Harms M, Baloh R, Houlden H, Sewry C, Manzur A, Muntoni F, Reilly MM (2013). THE PHENOTYPIC GENETIC SPECTRUM OF PATIENTS WITH MUTATIONS IN CYTOPLASMIC DYNEIN HEAVY CHAIN 1 (DYNC1H1).
    • Rossor AM, Oates EC, Hafezparast M, Cottenie E, Houlden H, Scoto M, Foley R, Clark N, Hermann DN, Grumbach AM, Zuchner S, Muntoni F, North K, Reilly MM (2013). A WINDOW INTO MOTOR NEURON DEVELOPMENT: WHOLE EXOME SEQUENCING OF DOMINANT CONGENITAL SPINAL MUSCULAR ATROPHY (DCSMA).
    • Burns J, Menezes MP, Shy R, Sanmaneechai O, Laura M, Muntoni F, Estilow T, Yum S, Finkel RS, Herrmann DN, Eichinger K, Moroni I, Pagliano E, Pareyson D, Reilly MM, Shy ME, Consortium IN (2013). TWO YEAR NATURAL HISTORY OF DISEASE PROGRESSION IN CHILDHOOD CHARCOT-MARIE-TOOTH DISEASE.
    • Sanmaneechai O, Laubenthal K, Shy R, Finkel RS, Burns J, Estilow T, Glanzman AM, Muntoni F, Reilly MM, Shy ME, INC-RDCRN (2013). THE CHARCOT-MARIE-TOOTH (CMT) DISEASE INFANT-TODDLER SCALE: DEVELOPING SCORING SYSTEM AND PILOT STUDY TESTING THE ABILITY OF THE SCALE TO ASSESS DISEASE SEVERITY IN INFANTS, TODDLERS AND SEVERELY AFFECTED CHILDREN WITH CMT.
    • Sanmaneechai O, Feely SME, Finkel RS, Burns J, Muntoni F, Scherer SS, Reilly MM, Shy ME, INC-RDCRN (2013). NATURAL HISTORY BASELINE PHENOTYPE AND GENOTYPE OF HEREDITARY MOTOR SENSORY PERIPHERAL NEUROPATHIES CAUSED BY MUTATION IN THE MYELIN PROTEIN ZERO.
    • Burns J, Menezes MP, Shy R, Sanmaneechai O, Laura M, Muntoni F, Estilow T, Yum S, Finkel RS, Herrmann DN, Eichinger K, Moroni I, Pagliano E, Pareyson D, Reilly MM, Shy ME, Consortium IN (2013). DETERMINANTS OF BALANCE DEFICIT IN CHILDREN WITH CHARCOT-MARIE-TOOTH DISEASE.
    • Mazzone E, Bianco F, Main M, van den Hauwe M, Ash M, de Vries R, Fagoaga Mata J, Stein S, De Sanctis R, D'Amico A, Palermo C, Fanelli L, Scoto MC, Mayhew A, Eagle M, Vigo M, Febrer A, Korinthenberg R, de Visser M, Bushby K, Muntoni F, Goemans N, Sormani MP, Bertini E, Pane M, Mercuri E (2013). Six minute walk test in type III spinal muscular atrophy: A 12month longitudinal study.. Neuromuscul Disord, , - . doi:10.1016/j.nmd.2013.06.001
    • Klein A, Pitt MC, McHugh JC, Niks EH, Sewry CA, Phadke R, Feng L, Manzur AY, Tirupathi S, DeVile C, Jayawant S, Finlayson S, Palace J, Muntoni F, Beeson D, Robb SA (2013). DOK7 congenital myasthenic syndrome in childhood: Early diagnostic clues in 23 children. Neuromuscular Disorders, , - .
    • Counsell J, Ferrer V, Meng J, Morgan J, Muntoni F, Danos O (2013). Development of a recombinogenic lentivirus for the delivery of full-length human dystrophin cDNA.
    • Meng J, Asfahani R, Chun S, Muntoni F, Morgan J (2013). Human skeletal muscle-derived AC133+cells form functional satellite cells after intramuscular transplantation into immunodeficient host mice.
    • Burns J, Menezes M, Finkel RS, Estilow T, Moroni I, Pagliano E, Laurá M, Muntoni F, Herrmann DN, Eichinger K, Shy R, Pareyson D, Reilly MM, Shy ME (2013). Transitioning outcome measures: relationship between the CMTPedS and CMTNSv2 in children, adolescents, and young adults with Charcot-Marie-Tooth disease.. J Peripher Nerv Syst, 18(2), 177 - 180. doi:10.1111/jns5.12024
    • Oates EC, Rossor AM, Hafezparast M, Gonzalez M, Speziani F, MacArthur DG, Lek M, Cottenie E, Scoto M, Foley AR, Hurles M, Houlden H, Greensmith L, Auer-Grumbach M, Pieber TR, Strom TM, Schule R, Herrmann DN, Sowden JE, Acsadi G, Menezes MP, Clarke NF, Züchner S, UK10K , Muntoni F, North KN, Reilly MM (2013). Mutations in BICD2 cause dominant congenital spinal muscular atrophy and hereditary spastic paraplegia.. Am J Hum Genet, 92(6), 965 - 973. doi:10.1016/j.ajhg.2013.04.018
    • Zhou H, Rokach O, Feng L, Munteanu I, Mamchaoui K, Wilmshurst JM, Sewry C, Manzur AY, Pillay K, Mouly V, Duchen M, Jungbluth H, Treves S, Muntoni F (2013). RyR1 deficiency in congenital myopathies disrupts excitation-contraction coupling.. Hum Mutat, 34(7), 986 - 996. doi:10.1002/humu.22326
    • Pane M, Scalise R, Berardinelli A, D'Angelo G, Ricotti V, Alfieri P, Moroni I, Hartley L, Pera MC, Baranello G, Catteruccia M, Casalino T, Romeo DM, Graziano A, Gandioli C, Bianco F, Mazzone ES, Lombardo ME, Scoto M, Sivo S, Palermo C, Gualandi F, Sormani MP, Ferlini A, Bertini E, Muntoni F, Mercuri E (2013). Early neurodevelopmental assessment in Duchenne muscular dystrophy.. Neuromuscul Disord, 23(6), 451 - 455. doi:10.1016/j.nmd.2013.02.012
    • Carss K, Stevens E, Foley A, Cirak S, Riemersma M, Torelli S, Hoischen A, Willer T, van Scherpenzeel M, Moore S, Messina S, Bertini E, Bönnemann C, Abdenur J, Grosmann C, Kesari A, Punetha J, Quinlivan R, Waddell L, Young H, Wraige E, Yau S, Brodd L, Feng L, Sewry C, MacArthur D, North K, Hoffman E, Stemple D, Hurles M, van Bokhoven H, Campbell K, Lefeber D, Lin Y-Y, Muntoni F (2013). Mutations in GDP-Mannose Pyrophosphorylase B Cause Congenital and Limb-Girdle Muscular Dystrophies Associated with Hypoglycosylation of α-Dystroglycan. American Journal of Human Genetics, , - .
    • Fletcher S, Meloni PL, Johnsen RD, Wong BL, Muntoni F, Wilton SD (2013). Antisense suppression of donor splice site mutations in the dystrophin gene transcript.. Mol Genet Genomic Med, 1(3), 162 - 173. doi:10.1002/mgg3.19
    • Fernandez-Fuente M, Martin-Duque P, Vassaux G, Brown SC, Muntoni F, Terracciano CM, Piercy RJ (2013). Adenovirus-mediated expression of myogenic differentiation factor 1 (MyoD) in equine and human dermal fibroblasts enables their conversion to caffeine-sensitive myotubes.. Neuromuscul Disord, , - . doi:10.1016/j.nmd.2013.11.009
    • Mercuri E, Muntoni F (2013). Muscular dystrophy: new challenges and review of the current clinical trials.. Curr Opin Pediatr, 25(6), 701 - 707. doi:10.1097/MOP.0b013e328365ace5
    • Gupta VA, Ravenscroft G, Shaheen R, Todd EJ, Swanson LC, Shiina M, Ogata K, Hsu C, Clarke NF, Darras BT, Farrar MA, Hashem A, Manton ND, Muntoni F, North KN, Sandaradura SA, Nishino I, Hayashi YK, Sewry CA, Thompson EM, Yau KS, Brownstein CA, Yu TW, Allcock RJ, Davis MR, Wallgren-Pettersson C, Matsumoto N, Alkuraya FS, Laing NG, Beggs AH (2013). Identification of KLHL41 Mutations Implicates BTB-Kelch-Mediated Ubiquitination as an Alternate Pathway to Myofibrillar Disruption in Nemaline Myopathy.. Am J Hum Genet, , - . doi:10.1016/j.ajhg.2013.10.020
    • Foley AR, Quijano-Roy S, Collins J, Straub V, McCallum M, Deconinck N, Mercuri E, Pane M, D'Amico A, Bertini E, North K, Ryan MM, Richard P, Allamand V, Hicks D, Lamandé S, Hu Y, Gualandi F, Auh S, Muntoni F, Bönnemann CG (2013). Natural history of pulmonary function in collagen VI-related myopathies.. Brain, , - . doi:10.1093/brain/awt284
    • Whitmore C, Fernandez-Fuente M, Booler H, Parr C, Kavishwar M, Ashraf A, Lacey E, Kim J, Terry R, Ackroyd MR, Wells KE, Muntoni F, Wells DJ, Brown SC (2013). The transgenic expression of LARGE exacerbates the muscle phenotype of dystroglycanopathy mice.. Hum Mol Genet, , - . doi:10.1093/hmg/ddt577
    • Anthony K, Arechavala-Gomeza V, Ricotti V, Torelli S, Feng L, Janghra N, Tasca G, Guglieri M, Barresi R, Armaroli A, Ferlini A, Bushby K, Straub V, Ricci E, Sewry C, Morgan J, Muntoni F (2013). Biochemical Characterization of Patients With In-Frame or Out-of-Frame DMD Deletions Pertinent to Exon 44 or 45 Skipping.. JAMA Neurol, , - . doi:10.1001/jamaneurol.2013.4908
    • Paco S, Kalko SG, Jou C, Rodriguez MA, Cusi V, Corbera J, Torner F, Muntoni F, Feng L, Rivas E, Nascimento A, Colomer J, Jimenez-Mallebrera C (2013). Gene expression profiling identifies molecular pathways associated with collagen VI deficiency. doi:10.1016/j.nmd.2013.06.389
    • Ravenscroft G, Miyatake S, Lehtokari V-L, Todd EJ, Vomauen P, Yau KS, Hayashi YK, Miyake N, Tsurusaki Y, Doi H, Saitsu H, Osaka H, Yamashita S, Ohya T, Sakamoto Y, Koshimizu E, Imamura S, Yamashita M, Ogata K, Shiina M, Bryson-Richardson RJ, Vaz R, Ceyhan O, Brownstein CA, Swanson LC, Monnot S, Romero NB, Amthor H, Kresoje N, Sivadorai P, Kiraly-Borri C, Haliloglu G, Talim B, Orhan D, Kale G, Charles AK, Fabian VA, Davis MR, Lammens M, Sewry CA, Manzur A, Muntoni F, Clarke NF, North KN, Bertini E, Nevo Y, Willichowski E, Silberg IE, Topaloglu H, Beggs AH, Allcock RJN, Nishino I, Wallgren-Pettersson C, Matsumoto N, laing NG (2013). Mutations in KLHL40 Are a Frequent Cause of Severe Autosomal-Recessive Nemaline Myopathy. AMERICAN JOURNAL OF HUMAN GENETICS, 93(1), 6 - 18. doi:10.1016/j.ajhg.2013.05.004
    • Aartsma-Rus A, Muntoni F (2013). 194th ENMC international workshop. 3rd ENMC workshop on exon skipping: Towards clinical application of antisense-mediated exon skipping for Duchenne muscular dystrophy 8-10 December 2012, Naarden, The Netherlands.. Neuromuscul Disord, , - . doi:10.1016/j.nmd.2013.06.369
    • Rokach O, Ullrich ND, Rausch M, Mouly V, Zhou H, Muntoni F, Zorzato F, Treves S (2013). Establishment of a human skeletal muscle-derived cell line: biochemical, cellular and electrophysiological characterization.. Biochem J, , - . doi:10.1042/BJ20130698
    • Yoshida-Moriguchi T, Willer T, Anderson ME, Venzke D, Whyte T, Muntoni F, Lee H, Nelson SF, Yu L, Campbell KP (2013). SGK196 Is a Glycosylation-Specific O-Mannose Kinase Required for Dystroglycan Function.. Science, , - . doi:10.1126/science.1239951
    • Mayhew AG, Cano SJ, Scott E, Eagle M, Bushby K, Manzur A, Muntoni F (2013). Detecting meaningful change using the North Star Ambulatory Assessment in Duchenne muscular dystrophy.. Dev Med Child Neurol, , - . doi:10.1111/dmcn.12220
    • Ricotti V, Ridout DA, Muntoni F (2013). Steroids in Duchenne muscular dystrophy. Neuromuscular Disorders, , - . doi:10.1016/j.nmd.2013.06.373
    • Quinlivan R, Mitsuahashi S, Sewry C, Cirak S, Aoyama C, Mooore D, Abbs S, Robb S, Newton T, Moss C, Birchall D, Sugimoto H, Bushby K, Guglieri M, Muntoni F, Nishino I, Straub V (2013). Muscular dystrophy with large mitochondria associated with mutations in the CHKB gene in three British patients: Extending the clinical and pathological phenotype. Neuromuscular Disorders, , - .
    • Dlamini N, Voermans NC, Lillis S, Stewart K, Kamsteeg EJ, Drost G, Quinlivan R, Snoeck M, Norwood F, Radunovic A, Straub V, Roberts M, Vrancken AF, van der Pol WL, de Coo RI, Manzur AY, Yau S, Abbs S, King A, Lammens M, Hopkins PM, Mohammed S, Treves S, Muntoni F, Wraige E, Davis MR, van Engelen B, Jungbluth H (2013). Mutations in RYR1 are a common cause of exertional myalgia and rhabdomyolysis.. Neuromuscul Disord, 23(7), 540 - 548. doi:10.1016/j.nmd.2013.03.008
    • Mitrpant C, Porensky P, Zhou H, Price L, Muntoni F, Fletcher S, Wilton SD, Burghes AH (2013). Improved antisense oligonucleotide design to suppress aberrant SMN2 gene transcript processing: towards a treatment for spinal muscular atrophy.. PLoS One, 8(4), e62114 - . doi:10.1371/journal.pone.0062114
    • Sarkozy A, Hicks D, Hudson J, Laval SH, Barresi R, Hilton-Jones D, Deschauer M, Harris E, Rufibach L, Hwang E, Bashir R, Walter MC, Krause S, van den Bergh P, Illa I, Pénisson-Besnier I, De Waele L, Turnbull D, Guglieri M, Schrank B, Schoser B, Seeger J, Schreiber H, Gläser D, Eagle M, Bailey G, Walters R, Longman C, Norwood F, Winer J, Muntoni F, Hanna M, Roberts M, Bindoff LA, Brierley C, Cooper RG, Cottrell DA, Davies NP, Gibson A, Gorman GS, Hammans S, Jackson AP, Khan A, Lane R, McConville J, McEntagart M, Al-Memar A, Nixon J, Panicker J, Parton M, Petty R, Price CJ, Rakowicz W, Ray P, Schapira AH, Swingler R, Turner C, Wagner KR, Maddison P, Shaw PJ, Straub V, Bushby K, Lochmüller H (2013). ANO5 gene analysis in a large cohort of patients with anoctaminopathy: confirmation of male prevalence and high occurrence of the common exon 5 gene mutation.. Hum Mutat, 34(8), 1111 - 1118. doi:10.1002/humu.22342
    • Mercuri E, Muntoni F (2013). Muscular dystrophies.. Lancet, 381(9869), 845 - 860. doi:10.1016/S0140-6736(12)61897-2
    • Stevens E, Carss KJ, Cirak S, Foley AR, Torelli S, Willer T, Tambunan DE, Yau S, Brodd L, Sewry CA, Feng L, Haliloglu G, Orhan D, Dobyns WB, Enns GM, Manning M, Krause A, Salih MA, Walsh CA, Hurles M, Campbell KP, Manzini MC, UK10K Consortium , Stemple D, Lin YY, Muntoni F (2013). Mutations in B3GALNT2 cause congenital muscular dystrophy and hypoglycosylation of α-dystroglycan.. Am J Hum Genet, 92(3), 354 - 365. doi:10.1016/j.ajhg.2013.01.016
    • Maggi L, Scoto M, Cirak S, Robb SA, Klein A, Lillis S, Cullup T, Feng L, Manzur AY, Sewry CA, Abbs S, Jungbluth H, Muntoni F (2013). Congenital myopathies--clinical features and frequency of individual subtypes diagnosed over a 5-year period in the United Kingdom.. Neuromuscul Disord, 23(3), 195 - 205. doi:10.1016/j.nmd.2013.01.004
    • McCormack P, Woods S, Aartsma-Rus A, Hagger L, Herczegfalvi A, Heslop E, Irwin J, Kirschner J, Moeschen P, Muntoni F, Ouillade MC, Rahbek J, Rehmann-Sutter C, Rouault F, Sejersen T, Vroom E, Straub V, Bushby K, Ferlini A (2013). Guidance in social and ethical issues related to clinical, diagnostic care and novel therapies for hereditary neuromuscular rare diseases: "translating" the translational.. PLoS Curr, 5, - . doi:10.1371/currents.md.f90b49429fa814bd26c5b22b13d773ec
    • Løseth S, Voermans NC, Torbergsen T, Lillis S, Jonsrud C, Lindal S, Kamsteeg EJ, Lammens M, Broman M, Dekomien G, Maddison P, Muntoni F, Sewry C, Radunovic A, de Visser M, Straub V, van Engelen B, Jungbluth H (2013). A novel late-onset axial myopathy associated with mutations in the skeletal muscle ryanodine receptor (RYR1) gene.. J Neurol, 260(6), 1504 - 1510. doi:10.1007/s00415-012-6817-7
    • Zhou H, Janghra N, Mitrpant C, Dickinson RL, Anthony K, Price L, Eperon IC, Wilton SD, Morgan J, Muntoni F (2013). A novel morpholino oligomer targeting ISS-N1 improves rescue of severe spinal muscular atrophy transgenic mice.. Hum Gene Ther, 24(3), 331 - 342. doi:10.1089/hum.2012.211
    • Rudnik-Schöneborn S, Senderek J, Jen JC, Houge G, Seeman P, Puchmajerová A, Graul-Neumann L, Seidel U, Korinthenberg R, Kirschner J, Seeger J, Ryan MM, Muntoni F, Steinlin M, Sztriha L, Colomer J, Hübner C, Brockmann K, Van Maldergem L, Schiff M, Holzinger A, Barth P, Reardon W, Yourshaw M, Nelson SF, Eggermann T, Zerres K (2013). Pontocerebellar hypoplasia type 1: clinical spectrum and relevance of EXOSC3 mutations.. Neurology, 80(5), 438 - 446. doi:10.1212/WNL.0b013e31827f0f66
    • Burke G, Hiscock A, Klein A, Niks EH, Main M, Manzur AY, Ng J, de Vile C, Muntoni F, Beeson D, Robb S (2013). Salbutamol benefits children with congenital myasthenic syndrome due to DOK7 mutations.. Neuromuscul Disord, 23(2), 170 - 175. doi:10.1016/j.nmd.2012.11.004
    • Mahjneh I, Lochmüller H, Muntoni F, Abicht A (2013). DOK7 limb-girdle myasthenic syndrome mimicking congenital muscular dystrophy.. Neuromuscul Disord, 23(1), 36 - 42. doi:10.1016/j.nmd.2012.06.355

    2012

    • Adkin CF, Meloni PL, Fletcher S, Adams AM, Muntoni F, Wong B, Wilton SD (2012). Multiple exon skipping strategies to by-pass dystrophin mutations.. Neuromuscul Disord, 22(4), 297 - 305. doi:10.1016/j.nmd.2011.10.007
    • Baumann M, Giunta C, Krabichler B, Rüschendorf F, Zoppi N, Colombi M, Bittner RE, Quijano-Roy S, Muntoni F, Cirak S, Schreiber G, Zou Y, Hu Y, Romero NB, Carlier RY, Amberger A, Deutschmann A, Straub V, Rohrbach M, Steinmann B, Rostásy K, Karall D, Bönnemann CG, Zschocke J, Fauth C (2012). Mutations in FKBP14 cause a variant of Ehlers-Danlos syndrome with progressive kyphoscoliosis, myopathy, and hearing loss.. Am J Hum Genet, 90(2), 201 - 216. doi:10.1016/j.ajhg.2011.12.004
    • Cullup T, Lamont PJ, Cirak S, Damian MS, Wallefeld W, Gooding R, Tan SV, Sheehan J, Muntoni F, Abbs S, Sewry CA, Dubowitz V, Laing NG, Jungbluth H (2012). Mutations in MYH7 cause Multi-minicore Disease (MmD) with variable cardiac involvement.. Neuromuscul Disord, 22(12), 1096 - 1104. doi:10.1016/j.nmd.2012.06.007
    • Cirak S, Foley RA, Herrmann R, Willer T, Elisabeth S, Yau M, Brodd L, Torelli S, Kamynina A, Vondracek P, Roper H, Longman C, Korinthenberg R, Marrosu G, Nurnberg P, Plagnol V, Hurles M, Sewry CA, Campbell KP, Voit T, Muntoni F, Consortium WTU (2012). Mutations in the human isoprenoid synthase domain containing gene are a common cause of congenital and limb girdle muscular dystrophies. doi:10.1016/j.nmd.2012.06.036
    • Ricotti V, Theodorou M, Jaegle H, Muntoni F, Thompson DA (2012). Ocular characteristics of Duchenne Muscular Dystrophy. doi:10.1016/j.nmd.2012.06.280
    • Zhou H, Janghra N, Anthony K, Morgan J, Muntoni F (2012). A morpholino antisense oligonucleotide rescues type I and type III SMA mice.
    • Bochukova E, Schoenmakers N, Agostini M, Schoenmakers E, Rajanayagam O, Keogh JM, Henning E, Reinemund J, Gevers E, Sarri M, Downes K, Offiah A, Albanese A, Halsall D, Schwabe JW, Bain M, Lindley K, Muntoni F, Vargha-Khadem F, Dattani M, Farooqi IS, Gurnell M, Chatterjee K (2012). A mutation in the thyroid hormone receptor alpha gene.. N Engl J Med, 366(3), 243 - 249. doi:10.1056/NEJMoa1110296
    • Jonuschies J, Boldrin L, Thrasher A, Muntoni F, Morgan J (2012). Assessment of potential promoters for lentiviral gene therapy in DMD.
    • Jaffer F, Murphy SM, Scoto M, Healy E, Rossor AM, Brandner S, Phadke R, Selcen D, Jungbluth H, Muntoni F, Reilly MM (2012). BAG3 mutations: another cause of giant axonal neuropathy.. J Peripher Nerv Syst, 17(2), 210 - 216. doi:10.1111/j.1529-8027.2012.00409.x
    • Anthony K, Arechavala-Gomeza V, Ricotti V, Torelli S, Feng L, Tasca G, Guglieri M, Barresi R, Armaroli A, Ferlini A, Bushby K, Straub V, Ricci E, Sewry C, Morgan J, Muntoni F (2012). Biochemical and clinical variability of Becker muscular dystrophy: Predicting optimal target exons for exon skipping therapy in Duchenne muscular dystrophy. doi:10.1016/j.nmd.2012.06.196
    • Zaharieva I, Cirak S, Kotelnikova E, Mazo I, Ferlini A, Morgan J, Muntoni F (2012). BIO-NMD: Identifying genomic pre-clinical biomarkers for diagnostics and therapeutics of Duchenne muscular dystrophy. doi:10.1016/j.nmd.2012.06.266
    • Fletcher S, Adkin CF, Meloni P, Wong B, Muntoni F, Kole R, Fragall C, Greer K, Johnsen R, Wilton SD (2012). Targeted exon skipping to address "leaky" mutations in the dystrophin gene.. Mol Ther Nucleic Acids, 1, e48 - . doi:10.1038/mtna.2012.40
    • Reza M, Laval S, Muntoni F, Bushby K, Straub V, Morgan J, Lochmueller H (2012). Optimal dystrophin mini-construct for gene delivery to skeletal muscle.
    • Pane M, Messina S, Vasco G, Foley AR, Morandi L, Pegoraro E, Mongini T, D'Amico A, Bianco F, Lombardo ME, Scalise R, Bruno C, Berardinelli A, Pini A, Moroni I, Mora M, Toscano A, Moggio M, Comi G, Santorelli FM, Bertini E, Muntoni F, Mercuri E (2012). Respiratory and cardiac function in congenital muscular dystrophies with alpha dystroglycan deficiency.. Neuromuscul Disord, 22(8), 685 - 689. doi:10.1016/j.nmd.2012.05.006
    • Cirak S, Feng L, Anthony K, Arechavala-Gomeza V, Torelli S, Sewry C, Morgan JE, Muntoni F (2012). Restoration of the dystrophin-associated glycoprotein complex after exon skipping therapy in Duchenne muscular dystrophy.. Mol Ther, 20(2), 462 - 467. doi:10.1038/mt.2011.248
    • Ross J, Lechertier T, Morgan J, Muntoni F, Hodivala-Dilke K, Conti F (2012). Roles of alpha 3-integrin in development of the neuromuscular system.
    • Zhou H, Feng L, Munteanu I, Duchen M, Treves S, Jungbluth H, Muntoni F (2012). RyR1 deficiency in congenital myopathies disrupts excitation-contraction coupling and induces the second calcium release system via IP3R.
    • Burns J, Ouvrier R, Estilow T, Shy R, Laurá M, Eichinger K, Muntoni F, Reilly MM, Pareyson D, Acsadi G, Shy ME, Finkel RS (2012). Symmetry of foot alignment and ankle flexibility in paediatric Charcot-Marie-Tooth disease.. Clin Biomech (Bristol, Avon), 27(7), 744 - 747. doi:10.1016/j.clinbiomech.2012.02.006
    • Neri M, Valli E, Alfano G, Bovolenta M, Spitali P, Rapezzi C, Muntoni F, Banfi S, Perini G, Gualandi F, Ferlini A (2012). The absence of dystrophin brain isoform expression in healthy human heart ventricles explains the pathogenesis of 5' X-linked dilated cardiomyopathy.. BMC Med Genet, 13, 20 - . doi:10.1186/1471-2350-13-20
    • Burns J, Ouvrier R, Estilow T, Shy R, Laurá M, Pallant JF, Lek M, Muntoni F, Reilly MM, Pareyson D, Acsadi G, Shy ME, Finkel RS (2012). Validation of the Charcot-Marie-Tooth disease pediatric scale as an outcome measure of disability.. Ann Neurol, 71(5), 642 - 652. doi:10.1002/ana.23572
    • Feng L, Phadke R, Muntoni F, Sewry C (2012). What do MHCn and MHCd antibodies recognise?.
    • Arechavala-Gomeza V, Anthony K, Morgan J, Muntoni F (2012). Antisense oligonucleotide-mediated exon skipping for Duchenne muscular dystrophy: progress and challenges.. Curr Gene Ther, 12(3), 152 - 160.
    • Whitmore C, Booler H, Terry R, Ashraf A, Parr C, Ackroyd MR, Fernandez-Fuente M, Muntoni F, Wells DJ, Brown SC (2012). Assessing the therapeutic potential of LARGE in a mouse model for the limb girdle muscular dystrophies.
    • Zaharieva I, Cirak S, Kole R, Ferlini A, Morgan J, Muntoni F (2012). BIO-NMD: Identifying serum miRNAs as biomarkers for diagnosis and monitoring therapeutic interventions in Duchenne Muscular Dystrophy. doi:10.1016/j.nmd.2012.06.265
    • Jungbluth H, Dowling JJ, Ferreiro A, Muntoni F (2012). 182nd ENMC International Workshop: RYR1-related myopathies, 15-17th April 2011, Naarden, The Netherlands.. Neuromuscul Disord, 22(5), 453 - 462. doi:10.1016/j.nmd.2011.12.003
    • Clement EM, Feng L, Mein R, Sewry CA, Robb SA, Manzur AY, Mercuri E, Godfrey C, Cullup T, Abbs S, Muntoni F (2012). Relative frequency of congenital muscular dystrophy subtypes: analysis of the UK diagnostic service 2001-2008.. Neuromuscul Disord, 22(6), 522 - 527. doi:10.1016/j.nmd.2012.01.010
    • Popplewell L, Arechavala V, Saleh A, Muntoni F, Gait M, Dickson G (2012). The next DMD exon skipping trial: selection of AO target.
    • Mercuri E, Muntoni F (2012). The ever-expanding spectrum of congenital muscular dystrophies.. Ann Neurol, 72(1), 9 - 17. doi:10.1002/ana.23548
    • Stevens E, Caress K, Torelli S, Lin Y-Y, Cirak S, Foley R, Stemple D, Hurles M, Muntoni F (2012). Validation of novel secondary dystroglycanopathy genes using biochemical, cellular and zebrafish studies.
    • Main M, Hiscock A, Selby V, Muntoni F (2012). Using the Motor Function Measure (MFM) in the assessment of children with Charcot-Marie-Tooth (CMT)1A; strengths and limitations. doi:10.1016/j.nmd.2012.06.294
    • Stevens E, Carss K, Cirak S, Torelli S, Foley AR, Sewry C, Topaloglu H, Haliloglu G, Stemple D, Hurles M, Lin YY, Muntoni F (2012). Validation of novel secondary dystroglycanopathy genes using biochemical, cellular and zebrafish studies. doi:10.1016/j.nmd.2012.06.035
    • Trump N, Cullup T, Verheij JB, Manzur A, Muntoni F, Abbs S, Jungbluth H (2012). X-linked myotubular myopathy due to a complex rearrangement involving a duplication of MTM1 exon 10.. Neuromuscul Disord, 22(5), 384 - 388. doi:10.1016/j.nmd.2011.11.004
    • Klein A, Lillis S, Munteanu I, Scoto M, Zhou H, Quinlivan R, Straub V, Manzur AY, Roper H, Jeannet P-Y, Rakowicz W, Jones DH, Jensen UB, Wraige E, Trump N, Schara U, Lochmuller H, Sarkozy A, Kingston H, Norwood F, Damian M, Kirschner J, Longman C, Roberts M, Auer-Grumbach M, Hughes I, Bushby K, Sewry C, Robb S, Abbs S, Jungbluth H, Muntoni F (2012). Clinical and genetic findings in a large cohort of patients with ryanodine receptor 1 gene associated myopathies (vol 33, pg 981, 2012). HUMAN MUTATION, 33(8), 1310 - 1310. doi:10.1002/humu.22136
    • Klein A, Lillis S, Munteanu I, Scoto M, Zhou H, Quinlivan R, Straub V, Manzur AY, Roper H, Jeannet PY, Rakowicz W, Jones DH, Jensen UB, Wraige E, Trump N, Schara U, Lochmuller H, Sarkozy A, Kingston H, Norwood F, Damian M, Kirschner J, Longman C, Roberts M, Auer-Grumbach M, Hughes I, Bushby K, Sewry C, Robb S, Abbs S, Jungbluth H, Muntoni F (2012). Clinical and genetic findings in a large cohort of patients with ryanodine receptor 1 gene-associated myopathies.. Hum Mutat, 33(6), 981 - 988. doi:10.1002/humu.22056
    • Meilleur KG, Jain M, Kim E, Hynan L, Shieh CY, Waite M, Duong T, Glanzman A, Main M, Rose K, McGuire M, Bendixen R, Foley R, Donkervoort S, Schindler A, Kokkinis A, Hartnett EJ, Leach M, Dastgir J, North K, Muntoni F, Rutkowski A, Bonnemann CG (2012). Clinical outcome measures in Collagen 6 (COL6) and Laminin alpha 2(LAMA2) related congenital muscular dystrophy. doi:10.1016/j.nmd.2012.06.296
    • Lillis S, Abbs S, Mueller CR, Muntoni F, Jungbluth H (2012). Clinical utility gene card for: Central core disease.. Eur J Hum Genet, 20(2), - . doi:10.1038/ejhg.2011.179
    • Lillis S, Abbs S, Ferreiro A, Muntoni F, Jungbluth H (2012). Clinical utility gene card for: Multi-minicore disease.. Eur J Hum Genet, 20(2), - . doi:10.1038/ejhg.2011.180
    • Ross J, Benn A, Jonuschies J, Boldrin L, Muntoni F, Morgan JE, Hewitt JE, Brown SC (2012). Defects in glycosylation impair satellite stem cell function and niche composition in the muscles of the dystrophic large mouse. Stem Cells, 30(10), 2330 - 2341. doi:10.1002/stem.1197
    • Scott E, Eagle M, Mayhew A, Freeman J, Main M, Sheehan J, Manzur A, Muntoni F, North Star Clinical Network for Paediatric Neuromuscular Disease (2012). Development of a functional assessment scale for ambulatory boys with Duchenne muscular dystrophy.. Physiother Res Int, 17(2), 101 - 109. doi:10.1002/pri.520
    • Mahjneh I, Lochmueller H, Muntoni F, Abicht A (2012). DOK 7 limb girdle myasthenic syndrome mimicking congenital muscular dystrophy. doi:10.1016/j.nmd.2012.06.096
    • Boldrin L, Neal A, Zammit PS, Muntoni F, Morgan JE (2012). Donor satellite cell engraftment is significantly augmented when the host niche is preserved and endogenous satellite cells are incapacitated.. Stem Cells, 30(9), 1971 - 1984. doi:10.1002/stem.1158
    • Johnson JO, Gibbs JR, Megarbane A, Urtizberea JA, Hernandez DG, Foley AR, Arepalli S, Pandraud A, Simón-Sánchez J, Clayton P, Reilly MM, Muntoni F, Abramzon Y, Houlden H, Singleton AB (2012). Exome sequencing reveals riboflavin transporter mutations as a cause of motor neuron disease.. Brain, 135(Pt 9), 2875 - 2882. doi:10.1093/brain/aws161
    • Cazzella V, Martone J, Pinnarò C, Santini T, Twayana SS, Sthandier O, D'Amico A, Ricotti V, Bertini E, Muntoni F, Bozzoni I (2012). Exon 45 Skipping Through U1-snRNA Antisense Molecules Recovers the Dys-nNOS Pathway and Muscle Differentiation in Human DMD Myoblasts. Molecular Therapy, , - .
    • Arechavala-Gomeza V, Cirak S, Anthony K, Morgan J, Muntoni F (2012). Exon-skipping therapy for Duchenne muscular dystrophy - Authors' reply.. Lancet, 379(9811), e10 - e11. doi:10.1016/S0140-6736(12)60064-6
    • Kim J, Jimenez-Mallebrera C, Foley AR, Fernandez-Fuente M, Brown SC, Torelli S, Feng L, Sewry CA, Muntoni F (2012). Flow cytometry analysis: a quantitative method for collagen VI deficiency screening.. Neuromuscul Disord, 22(2), 139 - 148. doi:10.1016/j.nmd.2011.08.006
    • Davidson G, Murphy S, Polke J, Laura M, Salih M, Muntoni F, Blake J, Brandner S, Davies N, Horvath R, Price S, Donaghy M, Roberts M, Foulds N, Ramdharry G, Soler D, Lunn M, Manji H, Davis M, Houlden H, Reilly M (2012). Frequency of mutations in the genes associated with hereditary sensory and autonomic neuropathy in a UK cohort.. J Neurol, 259(8), 1673 - 1685. doi:10.1007/s00415-011-6397-y
    • Pandraud A, Johnson JO, Singleton AB, Clayton P, Land J, Hargreaves I, Foley AR, Muntoni F, Reilly MM, Houlden H (2012). Genetic and functional investigation of Brown-Vialetto-Van Laere syndrome and related neuropathies.
    • Foley AR, Phadke R, Feng L, Sewry CA, Muntoni F (2012). Getting to the core of the matter: cores as a common muscle pathology finding in the collagen VI-related myopathies.
    • Foley AR, Phadke R, Feng L, Sewry CA, Muntoni F (2012). Getting to the core of the matter: Cores as a common muscle pathology finding in the collagen VI-related myopathies. doi:10.1016/j.nmd.2012.06.087
    • Foley AR, Broomfield AA, Pandraud A, Johnson JO, Singleton AB, Hargreaves IP, Land JM, Grunewald S, Rahman S, Clayton P, Houlden H, Reilly MM, Muntoni F (2012). High-dose riboflavin therapy in Brown-Vialetto-Van Laere syndrome: clinical and biochemical improvement.
    • Munteanu I, Zhou H, Hargreaves I, Yasukawa T, Duchen MR, Muntoni F (2012). Investigating mitochondria in cell culture models of core myopathies.
    • Pandraud A, Clayton P, Foley AR, Muntoni F, Johnson JO, Singleton AB, Reilly MM, Houlden H (2012). INVESTIGATION OF RIBOFLAVIN TRANSPORTER MUTATIONS IN BROWN-VIALETTO-VAN LAERE SYNDROME, A POTENTIALLY TREATABLE METABOLIC DISEASE. JOURNAL OF INHERITED METABOLIC DISEASE, 35, S18 - S18.
    • Harms MB, Ori-McKenney KM, Scoto M, Tuck EP, Bell S, Ma D, Masi S, Allred P, Al-Lozi M, Reilly MM, Miller LJ, Jani-Acsadi A, Pestronk A, Shy ME, Muntoni F, Vallee RB, Baloh RH (2012). Mutations in the tail domain of DYNC1H1 cause dominant spinal muscular atrophy.. Neurology, 78(22), 1714 - 1720. doi:10.1212/WNL.0b013e3182556c05
    • Scoto M, Cullup T, Cirak S, Yau M, Feng L, Manzur A, Jungbluth H, Abbs S, Sewry C, Muntoni F (2012). Nebulin mutations in a childhood onset distal myopathy with rods and cores uncovered by next generation sequencing.
    • Jain RK, Jayawant S, Squier W, Muntoni F, Sewry CA, Manzur A, Quinlivan R, Lillis S, Jungbluth H, Sparrow JC, Ravenscroft G, Nowak KJ, Memo M, Marston SB, Laing NG (2012). Nemaline myopathy with stiffness and hypertonia associated with an ACTA1 mutation.. Neurology, 78(14), 1100 - 1103. doi:10.1212/WNL.0b013e31824e8ebe
    • Ricotti V, Mandy WPL, Robb SA, Skuse DH, Muntoni F (2012). Neurobehavioural disorders in Duchenne Muscular dystrophy.
    • Ricotti V, Scoto M, Mandy WPL, Entwistle K, Robb SA, Mercuri E, Skuse DH, Muntoni F (2012). Neurobehavioural disorders in Duchenne Muscular Dystrophy. doi:10.1016/j.nmd.2012.06.278
    • Muntoni F (2012). Novel Neuromuscular Diseases. doi:10.1016/j.nmd.2012.06.011
    • Thompson D, Jaegle H, Theodorou M, Moore T, Ricotti V, Muntoni F (2012). Ocular findings in Duchenne muscular dystrophy - an observational case series.
    • Zaharieva I, Cirak S, Morgan J, Muntoni F (2012). Identifying genomic pre-clinical biomarkers for diagnostics and therapeutics of Duchenne muscular dystrophy.
    • Anthony K, Cirak S, Torelli S, Tasca G, Feng L, Arechavala-Gomeza V, Armaroli A, Guglieri M, Straathof C, Verschuuren J, Artsma-Rus A, Helderman-van den Enden P, Bushby K, Straub V, Sewry C, Ferlini A, Ricci E, Morgan J, Muntoni F (2012). Correlation of internally deleted dystrophin and dystrophin-associated protein expression with clinical severity in Becker muscular dystrophy.
    • Arechavala-Gomeza V, Feng L, Morgan JE, Muntoni F (2012). Correspondence: Measuring dystrophin-faster is not necessarily better.. Nat Rev Neurol, 8(8), 469 - . doi:10.1038/nrneurol.2012.15-c1
    • Scoto M, Baloh RH, Cirak S, Harms M, Cooper P, Feng L, Sewry C, Manzur A, Muntoni F (2012). Cytoplasmic Dynein Heavy Chain 1 causes autosomal recessive congenital distal SMA.
    • Main M, Hiscock A, Muntoni F (2012). Dislocating patellae in children with CMT1a. doi:10.1016/j.nmd.2012.06.220
    • Anthony K, Feng L, Arechavala-Gomeza V, Guglieri M, Straub V, Bushby K, Cirak S, Morgan J, Muntoni F (2012). Exon skipping quantification by quantitative reverse-transcription polymerase chain reaction in Duchenne muscular dystrophy patients treated with the antisense oligomer eteplirsen.. Hum Gene Ther Methods, 23(5), 336 - 345. doi:10.1089/hgtb.2012.117
    • Stevens E, Torelli S, Feng L, Sewry C, Muntoni F (2012). Flow cytometry in the assessment of functional alpha-dystroglycan glycosylation in dystroglycanopathy patient fibroblasts.
    • Willer T, Lee H, Lommel M, Yoshida-Moriguchi T, de Bernabe DB, Venzke D, Cirak S, Schachter H, Vajsar J, Voit T, Muntoni F, Loder AS, Dobyns WB, Winder TL, Strahl S, Mathews KD, Nelson SF, Moore SA, Campbell KP (2012). ISPD loss-of-function mutations disrupt dystroglycan O-mannosylation and cause Walker-Warburg syndrome.. Nat Genet, 44(5), 575 - 580. doi:10.1038/ng.2252
    • Ricotti V, Ridout DA, Scott E, Quinlivan R, Robb SA, Manzur AY, Muntoni F, Manzur A, Robb S, Main M, Bushby K, Straub V, Sarkozy A, Guglieri M, Strehle E, Eagle M, Mayhew A, Roper H, McMurchie H, Childs A, Pysden K, Pallant L, Spinty S, Peachey G, Shillington A, Wraige E, Jungbluth H, Sheehan J, Spahr R, Hughes I, Bateman E, Cammiss C, Willis T, Groves L, Emery N, Baxter P, Senior M, Hartley L, Parsons B, Majumdar A, Jenkins L, Naismith K, Keddie A, Horrocks I, Di Marco M, Chow G, Miah A, de Goede C, Thomas N, Geary M, Palmer J, White C, Greenfield K (2012). Long-term benefits and adverse effects of intermittent versus daily glucocorticoids in boys with Duchenne muscular dystrophy. Journal of Neurology, Neurosurgery and Psychiatry, , - .
    • Reza M, Johnson D, Cox D, Laval S, Chaouch A, Barresi R, Morgan J, Bushby K, Straub V, Muntoni F, Lochmueller H (2012). MRC NMD Centre Biobank: An overview.

    2011

    • Murphy SM, Davidson GL, Laura M, Salih MAM, Muntoni F, Lunn MP, Blake J, Bull K, Brandner S, Polke J, Davis M, Houlden H, Reilly MM (2011). GENETIC MUTATION FREQUENCY IN PATIENTS WITH HEREDITARY SENSORY AND AUTONOMIC NEUROPATHIES (HSAN).
    • Asfahani R, Meng J, Muntoni F, Morgan JE (2011). Human skeletal-muscle derived CD133+cells as a promising tool for cell therapy of Duchenne muscular dystrophy.
    • Robb SA, Sewry CA, Dowling JJ, Feng L, Cullup T, Lillis S, Abbs S, Lees MM, Laporte J, Manzur AY, Knight RK, Mills KR, Pike MG, Kress W, Beeson D, Jungbluth H, Pitt MC, Muntoni F (2011). Impaired neuromuscular transmission and response to acetylcholinesterase inhibitors in centronuclear myopathies.. Neuromuscul Disord, 21(6), 379 - 386. doi:10.1016/j.nmd.2011.02.012
    • Kinali M, Arechavala-Gomeza V, Cirak S, Glover A, Guglieri M, Feng L, Hollingsworth KG, Hunt D, Jungbluth H, Roper HP, Quinlivan RM, Gosalakkal JA, Jayawant S, Nadeau A, Hughes-Carre L, Manzur AY, Mercuri E, Morgan JE, Straub V, Bushby K, Sewry C, Rutherford M, Muntoni F (2011). Muscle histology vs MRI in Duchenne muscular dystrophy.. Neurology, 76(4), 346 - 353. doi:10.1212/WNL.0b013e318208811f
    • Klein A, Jungbluth H, Clement E, Lillis S, Abbs S, Munot P, Pane M, Wraige E, Schara U, Straub V, Mercuri E, Muntoni F (2011). Muscle magnetic resonance imaging in congenital myopathies due to ryanodine receptor type 1 gene mutations.. Arch Neurol, 68(9), 1171 - 1179. doi:10.1001/archneurol.2011.188
    • Feng LH, Scoto M, Phadke R, Lillis S, Cullup T, Mein R, Abbs S, Muntoni F, Sewry CA (2011). Muscle pathology in a large cohort of cases with SEPN1 mutations. doi:10.1016/j.nmd.2011.06.939
    • Reza M, Laval S, Morgan JE, Muntoni F, Bushby K, Straub V, Lochmuller H (2011). Optimal dystrophin mini-construct for gene delivery to skeletal muscle.
    • Heywood W, Mills KA, Carreno G, Mills PB, Worthington V, Clayton PT, Muntoni F, Grunewald S (2011). IDENTIFICATION OF C1INHIBITOR AS A POTENTIAL BIOMARKER FOR N- AND O-LINKED CONGENITAL DISORDERS OF GLYCOSYLATION (CDG). JOURNAL OF INHERITED METABOLIC DISEASE, 34, S182 - S182.
    • Zaharieva I, Cirak S, Morgan JE, Muntoni F (2011). Identifying genomic pre-clinical biomarkers for diagnostics and therapeutics of Duchenne muscular dystrophy.
    • Guergueltcheva V, Müller JS, Dusl M, Senderek J, Oldfors A, Lindbergh C, Maxwell S, Colomer J, Mallebrera CJ, Nascimento A, Vilchez JJ, Muelas N, Kirschner J, Nafissi S, Kariminejad A, Nilipour Y, Bozorgmehr B, Najmabadi H, Rodolico C, Sieb JP, Schlotter B, Schoser B, Herrmann R, Voit T, Steinlein OK, Najafi A, Urtizberea A, Soler DM, Muntoni F, Hanna MG, Chaouch A, Straub V, Bushby K, Palace J, Beeson D, Abicht A, Lochmüller H (2011). Congenital myasthenic syndrome with tubular aggregates caused by GFPT1 mutations.. J Neurol, , - . doi:10.1007/s00415-011-6262-z
    • Owen N, Zhou H, Malygin AA, Sangha J, Smith LD, Muntoni F, Eperon IC (2011). Design principles for bifunctional targeted oligonucleotide enhancers of splicing.. Nucleic Acids Res, 39(16), 7194 - 7208. doi:10.1093/nar/gkr152
    • Ricotti V, Roberts RG, Muntoni F (2011). Dystrophin and the brain.. Dev Med Child Neurol, 53(1), 12 - .
    • Garralda ME, Kinali M, Cirak S, Bushby K, Guglieri M, Straub V, Muntoni F (2011). Emotional impact of a paediatric exon-skipping therapy trial.. Dev Med Child Neurol, 53(12), 1157 - 1159. doi:10.1111/j.1469-8749.2011.04128.x
    • Treves S, Vukcevic M, Jeannet PY, Levano S, Girard T, Urwyler A, Fischer D, Voit T, Jungbluth H, Lillis S, Muntoni F, Quinlivan R, Sarkozy A, Bushby K, Zorzato F (2011). Enhanced excitation-coupled Ca(2+) entry induces nuclear translocation of NFAT and contributes to IL-6 release from myotubes from patients with central core disease.. Hum Mol Genet, 20(3), 589 - 600. doi:10.1093/hmg/ddq506
    • Godfrey C, Clement E, Abbs S, Muntoni F (2011). EXCLUSION OF WWP1 MUTATIONS IN A COHORT OF DYSTROGLYCANOPATHY PATIENTS. MUSCLE NERVE, 44(3), 388 - 392. doi:10.1002/mus.22068
    • Yis U, Uyanik G, Heck PB, Smitka M, Nobel H, Ebinger F, Dirik E, Feng L, Kurul SH, Brocke K, Unalp A, Özer E, Cakmakci H, Sewry C, Cirak S, Muntoni F, Hehr U, Morris-Rosendahl DJ (2011). Fukutin mutations in non-Japanese patients with congenital muscular dystrophy: less severe mutations predominate in patients with a non-Walker-Warburg phenotype.. Neuromuscul Disord, 21(1), 20 - 30. doi:10.1016/j.nmd.2010.08.007
    • Ackroyd MR, Whitmore C, Prior S, Kaluarachchi M, Nikolic M, Mayer U, Muntoni F, Brown SC (2011). Fukutin-related protein alters the deposition of laminin in the eye and brain.. J Neurosci, 31(36), 12927 - 12935. doi:10.1523/JNEUROSCI.2301-11.2011
    • Whitmore C, Ackroyd MR, Ashraf A, Muntoni F, Brown SC (2011). Generation of a new mouse model for therapeutic testing in the dystroglycanopathies.
    • Whitmore C, Ackroyd MR, Ashraf A, Alyoshkin B, Muntoni F, Brown SC (2011). Generation of a new mouse model for therapeutic testing in the dystroglycanopathies. doi:10.1016/j.nmd.2011.06.835
    • Dowling JJ, Lillis S, Amburgey K, Zhou HY, Al-Sarraj S, Buk SJA, Wraige E, Chow G, Abbs S, Leber S, Lachlan K, Baralle D, Taylor A, Sewry C, Muntoni F, Jungbluth H (2011). King-Denborough syndrome with and without mutations in the skeletal muscle ryanodine receptor (RYR1) gene. NEUROMUSCULAR DISORD, 21(6), 420 - 427. doi:10.1016/j.nmd.2011.03.006
    • Ackroyd MR, Whitmore C, Nikolic M, Mayer U, Muntoni F, Brown SC (2011). Novel insight in muscle and brain involvement in dystroglycanopathies.
    • Mayhew A, Cano S, Scott E, Eagle M, Bushby K, Muntoni F, North Star Clinical Network for Paediatric Neuromuscular Disease (2011). Moving towards meaningful measurement: Rasch analysis of the North Star Ambulatory Assessment in Duchenne muscular dystrophy.. Dev Med Child Neurol, 53(6), 535 - 542. doi:10.1111/j.1469-8749.2011.03939.x
    • Tosetti M, Linsalata S, Battini R, Volpi L, Cini C, Presciutti O, Muntoni F, Cioni G, Siciliano G (2011). Muscle metabolic alterations assessed by 31-phosphorus magnetic resonance spectroscopy in mild Becker muscular dystrophy.. Muscle Nerve, 44(5), 816 - 819. doi:10.1002/mus.22181
    • Muntoni F, Torelli S, Wells DJ, Brown SC (2011). Muscular dystrophies due to glycosylation defects: diagnosis and therapeutic strategies.. Curr Opin Neurol, 24(5), 437 - 442. doi:10.1097/WCO.0b013e32834a95e3
    • Logan CV, Lucke B, Pottinger C, Abdelhamed ZA, Parry DA, Szymanska K, Diggle CP, van Riesen A, Morgan JE, Markham G, Ellis I, Manzur AY, Markham AF, Shires M, Helliwell T, Scoto M, Hübner C, Bonthron DT, Taylor GR, Sheridan E, Muntoni F, Carr IM, Schuelke M, Johnson CA (2011). Mutations in MEGF10, a regulator of satellite cell myogenesis, cause early onset myopathy, areflexia, respiratory distress and dysphagia (EMARDD).. Nat Genet, 43(12), 1189 - 1192. doi:10.1038/ng.995
    • Quinlivan R, Nishino I, Mitsuahashi S, Ayoyama C, Sewry C, Muntoni F, Cirak S, Robb S, Moore D, Abbs S, Bushby K, Straub V (2011). Myopathy associated with mutations in CHKB in three UK patients. doi:10.1016/j.nmd.2011.06.943
    • Dlamini N, Voermans NC, Lillis S, Abbs S, Kamsteeg E, Al-Sarraj S, Lammens M, Muntoni F, Quinlivan R, Wraige E, van Engelen B, Jungbluth H (2011). Mutations in the skeletal muscle ryanodine receptor (RYR1) gene presenting with exertional myalgia and rhabdomyolysis. doi:10.1016/j.nmd.2011.06.1109
    • Mamchaoui K, Trollet C, Bigot A, Negroni E, Chaouch S, Wolff A, Kandalla PK, Marie S, Di Santo J, St Guily JL, Muntoni F, Kim J, Philippi S, Spuler S, Levy N, Blumen SC, Voit T, Wright WE, Aamiri A, Butler-Browne G, Mouly V (2011). Immortalized pathological human myoblasts: towards a universal tool for the study of neuromuscular disorders.. Skelet Muscle, 1, 34 - . doi:10.1186/2044-5040-1-34
    • Loseth S, Lillis S, Torbergsen T, Jonsrud C, Lindal S, Maddison P, Muntoni F, Sewry C, Abbs S, Straub V, Jungbluth H (2011). An adult-onset, slowly progressive axial myopathy with cataracts due to mutations in the skeletal muscle ryanodine receptor (RYR1) gene. doi:10.1016/j.nmd.2011.06.937
    • Muller T, Cirak S, Parton M, Lunn M, Hanna MG, Muntoni F (2011). An integrative database for clinical and research studies in neuromuscular diseases.
    • Whitmore C, Ackroyd MR, Muses S, Ashraf A, Muntoni F, Brown SC, Wells DJ (2011). Assessing the therapeutic potential of LARGE in a new mouse model of dystroglycanopathy. doi:10.1016/j.nmd.2011.06.838
    • Mazzone E, Bianco F, Martinelli D, Glanzman AM, Messina S, De Sanctis R, Main M, Eagle M, Florence J, Krosschell K, Vasco G, Pelliccioni M, Lombardo M, Pane M, Finkel R, Muntoni F, Bertini E, Mercuri E (2011). Assessing upper limb function in nonambulant SMA patients: development of a new module.. Neuromuscul Disord, 21(6), 406 - 412. doi:10.1016/j.nmd.2011.02.014
    • Jonuschies J, Boldrin L, Thrasher A, Morgan JE, Muntoni F (2011). Assessment of potential promoters for lentiviral gene therapy in DMD. HUM GENE THER, 22(10), A5 - A5.
    • Jonuschies J, Boldrin L, Thrasher A, Morgan JE, Muntoni F (2011). Assessment of potential promoters for lentiviral gene therapy in DMD. HUM GENE THER, 22(10), A62 - A63.
    • Ricotti V, Manzur AY, Scott E, Muntoni F, NorthStar CN (2011). Benefits and adverse effects of glucocorticoids in boys with Duchenne Muscular Dystrophy. doi:10.1016/j.nmd.2011.06.970
    • Straub V, Aartsma-Rus A, Szigyarto CAK, Beroud C, Bonaldo P, Borgiani P, Braghetta P, Chaouch A, Cirak S, Courtot L, Daraselia N, Gelfi C, 't Hoen PAC, Kotelnikova E, Le Priol Y, Lochmueller H, Morgan J, Muntoni F, Novelli G, Paolillo N, Tanzi R, Turner C, Uhlen M, Ferlini A (2011). BIO-NMD: Discovery and validation of biomarkers for neuromuscular diseases (NMDs) - An EU funded FP7 project. doi:10.1016/j.nmd.2011.06.812
    • Bönnemann CG, Rutkowski A, Mercuri E, Muntoni F, CMD Outcomes Consortium (2011). 173rd ENMC International Workshop: congenital muscular dystrophy outcome measures 5-7 March 2010, Naarden, The Netherlands.. Neuromuscul Disord, 21(7), 513 - 522. doi:10.1016/j.nmd.2011.04.004
    • Laura M, Murphy SM, Rossor A, Hiscock A, Main M, Shy ME, Muntoni F, Reilly MM (2011). Charcot-Marie-Tooth disease and related disorders: a natural history study.
    • Anthony K, Morgan JE, Muntoni F (2011). Quantification of exon skipping in Duchenne muscular dystrophy by qRT-PCR.
    • Meng J, Muntoni F, Morgan JE (2011). Stem cells to treat muscular dystrophies - where are we?. Neuromuscul Disord, 21(1), 4 - 12. doi:10.1016/j.nmd.2010.10.004
    • Matthews E, Manzur AY, Sud R, Muntoni F, Hanna MG (2011). Stridor as a neonatal presentation of skeletal muscle sodium channelopathy.. Arch Neurol, 68(1), 127 - 129. doi:10.1001/archneurol.2010.347
    • Boldrin L, Zammit PS, Muntoni F, Morgan JE (2011). The host muscle environment has got a profound effect on satellite cell function.
    • Aartsma-Rus A (2011). The risks of therapeutic misconception and individual patient (n=1) "trials" in rare diseases such as Duchenne dystrophy.. Neuromuscul Disord, 21(1), 13 - 15. doi:10.1016/j.nmd.2010.09.012
    • Feng L, Phadke R, Jungbluth H, Lillis S, Cullup T, Chambers D, Abbs S, Muntoni F, Sewry C (2011). The spectrum of genetic defects responsible for congenital fibre type disproportion.
    • Pitceathly RDS, He J, Foley AR, Muntoni F, Pearson N, Hanna MG (2011). Whole genome analysis in a family with dominant muscle disease.
    • Trump N, Cullup T, Muntoni F, Verheij J, Jungbluth H (2011). X-linked myotubular myopathy due to a complex rearrangement involving exon 10 of the myotubularin (MTM1) gene. doi:10.1016/j.nmd.2011.06.932
    • Lin YY, White RJ, Torelli S, Cirak S, Muntoni F, Stemple DL (2011). Zebrafish Fukutin family proteins link the unfolded protein response with dystroglycanopathies.
    • Malerba A, Sharp PS, Graham IR, Arechavala-Gomeza V, Foster K, Muntoni F, Wells DJ, Dickson G (2011). Chronic systemic therapy with low-dose morpholino oligomers ameliorates the pathology and normalizes locomotor behavior in mdx mice.. Mol Ther, 19(2), 345 - 354. doi:10.1038/mt.2010.261
    • Fernandez-Fuente M, Terracciano CM, Pilsworth R, Muntoni F, Brown SC, Piercy RJ (2011). Characterisation of sarcoplasmic reticulum calcium release in equine and human myotubes derived from MyoD-transformed fibroblasts. doi:10.1016/j.nmd.2011.06.938
    • Muntoni F (2011). Antisense therapy of muscular dystrophies.
    • Heemskerk H, Meng J, Chun S, Asfahani R, Muntoni F, Morgan J (2011). Assessment of the variability between human AC133+stem cells of different donors in delivery to skeletal muscle and subsequent contribution to muscle regeneration. HUM GENE THER, 22(10), A62 - A62.
    • Ricotti V, Manzur AY, Scott E, Muntoni F, NorthStar Clinical Network (2011). Benefits and adverse effects of glucocorticoids in boys with Duchenne muscular dystrophy: a UK perspective.
    • Hara Y, Balci-Hayta B, Yoshida-Moriguchi T, Kanagawa M, de Bernabe DBV, Gundesli H, Willer T, Satz JS, Crawford RW, Burden SJ, Kunz S, Oldstone MBA, Accardi A, Talim B, Muntoni F, Topaloglu H, Dincer P, Campbell KP (2011). BRIEF REPORT A Dystroglycan Mutation Associated with Limb-Girdle Muscular Dystrophy. NEW ENGL J MED, 364(10), 939 - 946.
    • Hara Y, Balci-Hayta B, Yoshida-Moriguchi T, Kanagawa M, Beltrán-Valero de Bernabé D, Gündeşli H, Willer T, Satz JS, Crawford RW, Burden SJ, Kunz S, Oldstone MB, Accardi A, Talim B, Muntoni F, Topaloğlu H, Dinçer P, Campbell KP (2011). A dystroglycan mutation associated with limb-girdle muscular dystrophy.. N Engl J Med, 364(10), 939 - 946. doi:10.1056/NEJMoa1006939
    • Scoto M, Cirak S, Mein R, Feng L, Manzur AY, Robb S, Childs AM, Quinlivan RM, Roper H, Hilton-Jones D, Longman C, Chow G, Pane M, Main M, Hanna MG, Bushby K, Sewry C, Abbs S, Mercuri E, Muntoni F (2011). SEPN1 related myopathies: Clinical course in a large cohort of patients.
    • Feng LH, Phadke R, Lillis S, Cullup T, Chambers D, Abbs S, Muntoni F, Sewry C (2011). Pathological features resembling congenital fibre type disproportion linked to a number of different genetic defects.
    • Uusimaa J, Jungbluth H, Fratter C, Bailey EMFV, Crisponi BG, Feng L, Zeviani M, Hughes I, Treacy E, Birks J, Brown GK, Sewry C, Muntoni F, Poulton J (2011). Reversible infantile respiratory chain deficiency is a genetically heterogenous mitochondrial disease.
    • Malfatti E, Martinez VG, Von der Hagen M, Chabalier D, Quijano-Roy S, David O, Moghadaszadeh B, Bonne-Mann C, Bushby K, Castiglioni C, Ceuterick C, Chaigne D, Colomer J, Desguerre I, De Visser M, Elcioglu N, Eymard B, Fidzianska A, Goemans N, Jungbluth H, Kaindl A, Labarre-Vila A, Schlotter-Weigel B, Leroy JP, Lochmuller H, Mayer M, Voit T, Martin JJ, Straub V, Stoetter M, Merlini L, Bertini E, Pellegrini N, Quinlivan R, Romero NB, Sewry C, Topaloglu H, Toutain A, Beggs A, Salih M, Urtizberea A, Van der Kooi A, Viollet L, Fardeau M, Muntoni F, Guicheney P, Richard P, Estournet B, Schara U, Ferreiro A (2011). Phenotype, Genetics and Natural History in 146 Patients with SEPN1-Related Myopathy: On the Way to Therapeutic Trials in a Rare Disorder.
    • Joanna P, Jungbluth H, Fatter C, Bailey EMFV, Crisponi G, Feng L, Zeviani M, Hughes I, Treacy E, Birks J, Brown GK, Sewry C, Muntoni F, Uusimaa J (2011). Reversible Infantile Respiratory Chain Deficiency is a Genetically Heterogenous Mitochondrial Disease.
    • Uusimaa J, Jungbluth H, Fratter C, Crisponi G, Feng L, Zeviani M, Hughes I, Treacy EP, Birks J, Brown GK, Sewry CA, McDermott M, Muntoni F, Poulton J (2011). Reversible infantile respiratory chain deficiency is a unique, genetically heterogenous mitochondrial disease.. J Med Genet, 48(10), 660 - 668. doi:10.1136/jmg.2011.089995
    • Shrewsbury SB, Cirak S, Guglieri M, Bushby K, Muntoni F (2011). Safety, Pharmacokinetic and Exploratory Efficacy of AVI-4658 a Phosphorodiamidate Morpholino Oligomer (PMO) To Skip Exon 51 in Duchenne Muscular Dystrophy Patients.
    • Scoto M, Cirak S, Mein R, Feng L, Manzur AY, Robb S, Childs AM, Quinlivan RM, Roper H, Jones DH, Longman C, Chow G, Pane M, Main M, Hanna MG, Bushby K, Sewry C, Abbs S, Mercuri E, Muntoni F (2011). SEPN1-related myopathies: clinical course in a large cohort of patients.. Neurology, 76(24), 2073 - 2078. doi:10.1212/WNL.0b013e31821f467c
    • Read J, Kinali M, Muntoni F, Weaver T, Garralda ME (2011). Siblings of young people with Duchenne muscular dystrophy--a qualitative study of impact and coping.. Eur J Paediatr Neurol, 15(1), 21 - 28. doi:10.1016/j.ejpn.2010.07.006
    • Muntoni F, Wood MJ (2011). Targeting RNA to treat neuromuscular disease.. Nat Rev Drug Discov, 10(8), 621 - 637. doi:10.1038/nrd3459
    • Main ML, Selby V, Muntoni F (2011). The effect of joint hypermobility on children with neuromuscular disorders: Considerations for natural history studies and the interpretation of outcome measures. doi:10.1016/j.nmd.2011.06.768
    • Foley AR, Quijano-Roy S, Collins J, Straub V, Deconinck N, Mercuri E, D'Amico A, Bertini E, Ryan M, Muntoni F, Bonnemann C (2011). The identification of a viable outcome measure in the collagen VI myopathies promotes progress toward clinical trials.
    • Foley AR, Quijano-Roy S, Collins J, Straub V, Deconinck N, Mercuri E, D'Amico A, Bertini E, North K, Ryan M, Rummey C, Meier T, Cole T, Muntoni F, Bonnemann C (2011). The identification of a viable outcome measure in the collagen VI myopathies promotes progress toward clinical trials. doi:10.1016/j.nmd.2011.06.828
    • Sewry C, Jungbluth H, Feng L, Muntoni F (2011). The pathological spectrum associated with mutations in the skeletal muscle ryanodine receptor (RYR1) gene.
    • Sewry C, Jungbluth H, Feng L, Muntoni F (2011). The pathological spectrum associated with mutations in the skeletal muscle ryanodine receptor (RYR1) gene.
    • Ambegaonkar G, Manzur AY, Robb SA, Kinali M, Muntoni F (2011). The multiple phenotypes of arthrogryposis multiplex congenita with reference to the neurogenic variant.. Eur J Paediatr Neurol, 15(4), 316 - 319. doi:10.1016/j.ejpn.2011.01.007
    • Lu QL, Yokota T, Takeda S, Garcia L, Muntoni F, Partridge T (2011). The status of exon skipping as a therapeutic approach to duchenne muscular dystrophy.. Mol Ther, 19(1), 9 - 15. doi:10.1038/mt.2010.219
    • Stevens E, Torelli S, Tinsley J, Muntoni F (2011). The versatility of flow cytometry in the assessment of functional alpha-dystroglycan glycosylation. doi:10.1016/j.nmd.2011.06.837
    • Lin YY, White RJ, Torelli S, Cirak S, Muntoni F, Stemple DL (2011). Zebrafish Fukutin family proteins link the unfolded protein response with dystroglycanopathies.. Hum Mol Genet, 20(9), 1763 - 1775. doi:10.1093/hmg/ddr059
    • Klein A, Lillis S, Oprea I, Scoto M, Robb S, Manzur A, Straub V, Roper H, Jeannet PY, Kingston H, Jensen UB, Wraige E, Trump N, Rakowicz W, Roberts M, Longman C, Lochmuller H, Bushby K, Hughes MI, Abbs S, Jungbluth H, Muntoni F (2011). Clinical and genetic findings in a large cohort of patients with congenital myopathies due to mutations in the skeletal muscle ryanodine receptor (RYR1) gene. doi:10.1016/j.nmd.2011.06.935
    • Cirak S, Olmez A, Karasoy H, Bakouche B, Heise M, Muntoni F, Winkler J, Topaloglu H, Uyanik G (2011). Clinical phenotype and novel mutations in Alsin related motorneuron disease.
    • Shrewsbury SB, Sazani P, Muntoni F (2011). Comparative pharmacokinetics (PK) in primates and humans of AVI-4658, a phosphorodiamidate morpholino oligomer (PMO) for treating DMD patients. doi:10.1016/j.nmd.2011.06.770
    • Maggi L, Scoto M, Cirak S, Feng L, Lillis S, Cullup T, Robb S, Manzur A, Sewry CA, Abbs S, Jungbluth H, Muntoni F (2011). Congenital myopathies - clinical features and frequency of individual subtypes diagnosed in a five-year period: the UK experience. doi:10.1016/j.nmd.2011.06.925
    • Meng J, Adkin CF, Xu SW, Muntoni F, Morgan JE (2011). Contribution of human muscle-derived cells to skeletal muscle regeneration in dystrophic host mice.. PLoS One, 6(3), e17454 - . doi:10.1371/journal.pone.0017454
    • Jungbluth H, Sewry CA, Muntoni F (2011). Core myopathies.. Semin Pediatr Neurol, 18(4), 239 - 249. doi:10.1016/j.spen.2011.10.005
    • Farmer S, Lorain S, Thrasher A, Garcia L, Muntoni F, Conti F (2011). Correction of FKRP function via RNA trans-splicing.
    • Farmer S, Lorain S, Thrasher A, Garcia L, Muntoni F, Conti F (2011). Correction of FKRP function via RNA trans-splicing. doi:10.1016/j.nmd.2011.06.1016
    • Burns J, Finkel R, Estilow T, Hiscock A, Laura M, Swingle P, Patzko A, Glanzman A, Acsadi G, Muntoni F, Reilly M, Pareyson D, Moroni I, Pagliano E, Ramchandren S, Eichinger K, Ryan M, Ouvrier R, Shy M, Shy R (2011). Development, Reliability and Validity of the Charcot-Marie-Tooth Disease Pediatric Scale (CMTPedS).
    • Burns J, Finkel R, Estilow T, Hiscock A, Laura M, Swingle P, Patzko A, Glanzman A, Acsadi G, Muntoni F, Reilly MM, Pareyson D, Moroni I, Pagliano E, Ramchandren S, Eichinger K, Ryan M, Ouvrier RA, Shy R, Shy ME (2011). DEVELOPMENT, RELIABILITY AND VALIDITY OF THE CHARCOT-MARIE-TOOTH DISEASE PEDIATRIC SCALE (CMTPEDS).
    • Mercuri E, Bushby K, McDonald C, Goemans N, Muntoni F, Darras BT, Elfring GL, Barth J, Reha A, Peltz SW (2011). Disease progression observed in clinical outcome measures in placebo-treated patients with nonsense mutation dystrophinopathy. doi:10.1016/j.nmd.2011.06.793
    • Duchen MR, Heath K, Baruch NB, Hanna MG, Muntoni F (2011). Dysregulation of calcium and mitochondrial function as potential therapeutic targets in muscle disease.
    • Godfrey C, Foley AR, Clement E, Muntoni F (2011). Dystroglycanopathies: coming into focus.. Curr Opin Genet Dev, 21(3), 278 - 285. doi:10.1016/j.gde.2011.02.001
    • Anthony K, Cirak S, Torelli S, Tasca G, Feng L, Arechavala-Gomeza V, Armaroli A, Guglieri M, Straathof CS, Verschuuren JJ, Aartsma-Rus A, Helderman-van den Enden P, Bushby K, Straub V, Sewry C, Ferlini A, Ricci E, Morgan JE, Muntoni F (2011). Dystrophin quantification and clinical correlations in Becker muscular dystrophy: implications for clinical trials.. Brain, 134(Pt 12), 3547 - 3559. doi:10.1093/brain/awr291
    • Treves S, Vukcevic M, Jeannet PY, Levano S, Girard T, Urwyler A, Fischer D, Voit T, Jungbluth H, Lillis S, Muntoni F, Quinlivan R, Sarkozy A, Bushby K, Zorzato F (2011). Enhanced excitation-coupled Ca2+ entry induces nuclear translocation of NFAT and contributes to IL-6 release from myotubes from patients with central core disease (vol 20, pg 589, 2011). HUM MOL GENET, 20(10), 2079 - 2079. doi:10.1093/hmg/ddr083
    • Cirak S, Arechavala-Gomeza V, Guglieri M, Feng L, Torelli S, Anthony K, Garralda ME, Wells D, Dickson G, Wood MJA, Wilton SD, Straub V, Shrewsbury SB, Sewry C, Morgan JE, Bushby K, Muntoni F (2011). Exon skipping and dystrophin restoration in Duchenne muscular dystrophy patients after systemic phosphorodiamidate morpholino oligomer treatment.
    • Cirak S, Arechavala-Gomeza V, Guglieri M, Feng L, Torelli S, Anthony K, Abbs S, Garralda ME, Bourke J, Wells DJ, Dickson G, Wood MJ, Wilton SD, Straub V, Kole R, Shrewsbury SB, Sewry C, Morgan JE, Bushby K, Muntoni F (2011). Exon skipping and dystrophin restoration in patients with Duchenne muscular dystrophy after systemic phosphorodiamidate morpholino oligomer treatment: an open-label, phase 2, dose-escalation study.. Lancet, 378(9791), 595 - 605. doi:10.1016/S0140-6736(11)60756-3
    • Burns J, Finkel R, Estilow T, Hiscock A, Laura M, Swingle P, Patzko A, Glanzman A, Acsadi G, Muntoni F, Reilly MM, Pareyson D, Moroni I, Pagliano E, Ramchandren S, Eichinger K, Ryan M, Ouvrier RA, Shy R, Shy ME (2011). FOOT AND ANKLE SYMMETRY IN CHARCOT-MARIE-TOOTH DISEASE.
    • Murphy SM, Davidson GL, Laura M, Salih M, Muntoni F, Lunn M, Blake J, Brandner S, Polke J, Davies M, Houlden H, Reilly MM (2011). Genetic mutation frequency in patients with hereditary sensory and autonomic neuropathies (HSAN).

    2010

    • Zhou H, Owen N, Muntoni F, Eperon IC (2010). Antisense approaches in SMA.
    • Schoenmakers E, Agostini M, Mitchell C, Schoenmakers N, Papp L, Rajanayagam O, Padidela R, Ceron-Gutierrez L, Doffinger R, Prevosto C, Luan J, Montano S, Lu J, Castanet M, Clemons N, Groeneveld M, Castets P, Karbaschi M, Aitken S, Dixon A, Williams J, Campi I, Blount M, Burton H, Muntoni F, O'Donovan D, Dean A, Warren A, Brierley C, Baguley D, Guicheney P, Fitzgerald R, Coles A, Gaston H, Todd P, Holmgren A, Khanna KK, Cooke M, Semple R, Halsall D, Wareham N, Schwabe J, Grasso L, Beck-Peccoz P, Ogunko A, Dattani M, Gurnell M, Chatterjee K (2010). Mutations in the selenocysteine insertion sequence-binding protein 2 gene lead to a multisystem selenoprotein deficiency disorder in humans.. J Clin Invest, 120(12), 4220 - 4235. doi:10.1172/JCI43653
    • Boldrin L, Muntoni F, Morgan JE (2010). Are Human and Mouse Satellite Cells Really the Same?. HEALTH TECHNOL ASSES, 14(42), 941 - 955. doi:10.1369/jhc.2010.956201
    • Reilly MM, Shy ME, Muntoni F, Pareyson D (2010). 168th ENMC International Workshop: outcome measures and clinical trials in Charcot-Marie-Tooth disease (CMT).. Neuromuscul Disord, 20(12), 839 - 846. doi:10.1016/j.nmd.2010.08.001
    • Walmsley GL, Arechavala-Gomeza V, Fernandez-Fuente M, Burke MM, Nagel N, Holder A, Stanley R, Chandler K, Marks SL, Muntoni F, Shelton GD, Piercy RJ (2010). A duchenne muscular dystrophy gene hot spot mutation in dystrophin-deficient cavalier king charles spaniels is amenable to exon 51 skipping.. PLoS One, 5(1), e8647 - . doi:10.1371/journal.pone.0008647
    • Muntoni F, Bushby K, Sebahattin C, Guglieri M, Leow S, Shrewsbury SB (2010). Preliminary Results with AVI-4658 of Dystrophin Expression, Safety and Pharmacokinetics from the First Systemic Administration Study in Boys with Duchene Muscular Dystrophy (DMD), with a Phosphorodiamidate Morpholino Oligomer (PMO) to Skip Exon 51.
    • Read J, Kinali M, Muntoni F, Garralda ME (2010). Psychosocial adjustment in siblings of young people with Duchenne muscular dystrophy.. Eur J Paediatr Neurol, 14(4), 340 - 348. doi:10.1016/j.ejpn.2009.09.011
    • Clarke NF, Waddell LB, Cooper ST, Perry M, Smith RL, Kornberg AJ, Muntoni F, Lillis S, Straub V, Bushby K, Guglieri M, King MD, Farrell MA, Marty I, Lunardi J, Monnier N, North KN (2010). Recessive mutations in RYR1 are a common cause of congenital fiber type disproportion.. Hum Mutat, 31(7), E1544 - E1550. doi:10.1002/humu.21278
    • Robb SA, Muntoni F, Simonds AK (2010). Respiratory management of congenital myasthenic syndromes in childhood: Workshop 8th December 2009, UCL Institute of Neurology, London, UK.. Neuromuscul Disord, 20(12), 833 - 838. doi:10.1016/j.nmd.2010.08.002
    • Arechavala-Gomeza V, Kinali M, Feng L, Guglieri M, Edge G, Main M, Hunt D, Lehovsky J, Straub V, Bushby K, Sewry CA, Morgan JE, Muntoni F (2010). Revertant fibres and dystrophin traces in Duchenne muscular dystrophy: implication for clinical trials.. Neuromuscul Disord, 20(5), 295 - 301. doi:10.1016/j.nmd.2010.03.007
    • Kim J, Arechavala V, Muntoni F (2010). The characterisation of out of frame duplications in DMD patients.
    • Meng J, Adkin CF, Arechavala-Gomeza V, Boldrin L, Muntoni F, Morgan JE (2010). The contribution of human synovial stem cells to skeletal muscle regeneration.. Neuromuscul Disord, 20(1), 6 - 15. doi:10.1016/j.nmd.2009.11.007
    • Munteanu I, Yasukawa T, Duchen MR, Muntoni F (2010). Uncovering the role of mitochondria in the pathogenesis of core myopathies.
    • Sewry CA, Holton JH, Dick DJ, Jacques TS, Muntoni F, Hanna MG (2010). Zebra body myopathy resolved.
    • Malerba A, Sharp P, Graham I, Arechavala V, Foster K, Morgan JE, Muntoni F, Wells D, Dickson G (2010). Chronic long term administration of phosphorodiamidate morpholino oligomer profoundly ameliorates activity, muscle strength and phenotype in dystrophic mdx mice.
    • Malerba A, Sharp P, Graham IR, Arechavala-Gomeza V, Foster K, Morgan JE, Muntoni F, Wells D, Dickson G (2010). Clinically Applicable Dosing Regimens of Phosphorodiamidate Morpholino Oligomer Profoundly Improve Behaviour, Activity, and Dystrophic phenotype in mdx mice.
    • Jungbluth H, Cullup T, Lillis S, Zhou H, Abbs S, Sewry C, Muntoni F (2010). Centronuclear myopathy with cataracts due to a novel dynamin 2 (DNM2) mutation.. Neuromuscul Disord, 20(1), 49 - 52. doi:10.1016/j.nmd.2009.10.005
    • Acsadi G, Shy R, Dias A, Estilow T, Muntoni F, Reilly M, Shy M, Finkel R, Burns J (2010). Pediatric Neuropathy Scale (CMTPed) for Charcot-Marie-Tooth Disease (CMT).
    • Forrest S, Meloni PL, Muntoni F, Kim J, Fletcher S, Wilton SD (2010). Personalized exon skipping strategies to address clustered non-deletion dystrophin mutations.. Neuromuscul Disord, 20(12), 810 - 816. doi:10.1016/j.nmd.2010.07.276
    • Muntoni F, Cirak SS, Guglieri M, Arechavala V, Morgan JE, Feng L, Torelli S, Bhardwaj N, Sewry CA, Straub V, Shrewsbury S, Bushby K (2010). Results of a systemic antisense study in Duchenne muscular dystrophy.
    • McCauley J, Storey H, Ashton E, Muntoni F, Yau S, Abbs S (2010). Sequencing the DMD gene - review of results from 300+ cases.
    • Wilmshurst JM, Lillis S, Zhou H, Pillay K, Henderson H, Kress W, Müller CR, Ndondo A, Cloke V, Cullup T, Bertini E, Boennemann C, Straub V, Quinlivan R, Dowling JJ, Al-Sarraj S, Treves S, Abbs S, Manzur AY, Sewry CA, Muntoni F, Jungbluth H (2010). RYR1 mutations are a common cause of congenital myopathies with central nuclei.. Ann Neurol, 68(5), 717 - 726. doi:10.1002/ana.22119
    • Read J, Simonds A, Kinali M, Muntoni F, Garralda ME (2010). Sleep and well-being in young men with neuromuscular disorders receiving non-invasive ventilation and their carers.. Neuromuscul Disord, 20(7), 458 - 463. doi:10.1016/j.nmd.2010.05.011
    • Muntoni F, Meeting Steering Committee and TREAT-NMD Network (2010). The development of antisense oligonucleotide therapies for Duchenne muscular dystrophy: report on a TREAT-NMD workshop hosted by the European Medicines Agency (EMA), on September 25th 2009.. Neuromuscul Disord, 20(5), 355 - 362. doi:10.1016/j.nmd.2010.03.005
    • Brockington M, Torelli S, Sharp PS, Liu K, Cirak S, Brown SC, Wells DJ, Muntoni F (2010). Transgenic overexpression of LARGE induces α-dystroglycan hyperglycosylation in skeletal and cardiac muscle.. PLoS One, 5(12), e14434 - . doi:10.1371/journal.pone.0014434
    • Choudhury R, Barreto G, Ganeshaguru K, Cirax S, Scoto M, Muntoni F, Guglieri M, Straub V, Bell G, Speed C, Bourke J, Bushby K, Quinlivan R, Jones R, Hunt A (2010). Translation related clinical trials in duchenne muscular dystrophy (DMD) in the UK.
    • Manzur AY, Scott E, Munot P, Vijaykumar K, Muntoni F, UK NorthStar Clinical Network (2010). UK North Star Neuromuscular Clinical Network (NSCN): National audit results in Duchenne muscular dystrophy (DMD) corticosteroid practice, vitamin D status and bone health.
    • Popplewell LJ, Adkin C, Arechavala-Gomeza V, Aartsma-Rus A, de Winter CL, Wilton SD, Morgan JE, Muntoni F, Graham IR, Dickson G (2010). Comparative analysis of antisense oligonucleotide sequences targeting exon 53 of the human DMD gene: Implications for future clinical trials.. Neuromuscul Disord, 20(2), 102 - 110. doi:10.1016/j.nmd.2009.10.013
    • Jephson CG, Mills NA, Pitt MC, Beeson D, Aloysius A, Muntoni F, Robb SA, Bailey CM (2010). Congenital stridor with feeding difficulty as a presenting symptom of Dok7 congenital myasthenic syndrome.. Int J Pediatr Otorhinolaryngol, 74(9), 991 - 994. doi:10.1016/j.ijporl.2010.05.022
    • Shrewsbury SB, Cirak S, Guglieri M, Bushby K, Muntoni F (2010). Current progress and preliminary results with the systemic administration trial of AVI-4658, a novel phosphorodiamidate morpholino oligomer (PMO) skipping dystrophin exon 51 in Duchenne muscular dystrophy (DMD). doi:10.1016/j.nmd.2010.07.140
    • Cirak S, Guglieri M, Shrewsbury S, Bushby K, Muntoni F (2010). Current progress with the systemic administration trial of AVI-4658, a novel Phosphorodiamidate Morpholino Oligomer (PMO) skipping dystrophin exon 51 in Duchenne muscular dystrophy (DMD).
    • Burns J, Shy R, Estilow T, Acsadi G, Glanzman A, Ouvrier R, Muntoni F, Reilly M, Shy M, Finkel R (2010). Development and Validation of the Charcot-Marie-Tooth Disease Pediatric (CMTPed) Scale.
    • Yau S, Cirak S, Castleman V, Abbs S, Muntoni F (2010). Development of NMD Gene Chips for the complete DNA diagnosis of Inherited Neuromuscular Disorders.
    • Meng J, Beley C, Adkin C, Muntoni F, Garcia L, Morgan JE (2010). Dystrophin expression in DMD pericytes after infection with U7 lentivirus designed to skip dystrophin exon 51.
    • Cirak S, Feng L, Torelli S, Arechavala-Gomeza V, Kinali M, Shrewsbury S, Morgan JE, Sewry C, Muntoni F (2010). Induction of dystrophin in DMD patients by antisense oligonucleotide AVI-4658 restores the dystrophin glycoprotein complex. doi:10.1016/j.nmd.2010.07.150
    • Cirak S, Feng L, Arechavala V, Torelli S, Ganeshaguru K, Kinali M, Shrewsbury S, Morgan JE, Sewry C, Muntoni F (2010). Induction of dystrophin in Duchenne muscular dystrophy patients by antisense oligonucleotide AVI-4658 restores the dystrophin-associated glycoprotein complex.
    • Jonuschies J, Boldrin L, Muntoni F, Morgan JE (2010). Lentivirus-mediated stem cell therapy for Duchenne muscular dystrophy.
    • Johnson D, Reza M, Morgan JE, Barresi R, Lochmuller H, Muntoni F (2010). MRC NMD Biobank service: an overview.
    • Zhou H, Lillis S, Loy RE, Ghassemi F, Rose MR, Norwood F, Mills K, Al-Sarraj S, Lane RJ, Feng L, Matthews E, Sewry CA, Abbs S, Buk S, Hanna M, Treves S, Dirksen RT, Meissner G, Muntoni F, Jungbluth H (2010). Multi-minicore disease and atypical periodic paralysis associated with novel mutations in the skeletal muscle ryanodine receptor (RYR1) gene.. Neuromuscul Disord, 20(3), 166 - 173. doi:10.1016/j.nmd.2009.12.005
    • Arechavala-Gomeza V, Kinali M, Feng L, Brown SC, Sewry C, Morgan JE, Muntoni F (2010). Immunohistological intensity measurements as a tool to assess sarcolemma-associated protein expression.. Neuropathol Appl Neurobiol, 36(4), 265 - 274. doi:10.1111/j.1365-2990.2009.01056.x
    • Munot P, Lashley D, Jungbluth H, Feng L, Pitt M, Robb SA, Palace J, Jayawant S, Kennet R, Beeson D, Cullup T, Abbs S, Laing N, Sewry C, Muntoni F (2010). Congenital fibre type disproportion associated with mutations in the tropomyosin 3 (TPM3) gene mimicking congenital myasthenia.. Neuromuscul Disord, 20(12), 796 - 800. doi:10.1016/j.nmd.2010.07.274
    • Wang CH, Bonnemann CG, Rutkowski A, Sejersen T, Bellini J, Battista V, Florence JM, Schara U, Schuler PM, Wahbi K, Aloysius A, Bash RO, Béroud C, Bertini E, Bushby K, Cohn RD, Connolly AM, Deconinck N, Desguerre I, Eagle M, Estournet-Mathiaud B, Ferreiro A, Fujak A, Goemans N, Iannaccone ST, Jouinot P, Main M, Melacini P, Mueller-Felber W, Muntoni F, Nelson LL, Rahbek J, Quijano-Roy S, Sewry C, Storhaug K, Simonds A, Tseng B, Vajsar J, Vianello A, Zeller R, International Standard of Care Committee for Congenital Muscular Dystrophy (2010). Consensus statement on standard of care for congenital muscular dystrophies.. J Child Neurol, 25(12), 1559 - 1581. doi:10.1177/0883073810381924
    • Garralda EM, Kinali M, Cirak S, Muntoni F (2010). Exploring emotional impact in a proof-of-principle single-blind, controlled, two-doses escalation intramuscular study of a morpholino splice-switching oligonucleotide (AVI-4658) trial to induce dystrophin restoration in children with Duchenne muscular dystrophy.
    • Geranmayeh F, Clement E, Feng LH, Sewry C, Pagan J, Mein R, Abbs S, Brueton L, Childs AM, Jungbluth H, De Goede CG, Lynch B, Lin JP, Chow G, Sousa CD, O'Mahony O, Majumdar A, Straub V, Bushby K, Muntoni F (2010). Genotype-phenotype correlation in a large population of muscular dystrophy patients with LAMA2 mutations.. Neuromuscul Disord, 20(4), 241 - 250. doi:10.1016/j.nmd.2010.02.001
    • Mercuri E, Clements E, Offiah A, Pichiecchio A, Vasco G, Bianco F, Berardinelli A, Manzur A, Pane M, Messina S, Gualandi F, Ricci E, Rutherford M, Muntoni F (2010). Muscle magnetic resonance imaging involvement in muscular dystrophies with rigidity of the spine.. Ann Neurol, 67(2), 201 - 208. doi:10.1002/ana.21846
    • Babcock MA, Kostova FV, Moxley RT, Chamberlain JS, Maria BL, Muntoni F, Wagner K, Mathews KD, Bushby K, Moxley RT, Sussman MD, Pandya S, Birnkrant DJ, Chamberlain JS, Partridge T, Finkel RS, Leshner R, Mendell JR (2010). Muscular Dystrophy: New Opportunities for Diagnosis and Treatment. J CHILD NEUROL, 25(9), 1080 - 1097. doi:10.1177/0883073810371000
    • Boldrin L, Muntoni F, Morgan JE (2010). Are human and mouse satellite cells really the same?. J Histochem Cytochem, 58(11), 941 - 955. doi:10.1369/jhc.2010.956201

    2009

    • Godfrey C, Clement E, Torelli S, Brockington M, Abbs S, Muntoni F (2009). An investigation of candidate genes in dystroglycanopathy patients. doi:10.1016/j.nmd.2009.06.032
    • Nadeau A, Kinali M, Main M, Jimenez-Mallebrera C, Aloysius A, Clement E, North B, Manzur AY, Robb SA, Mercuri E, Muntoni F (2009). Natural history of Ullrich congenital muscular dystrophy. Neurology, 73(1), 25 - 31.
    • Jimenez-Mallebrera C, Torelli S, Feng L, Kim J, Godfrey C, Clement E, Mein R, Abbs S, Brown SC, Campbell KP, Kroger S, Talim B, Topaloglu H, Quinlivan R, Roper H, Childs AM, Kinali M, Sewry CA, Muntoni F (2009). A comparative study of alpha-dystroglycan glycosylation in. Brain Pathol, 19(4), 596 - 611.
    • Kinali M, Arechavala-Gomeza V, Feng L, Cirak S, Hunt D, Adkin C, Guglieri M, Abbs S, Nihoyannopoulos P, Garralda ME, Rutherford M, McCulley C, Popplewell L, Graham IR, Dickson G, Wood MJA, Wells DJ, Wilton SD, Holt T, Kole R, Straub V, Bushby K, Sewry C, Morgan JE, Muntoni F (2009). Restoration of dystrophin expression in Duchenne muscular dystrophy: A single blind, placebo-controlled dose escalation study using morpholino oligomer AVI-4658. doi:10.1016/j.nmd.2009.06.358
    • Meng J, Adkin CF, rechavala-Gomeza V, Boldrin L, Muntoni F, Morgan JE (2009). The contribution of human synovial stem cells to skeletal. Neuromuscul Disord, , - .
    • Boldrin L, Zammit P, Muntoni F, Morgan J (2009). The Mature Adult Dystrophic Mouse Muscle Environment Does Not Impede Efficient Engrafted Satellite Cell Regeneration And Self-Renewal. Stem Cells, , - .
    • Sewry CA, Holton J, Dick DJ, Jacques T, Muntoni F, Hanna M (2009). Zebra body myopathy resolved. doi:10.1016/j.nmd.2009.06.292
    • Ghassemi F, Vukcevic M, Xu L, Zhou HY, Meissner G, Muntoni F, Jungbluth H, Zorzato F, Treves S (2009). A recessive ryanodine receptor 1 mutation in a CCD patient increases channel activity. Cell Calcium, 45(2), 192 - 197.
    • Wilmshurst J, Lillis S, Zhou H, Kress W, Solomon R, Ndondo A, Greenberg J, Sinclair-Smith CC, Bertini E, Boennemann C, Straub V, Quinlivan R, Sewry CA, Wraige E, Abbs S, Muntoni F, Jungbluth H (2009). An autosomal-recessive form of centronuclear myopathy is caused by mutations in the skeletal muscle ryanodine receptor (RYR1) gene. doi:10.1016/j.nmd.2009.06.046
    • Jimenez-Mallebrera C, Torelli S, Feng L, Kim J, Godfrey C, Clement E, Mein R, Abbs S, Brown SC, Campbell KP, Kroger S, Talim B, Topaloglu H, Quinlivan R, Roper H, Childs AM, Kinali M, Sewry CA, Muntoni F (2009). A comparative study of alpha-dystroglycan glycosylation in dystroglycanopathies suggests that the hypoglycosylation of alpha-dystroglycan does not consistently correlate with clinical severity.. Brain Pathol, 19(4), 596 - 611.
    • Jungbluth H, Cullup T, Lillis S, Zhou H, Sewry C, Abbs S, Muntoni F (2009). Centronuclear myopathy with cataracts due to a novel heterozygous mutation in the dynamin 2 (DNM2) gene. doi:10.1016/j.nmd.2009.06.287
    • Arbogast S, Zhou H, Muntoni F, Ferreiro A (2009). Oxidative stress in SEPN1-related myopathy: A new therapeutical target.
    • Arbogast S, Beuvin M, Fraysse B, Zhou H, Muntoni F, Ferreiro A (2009). Oxidative Stress in SEPN1-Related Myopathy: From Pathophysiology to Treatment. Annals of Neurology, 65(6), 677 - 686.
    • McSweeney N, Cowan F, Manzur A, Robb S, Muntoni F (2009). Perinatal dyskinesia as a presenting feature in Prader Willi Syndrome. European Journal of Paediatric Neurology, 13(4), 350 - 355.
    • Mitrpant C, Adams AM, Meloni PL, Muntoni F, Fletcher S, Wilton SD (2009). Rational design of antisense oligomers to induce dystrophin exon skipping.. Mol Ther, 17(8), 1418 - 1426. doi:10.1038/mt.2009.49
    • Ackroyd MR, Skordis L, Kaluarachchi M, Godwin J, Prior S, Fidanboylu M, Piercy RJ, Muntoni F, Brown SC (2009). Reduced expression of fukutin related protein in mice results in a model for fukutin related protein associated muscular dystrophies. Brain, 132, 439 - 451.
    • Hicks D, Lampe A, Laval S, Allamand V, Jimenez-Mallebrera C, Walter M, Muntoni F, Quijano-Roy S, Richard P, Straub V, Lochmuller H, Bushby K (2009). Response to letter from Bernardi.
    • Feng LH, Bhardwaj N, Muntoni F, Sewry CA (2009). The value of immunolabelling of myosin heavy chains in the assessment of muscle biopsies. Neuromuscular Disorders, 19(8-9), 604 - 604.
    • Mercuri E, Clement E, Offiah A, Pichiecchio A, Alsopp J, Vasco G, Bianco F, Manzur A, Messina S, Ricci E, Rutherford M, Muntoni F (2009). Specificity and sensitivity of patterns of muscle MRI involvement in muscular dystrophies with rigidity of the spine. Neuromuscular Disorders, 19(8-9), 627 - 628.
    • Mayhew AG, Scott E, Muntoni F, Manzur A (2009). The Smartnet Clinical Network - Creation of a national standardised assessment tool and natural history database for spinal muscular atrophy. doi:10.1016/j.nmd.2009.06.018
    • Feng L, Jungbluth H, Jimenez-Mallebrera C, Zhou H, Brown SC, Quinlivan R, Muntoni F, Sewry CA (2009). The pathological spectrum associated with mutations in the skeletal muscle ryanodine receptor 1 (RYR1) gene.
    • Schessl J, Taratuto AL, Sewry C, Battini R, Chin SS, Maiti B, Dubrovsky AL, Erro MG, Espada G, Robertella M, Saccoliti M, Olmos P, Bridges LR, Standring P, Hu Y, Zou YQ, Swoboda KJ, Scavina M, Goebel HH, Mitchell CA, Flanigan KM, Muntoni F, Bonnemann CG (2009). Clinical, histological and genetic characterization of reducing body myopathy caused by mutations in FHL1. Brain, 132, 452 - 464.
    • Ackroyd MR, Prior S, Whitmore C, Kaluarachchi M, Muntoni F, Brown SC (2009). Deficiency of multiple alpha dystroglycan ligand interactions underlie the phenotype of a FKRP-deficient mouse model for muscle eye brain disease. doi:10.1016/j.nmd.2009.06.039
    • Brockington M, Torelli S, Godfrey C, Muntoni F (2009). Expression analysis of alpha-dystroglycan glycosyltransferases during myoblast-myotube differentiation. doi:10.1016/j.nmd.2009.06.030
    • Dowling J, Lillis S, Amburgey K, Leber S, Zhou H, Al-Sarraj S, Wraige E, Abbs S, Sewry C, Muntoni F, Jungbluth H (2009). King-Denborough syndrome associated with mutations in the skeletal muscle ryanodine receptor (RYR1) gene. NEUROMUSCULAR DISORDERS, 19(8-9), 556 - 557. doi:10.1016/j.nmd.2009.06.045
    • Dowling JJ, Leber S, Lillis S, Zhou H, Ai-Sarraj S, Wraige E, Abbs S, Sewry C, Muntoni F, Jungbluth H (2009). King-Denborough Syndrome Associated with Mutations in the Skeletal Muscle Ryanodine Receptor (RYR1) Gene.
    • Kinali M, Arechavala-Gomeza V, Feng L, Cirak S, Hunt D, Adkin C, Guglieri M, Ashton E, Abbs S, Nihoyannopoulos P, Garralda ME, Rutherford M, McCulley C, Popplewell L, Graham IR, Dickson G, Wood MJ, Wells DJ, Wilton SD, Kole R, Straub V, Bushby K, Sewry C, Morgan JE, Muntoni F (2009). Local restoration of dystrophin expression with the morpholino oligomer AVI-4658 in Duchenne muscular dystrophy: a single-blind, placebo-controlled, dose-escalation, proof-of-concept study. Lancet Neurol., 8(10), 918 - 928.
    • Boldrin L, Zammit PS, Muntoni F, Morgan JE (2009). Mature Adult Dystrophic Mouse Muscle Environment Does Not Impede Efficient Engrafted Satellite Cell Regeneration and Self-Renewal. Stem Cells, 27(10), 2478 - 2487.
    • Muntoni F (2009). Molecular therapies of Duchenne muscular dystrophy. doi:10.1016/j.nmd.2009.06.353
    • Muntoni F (2009). Muscular dystrophy: diagnosis and management.
    • Selcen D, Muntoni F, Burton BK, Pegoraro E, Sewry C, Bite AV, Engel AG (2009). Mutation in BAG3 causes severe dominant childhood muscular dystrophy.. Ann Neurol, 65(1), 83 - 89. doi:10.1002/ana.21553
    • rechavala-Gomeza V, Kinali M, Feng L, Brown SC, Sewry C, Morgan JE, Muntoni F (2009). Immunohistological intensity measurements as a tool to assess. Neuropathol Appl Neurobiol, , - .
    • Zhou H, Owen N, Eperon IC, Muntoni F (2009). Correcting SMN2 splicing with tailed antisense oligoribonucleotides: a promising therapeutic strategy for spinal muscular atrophy. doi:10.1016/j.nmd.2009.06.112
    • Hicks D, Lampe AK, Laval SH, Allamand V, Jimenez-Mallebrera C, Walter MC, Muntoni F, Quijano-Roy S, Richard P, Straub V, Lochmüller H, Bushby KM (2009). Cyclosporine A treatment for Ullrich congenital muscular dystrophy: a cellular study of mitochondrial dysfunction and its rescue.. Brain, 132(Pt 1), 147 - 155. doi:10.1093/brain/awn289
    • Manzur AY, Muntoni F (2009). Diagnosis and new treatments in muscular dystrophies. Postgrad Med J, 85(1009), 622 - 630.
    • Manzur AY, Muntoni F (2009). Diagnosis and new treatments in muscular dystrophies. Journal of Neurology, Neurosurgery and Psychiatry, 80(7), 706 - 714.
    • Robb SA, Sewry CA, Manzur AY, Knight RK, Mills KR, Pike M, Muller C, Lees MM, Cullup T, Jungbluth H, Pitt MC, Muntoni F (2009). Impaired neuromuscular transmission and response to acetylcholinesterase inhibitors in centronuclear myopathy. Neuromuscular Disorders, 19(8-9), 600 - 600.
    • Mercuri E, Manzur A, Main M, Alsopp J, Muntoni F (2009). Is there post-natal muscle growth in amyoplasia? A sequential MRI study. Neuromuscul Disord, , - .
    • Jungbluth H, Lillis S, Zhou H, Abbs S, Sewry C, Swash M, Muntoni F (2009). Late-onset axial myopathy with cores due to a novel heterozygous dominant mutation in the skeletal muscle ryanodine receptor (RYR1) gene. Neuromuscular Disorders, 19(5), 344 - 347.
    • Arechavala-Gomeza V, Feng L, Malerba A, Graham IR, Brown SC, Sewry C, Morgan J, Muntoni F (2009). Measuring restored dystrophin in treated muscle: An immunohistological intensity measurement method. doi:10.1016/j.nmd.2009.06.224
    • Astrea G, Schessl J, Clement E, Tosetti M, Mercuri E, Rutherford M, Cioni G, Bönnemann CG, Muntoni F, Battini R (2009). Muscle MRI in FHL1-linked reducing body myopathy.. Neuromuscul Disord, 19(10), 689 - 691. doi:10.1016/j.nmd.2009.06.372
    • Muntoni F, Guicheney P, Voit T (2009). 158th ENMC international workshop on congenital muscular dystrophy (Xth international CMD workshop) 8th-10th February 2008 Naarden, The Netherlands.. Neuromuscul Disord, 19(3), 229 - 234. doi:10.1016/j.nmd.2008.11.008

    2008

    • Adkin C, Meng J, Arechevala-Gomeza V, Morgan J, Muntoni F (2008). A model of human muscle regeneration in vivo to test potential therapies for DMD. doi:10.1016/j.nmd.2008.06.123
    • Muntoni F, Torelli S, Brockington M (2008). Muscular dystrophies due to glycosylation defects. Neurotherapeutics, 5(4), 627 - 632.
    • Nicholson C, Main M, Kinali M, Muntoni F, Mercuri E (2008). Predictive factors for progressive foot deformity in non-ambulant boys with Duchenne muscular dystrophy. doi:10.1016/j.nmd.2008.06.284
    • Bovolenta M, Neri M, Fini S, Fabris M, Trabanelli C, Venturoli A, Martoni E, Bassi E, Spitali P, Brioschi S, Falzarano MS, Rimessi P, Ciccone R, Ashton E, McCauley J, Yau S, Abbs S, Muntoni F, Merlini L, Gualandi F, Ferlini A (2008). A novel custom high density-comparative genomic hybridization array detects common rearrangements as well as deep intronic mutations in dystrophinopathies. BMC Genomics, 9, 572 - .
    • Fernandez-Fuente M, Ames EG, Wagner ML, Zhou H, Strom M, Zammit PS, Mickelson JR, Muntoni F, Brown SC, Piercy RJ (2008). Assessment of the transformation of equine skin-derived fibroblasts to multinucleated skeletal myotubes following lentiviral-induced expression of equine myogenic differentiation 1. Am J Vet.Res, 69(12), 1637 - 1645.
    • Clement E, Mercuri E, Godfrey C, Smith J, Robb S, Kinali M, Straub V, Bushby K, Manzur A, Talim B, Cowan F, Quinlivan R, Klein A, Longman C, McWilliam R, Topaloglu H, Mein R, Abbs S, North K, Barkovich AJ, Rutherford M, Muntoni F (2008). Brain involvement in muscular dystrophies with defective dystroglycan glycosylation. Ann.Neurol., 64(5), 573 - 582. doi:10.1002/ana.21482
    • Otto A, Schmidt C, Luke G, Allen S, Valasek P, Muntoni F, Lawrence-Watt D, Patel K (2008). Canonical Wnt signalling induces satellite-cell proliferation during adult skeletal muscle regeneration. J Cell Sci, 121(Pt 17), 2939 - 2950.
    • Muntoni F, Bushby KD, van OG (2008). 149th ENMC International Workshop and 1st TREAT-NMD Workshop on: "planning phase i/ii clinical trials using systemically delivered antisense oligonucleotides in duchenne muscular dystrophy". Neuromuscul Disord, 18(3), 268 - 275.
    • Jimenez-Mallebrera C, Torelli S, Feng L, Kim J, Godfrey C, Clement E, Mein R, Abbs S, Brown SC, Campbell KP, Kroger S, Talim B, Topaloglu H, Quinlivan R, Roper H, Childs AM, Kinali M, Sewry CA, Muntoni F (2008). A Comparative Study of alpha-Dystroglycan Glycosylation in Dystroglycanopathies Suggests that the Hypoglycosylation of alpha-Dystroglycan Does Not Consistently Correlate with Clinical Severity. Brain Pathol, , - .
    • Ackroyd MR, Skordis L, Kaluarachchi M, Prior S, Muntoni F, Brown SC (2008). Characterisation of the brain and eye phenotype of a FKRP knock-down mouse model of Muscle-Eye-Brain disease. doi:10.1016/j.nmd.2008.06.050
    • Schessl J, Zou Y, McGrath MJ, Cowling BS, Maiti B, Chin SS, Sewry C, Battini R, Hu Y, Cottle DL, Rosenblatt M, Spruce L, Ganguly A, Kirschner J, Judkins AR, Golden JA, Goebel HH, Taratuto AL, Muntoni F, Flanigan KM, Mitchell CA, Bonnemann CG (2008). Proteomic identification of the LIM domain protein FHL1 as the geneproduct mutated in reducing body myopathy. doi:10.1016/j.nmd.2008.06.012
    • Schessl J, Zou Y, McGrath MJ, Cowling BS, Maiti B, Chin SS, Sewry C, Battini R, Hu Y, Cottle DL, Rosenblatt M, Spruce L, Ganguly A, Kirschner J, Judkins AR, Golden JA, Goebel HH, Muntoni F, Flanigan KM, Mitchell CA, Bonnemann CG (2008). Proteomic identification of FHL1 as the protein mutated in human reducing body myopathy. J Clin Invest, 118(3), 904 - 912.
    • Nadeau A, Muntoni F (2008). Skin changes in Ullrich congenital muscular dystrophy. Neuromuscul Disord, 18(12), 982 - .
    • Ambegaonkar GP, Kinali M, Muntoni F, Robb SA, Manzur AY (2008). Vertebral fractures in corticosteroid-treated boys with Duchenne muscular dystrophy. doi:10.1016/j.nmd.2008.06.349
    • Hicks D, Lampe AK, Laval SH, Allamand V, Jimenez-Mallebrera C, Walter M, Muntoni F, Quijano-Roy S, Richard P, Straub V, Lochmuller H, Bushby KMD (2008). Testing therapies in neuromuscular disease: Oral presentations. doi:10.1016/j.nmd.2008.06.376
    • Cullup T, Pagan J, Mein R, Lillis S, Jimenez-Mallebrera C, Feng L, Sewry C, Jungbluth H, Muntoni F, Abbs S (2008). The National Molecular Genetics service for Congenital Muscular Dystrophies and Myopathies.
    • Mercuri E, Mayhew A, Muntoni F, Messina S, Straub V, Van Ommen GJ, Voit T, Bertini E, Bushby K, TREAT-NMD Neuromuscular Network (2008). Towards harmonisation of outcome measures for DMD and SMA within TREAT-NMD; report of three expert workshops: TREAT-NMD/ENMC workshop on outcome measures, 12th--13th May 2007, Naarden, The Netherlands; TREAT-NMD workshop on outcome measures in experimental trials for DMD, 30th June--1st July 2007, Naarden, The Netherlands; conjoint Institute of Myology TREAT-NMD meeting on physical activity monitoring in neuromuscular disorders, 11th July 2007, Paris, France.. Neuromuscul Disord, 18(11), 894 - 903. doi:10.1016/j.nmd.2008.07.003
    • Budde BS, Namavar Y, Barth PG, Poll-The BT N, G B, C V, Ruissen F W, M A F, K TB, E T A, E VDK, M S H, W T, M R C, Y J S, M V, T R, F B, W B, K K, M B, E H, G W, M B-V, L K-M, I DV, L S S, L M, F F, C D B, R H, R C G, E B, F A S, L M W, B N, P B, F (2008). tRNA splicing endonuclease mutations cause pontocerebellar hypoplasia. Nat Genet, 40(9), 1113 - 1118.
    • Manzur AY, Kinali M, Muntoni F (2008). Update on the management of Duchenne muscular dystrophy. Arch Dis Child, 93(11), 986 - 990.
    • Nadeau A, Kinali M, Main M, Jimenez-Mallebrera C, North B, Clement E, Manzur AY, Robb SA, Muntoni F (2008). Collagen VI, laminopathies and neuropathies: Poster presentations. doi:10.1016/j.nmd.2008.06.027
    • Kinali M, Beeson D, Pitt MC, Jungbluth H, Simonds AK, Aloysius A, Cockerill H, Davis T, Palace J, Manzur AY, Jimenez-Mallebrera C, Sewry C, Muntoni F, Robb SA (2008). Congenital myasthenic syndromes in childhood: diagnostic and management challenges. J Neuroimmunol, 201-202, 6 - 12.
    • Marchesi C, Main M, Kinali M, Muntoni F (2008). Correlation of hand-held myometry with alternative methods of assessment of muscle strength and function in DMD patients. doi:10.1016/j.nmd.2008.06.061
    • Pane M, Staccioll S, Messina S, D 'Arnico A, Pelliccioni M, Mazzone ES, Cuttini M, Alfieri P, Battinif R, Main M, Muntoni F, Bertini E, Villanova M, Mercuri E (2008). Daily salbutamol in young patients with SMA type II. Neuromuscular Disorders, 18(7), 536 - 540.
    • Pane MP, Staccioli SS, Messina SM, d'Amico AD, Pelliccioni MP, Mazzone EM, Cuttini MC, Alfieri PA, Battini RB, Main MM, Muntoni FM, Bertini EB, Villanova MV, Mercuri EM (2008). Daily salbutamol in young patients with SMA type II. doi:10.1016/j.nmd.2008.06.133
    • Steffensen BF, Mayhew A, Aloysius A, Eagle M, Mercuri E, Messina S, Mazzone E, Nadeau A, Main M, Scott E, Werlauff U, Werge B, Glanzmann AM, Muntoni F (2008). Egen classification revisited in SMA. doi:10.1016/j.nmd.2008.06.059
    • Bovolenta M, Fini S, Neri M, Fabris M, Martoni E, Bassi E, Spitali P, Falzarano S, Trabanelli C, Venturoli A, Ashton E, Abbs S, Muntoni F, Rimessi P, Gualandi F, Ferlini A (2008). High Density-comparative genomic hybridization (HD-CGH) array as a tool to detect deep intronic mutations in the dystrophin gene. doi:10.1016/j.nmd.2008.06.184
    • Treves S, Jungbluth H, Muntoni F, Zorzato F (2008). Congenital muscle disorders with cores: the ryanodine receptor calcium channel paradigm. Curr Opin Pharmacol, 8(3), 319 - 326.
    • Kinali M, Arechavala-Omeza V, Feng L, Glover A, Guglieri M, Jungbluth H, Roper H, Quinlivan RM, Hunt D, Marizur AM, Henderson A, Gosalakkal J, Hollingsworth K, Allsop J, Mercuri E, Morgan J, Sewry C, Straub V, Bushby K, Rutherford M, Muntoni F (2008). Establishing the parameters for clinical trials of antisense oligonucleotide therapy in Duchenne muscular dystrophy. doi:10.1016/j.nmd.2008.06.171
    • Sewry CA, Jimenez-Mallebrera C, Muntoni F (2008). Congenital myopathies. Current Opinion in Neurology, 21(5), 569 - 575.
    • Selcen D, Muntoni F, Burton BK, Pegoraro E, Sewry C, Engel AG (2008). Mutation in BAG3 defines severe novel muscular dystrophy of childhood.
    • Quijano-Roy S, Mbieleu B, Bonnemann CG, Jeannet PY, Colomer J, Clarke NF, Cuisset JM, Roper H, De ML, D'Amico A, Ben YR, Nascimento A, Barois A, Demay L, Bertini E, Ferreiro A, Sewry CA, Romero NB, Ryan M, Muntoni F, Guicheney P, Richard P, Bonne G, Estournet B (2008). De novo LMNA mutations cause a new form of congenital muscular dystrophy. Ann Neurol, 64(2), 177 - 186.
    • Klein A, Clement E, Mercuri E, Muntoni F (2008). Differential diagnosis of congenital muscular dystrophies. Eur J Paediatr Neurol, 12(5), 371 - 377.
    • Lampe AK, Zou Y, Sudano D, O'Brien KK, Hicks D, Laval SH, Charlton R, Jimenez-Mallebrera C, Zhang RZ, Finkel RS, Tennekoon G, Schreiber G, van der Knaap MS, Marks H, Straub V, Flanigan KM, Chu ML, Muntoni F, Bushby KM, Bonnemann CG (2008). Exon skipping mutations in collagen VI are common and are predictive for severity and inheritance. Hum Mutat, 29(6), 809 - 822.
    • Brockington M, Torelli S, Cirak S, Brown SC, Wells DJ, Muntoni F (2008). LARGE overexpression in transgenic mice: Implications for therapeutic interventions in muscular dystrophy. doi:10.1016/j.nmd.2008.06.048
    • Brown SC, Piercy RJ, Muntoni F, Sewry CA (2008). Investigating the pathology of Emery-Dreifuss muscular dystrophy.. Biochem Soc Trans, 36(Pt 6), 1335 - 1338. doi:10.1042/BST0361335
    • Jungbluth H, Lillis S, Zhou H, Abbs S, Swash M, Muntoni F (2008). Late-onset axial myopathy with cores due to a novel dominant mutation in the skeletal muscle ryanodine receptor (RYR1) gene. doi:10.1016/j.nmd.2008.06.292
    • Clement EM, Godfrey C, Tan J, Brockington M, Torelli S, Feng L, Brown SC, Jimenez-Mallebrera C, Sewry CA, Longman C, Mein R, Abbs S, Vajsar J, Schachter H, Muntoni F (2008). Mild POMGnT1 mutations underlie a novel limb-girdle muscular dystrophy variant. Arch Neurol, 65(1), 137 - 141.
    • Jungbluth H, Muntoni F, Ferreiro A (2008). 150th ENMC International Workshop: Core Myopathies, 9-11th March 2007, Naarden, The Netherlands. Neuromuscul Disord, 18(12), 989 - 996.

    2007

    • Fletcher S, Adams AM, Harding PL, McClorey G, Muntoni F, Iversen PL, Wilton SD (2007). A personalised genetic treatment for DMD.
    • Muntoni F (2007). Are we any further in the treatment of muscular dystrophies?. doi:10.1016/j.nmd.2007.06.455
    • Hartley L, Kinali M, Knight R, Mercuri E, Hubner C, Bertini E, Manzur AY, Jimenez-Mallebrera C, Sewry CA, Muntoni F (2007). A congenital myopathy with diaphragmatic weakness not linked to the SMARD1 locus. Neuromuscul.Disord, 17(2), 174 - 179.
    • Jungbluth H, Zhou H, Sewry CA, Robb S, Treves S, Bitoun M, Guicheney P, Buj-Bello A, Bonnemann C, Muntoni F (2007). Centronuclear myopathy due to a de novo dominant mutation in the skeletal muscle ryanodine receptor (RYR1) gene. Neuromuscul.Disord, 17(4), 338 - 345.
    • Zhou HY, Yamaguchi N, Xu L, Wang Y, Sewry C, Jungbluth H, Zorzato F, Bertini E, Muntoni F, Meissner G, Treves S (2007). Characterization of recessive RYR1 mutations in core myopathies (vol 15, pg 2791, 2006). HUM MOL GENET, 16(10), 1269 - 1269. doi:10.1093/hmg/ddm092
    • Kinali M, Main M, Eliahoo J, Messina S, Knight RK, Lehovsky J, Edge G, Mercuri E, Manzur AY, Muntoni F (2007). Predictive factors for the development of scoliosis in Duchenne muscular dystrophy. Eur J Paediatr Neurol, 11(3), 160 - 166.
    • Muntoni F (2007). Prospects for the treatment of Duchenne muscular dystrophy.
    • Godfrey C, Clement E, Mein R, Brockington M, Smith J, Talim B, Straub V, Robb S, Quinlivan R, Feng L, Jimenez-Mallebrera C, Mercuri E, Manzur AY, Kinali M, Torelli S, Brown SC, Sewry CA, Bushby K, Topaloglu H, North K, Abbs S, Muntoni F (2007). Refining genotype phenotype correlations in muscular dystrophies with defective glycosylation of dystroglycan.. Brain, 130(Pt 10), 2725 - 2735. doi:10.1093/brain/awm212
    • Treves S, Jungbluth H, Zhou H, Yamaguchi N, Meissner G, Sewry'Md C, Zorzato F, Muntoni F (2007). RYR1 mutations and multi-minicore disease.
    • Main M, Mercuri E, Haliloglu G, Baker R, Kinali M, Muntoni F (2007). Serial casting of the ankles in Duchenne muscular dystrophy: can it be an alternative to surgery?. Neuromuscul.Disord, 17(3), 227 - 230.
    • Zou Y, Schessl J, Lampe A, Hu Y, Jimenez-Mallebrera C, Schreiber G, Stolte-Dijkstra I, Fock A, Chu M, Bushby K, Weiss R, Flanigan K, Muntoni F, Bonnemann C (2007). Skipping of exon 16 in COL6A3 is a recurrent mutation causing severe congenital muscular dystrophy type Ullrich. doi:10.1016/j.nmd.2007.06.280
    • Clement E, Mercuri E, Rutherford M, Smith J, North K, Kinali M, Straub V, Bushby K, Cowan F, Godfrey C, Quirdiva R, Topaloglu H, Klein A, Muntoni F (2007). Spectrum of brain changes and genotype-phenotype correlations in secondary dystroglycanopathies. doi:10.1016/j.nmd.2007.06.366
    • Kinali M, Robinson R, Sagi L, Nihoyannopoulos P, Manzur A, Muntoni F (2007). The role of ACE inhibitor therapy in presymptomatic cardiomyopathy in Duchenne muscular dystrophy.
    • Neri M, Gualandi F, Rimessi P, Bovolenta M, Alfano G, Banfi S, Calzolari E, Muntoni F, Ferlini A (2007). The topographic distribution of the dystrophin brain isoform in the human cardiac muscle: Implications for the pathogenesis of the x-linked dilated cardiomyopathy. doi:10.1016/j.nmd.2007.06.268
    • Jimenez-Mallebrera C, Kim J, Brown S, Feng L, Muntoni F (2007). Ullrich congenital muscular dystrophy fibroblasts and their adhesion to extracellular matrix proteins.
    • Arechavala-Gomeza V, Graham IR, Popplewell LJ, Adams AM, artsma-Rus A, Kinali M, Morgan JE, van Deutekom JC, Wilton SD, Dickson G, Muntoni F (2007). Comparative analysis of antisense oligonucleotide sequences for targeted skipping of exon 51 during dystrophin pre-mRNA splicing in human muscle. Human Gene Therapy, 18(9), 798 - 810. doi:10.1089/hum.2006.061
    • Jimenez-Mallebrera C, Zhou H, Manzur A, Feng L, Sewry C, Muntoni F (2007). Core myopathy without mutations in RYRI or SEPNI genes. doi:10.1016/j.nmd.2007.06.406
    • Arechavala-Gomeza V, Kinali M, Feng L, Edge G, Hunt D, Lehovsky J, Chambers D, Straub V, Bushby K, Sewry C, Morgan J, Muntoni F (2007). Do revertants increase with age in Duchenne muscular dystrophy boys?. doi:10.1016/j.nmd.2007.06.274
    • Messina S, Mora M, Pegoraro E, Pini A, Mongini T, D'Amico A, Pane M, Bruno C, Biancheri R, Berardinelli A, Toscano A, Morandi L, Moroni I, Farina L, Uggetti C, Pichiecchio , Scuderi C, Ruggieri A, Muntoni F, Santorelli F, Bertini E, Mercuri E (2007). Expanding the clinical spectrum of POMT1 and POMT2 phenotype: A multicentric study in the Italian population. doi:10.1016/j.nmd.2007.06.362
    • Neri M, Torelli S, Brown S, Sewry C, Sabatelli P, Merlini L, Spitali P, Gualandi F, Calzolari E, Ferlini A, Muntoni F (2007). How much dystrophin to avoid muscular dystrophy?. doi:10.1016/j.nmd.2007.06.265
    • Quijano-Roy S, Mbieleu B, Bonnemann C, Colomer J, Clarke N, Cuisset J, Roper H, De Meirleir L, D'Arnico A, Ben Yaou R, Barois A, Demay L, Romero N, Sewry C, Bertini E, Ferreiro A, Muntoni F, Guicheney P, Richard P, Bonne G, Estournet B (2007). LMNA is responsible for a recognisable form of congenital muscular dystrophy associated with selective axial muscle weakness and progressive course (L-CMD). doi:10.1016/j.nmd.2007.06.125
    • Prothero J, Lunt P, Muntoni F, Manzur A, O'Shea S, Williams M, Wakeling E (2007). Interpretation of a complex FSHD result in an Asian family in relation to initially apparent compound heterozygosity.
    • Godfrey C, Clement E, Tan J, Brockington M, Torelli S, Feng L, Brown S, Jimenez-Mallebrera C, Sewry C, Longman C, Mein R, Abbs S, Vajsar J, Schachter H, Muntoni F (2007). Mild POMGnT1 mutations underlie a novel limb girdle muscular dystrophy variant. doi:10.1016/j.nmd.2007.06.364
    • Boor I, Nagtegaal M, Kamphorst W, van D, V P, J C VH, J D, A B, K E P-C, I M, F E, R S, G C VDK, M S (2007). MLC1 is associated with the Dystrophin-Glycoprotein Complex at astrocytic endfeet. Acta Neuropathol.(Berl), , - .
    • Morgan J, Muntoni F (2007). Mural cells paint a new picture of muscle stem cells. Nat Cell Biol, 9(3), 249 - 251.
    • Voit T, Cirak S, Abraham S, Karakesisoglou I, Parano E, Pavone P, Falsaperia R, Amthor H, Schroeder J, Muntoni F, Guicheney P, Nurnberg P, Noegel A, Herrmann R (2007). Congenital muscular dystrophy with adducted thumbs, mental retardation, cerebellar hypoplasia and cataracts is caused by mutation of Enaptin (Nesprin-1): The third nuclear envelopathy with muscular dystrophy.
    • Piercy RJ, Zhou H, Feng L, Pombo A, Muntoni F, Brown SC (2007). Desmin immunolocalisation in autosomal dominant Emery-Dreifuss muscular dystrophy. Neuromuscul.Disord, 17(4), 297 - 305.
    • Neri M, Torelli S, Brown S, Ugo I, Sabatelli P, Merlini L, Spitali P, Rimessi P, Gualandi F, Sewry C, Ferlini A, Muntoni F (2007). Dystrophin levels as low as 30% are sufficient to avoid muscular dystrophy in the human.. Neuromuscul Disord, 17(11-12), 913 - 918. doi:10.1016/j.nmd.2007.07.005
    • Zorzato F, Jungbluth H, Zhou H, Muntoni F, Treves S (2007). Functional effects of mutations identified in patients with multiminicore disease. IUBMB.Life, 59(1), 14 - 20.
    • Ramelli GP, Aloysius A, King C, Davis T, Muntoni F (2007). Gastrostomy placement in paediatric patients with neuromuscular disorders: indications and outcome. Dev Med Child Neurol, 49(5), 367 - 371.
    • Muntoni F, Wells D (2007). Genetic treatments in muscular dystrophies.. Curr Opin Neurol, 20(5), 590 - 594. doi:10.1097/WCO.0b013e3282efc157
    • Kaufmann P, Muntoni F (2007). Issues in SMA clinical trial design. The International Coordinating Committee (ICC) for SMA Subcommittee on SMA Clinical Trial Design. Neuromuscul.Disord, 17(6), 499 - 505.
    • Amthor H, Macharia R, Navarrete R, Schuelke M, Brown SC, Otto A, Voit T, Muntoni F, Vrbova G, Partridge T, Zammit P, Bunger L, Patel K (2007). Lack of myostatin results in excessive muscle growth but impaired force generation. Proc.Natl.Acad Sci U.S.A, 104(6), 1835 - 1840.
    • Amthor H, Macharia R, Navarrete R, Schuelke M, Brown SC, Otto A, Voit T, Muntoni F, Vrbova G, Partridge T, Zammit P, Bunger L, Patel K (2007). Lack of myostatin results in excessive muscle growth but impaired force generation (vol 104, pg 1835, 2007). P NATL ACAD SCI USA, 104(10), 4240 - 4240. doi:10.1073/pnas.0701154104
    • Poulton C, Kinali M, Robb S, Main M, Manzur A, Muntoni F (2007). Long-term steroid use of intermittent low-dosage prednisolone therapy in Duchenne muscular dystrophy with special reference to tolerance and functional outcomes. doi:10.1016/j.nmd.2007.06.044
    • Popplewell L, Arechavala-Gomeza V, Van Deutekom J, Muntoni F, Dickson G, Graham I (2007). Oligonucleotide-induced exon skipping of the human dystrophin gene.
    • Zhou H, Jungbluth H, Sewry CA, Feng L, Bertini E, Bushby K, Straub V, Roper H, Rose MR, Brockington M, Kinali M, Manzur A, Robb S, Appleton R, Messina S, D'Amico A, Quinlivan R, Swash M, Muller CR, Brown S, Treves S, Muntoni F (2007). Molecular mechanisms and phenotypic variation in RYR1-related congenital myopathies. Brain, , - .
    • Mercuri E, Pichiecchio A, Allsop J, Messina S, Pane M, Muntoni F (2007). Muscle MRI in inherited neuromuscular disorders: past, present, and future. J Magn Reson.Imaging, 25(2), 433 - 440.
    • Muntoni F, Brockington M, Godfrey C, Ackroyd M, Robb S, Manzur A, Kinali M, Mercuri E, Kaluarachchi M, Feng L, Jimenez-Mallebrera C, Clement E, Torelli S, Sewry CA, Brown SC (2007). Muscular dystrophies due to defective glycosylation of dystroglycan.. Acta Myol, 26(3), 129 - 135.
    • Nowak KJ, Sewry CA, Navarro C, Squier W, Reina C, Ricoy JR, Jayawant SS, Childs AM, Dobbie JA, Appleton RE, Mountford RC, Walker KR, Clement S, Barois A, Muntoni F, Romero NB, Laing NG (2007). Nemaline myopathy caused by absence of alpha-skeletal muscle actin. Ann Neurol, 61(2), 175 - 184.
    • Feng L, Jimenez-Mallebrera C, Quinlivan R, Muntoni F, Sewry C (2007). Non-specific over-expression of utrophin in a variety of neuromuscular disorders including limb girdle muscular dystrophies and congenital myopathies. doi:10.1016/j.nmd.2007.06.275

    2006

    • Senderek J, Krieger M, Stendel C, North K, Muntoni F, Quijano-Roy S, Ebinger F, Schroder JM, Voit T, Weis J, Topaloglu H, Zerres K (2006). Mutations in SIL1 cause Marinesco-Sjogren syndrome, a cerebellar ataxia with cataract and myopathy. doi:10.1016/j.nmd.2006.05.132
    • Mercuri E, Topaloglu H, Brockington M, Berardinelli A, Santorelli F, Rutherford M, Talim B, Ricci E, Voit T, Muntoni F (2006). The spectrum of brain changes in patients with congenital muscular dystrophy and FKRP gene mutations. DEV MED CHILD NEUROL, 48, 6 - 6.
    • Ramelli GP, Bagnall A, King C, Davies T, Muntoni F (2006). Gastrostomy placement in paediatric neuromuscular patients: indications and outcome. DEV MED CHILD NEUROL, 48, 27 - 28.
    • Main M, Kinali M, Muntoni F (2006). Limitation of neck movement may be a feature of most of the childhood neuromuscular disorders. doi:10.1016/j.nmd.2006.05.076
    • Gualandi F, Rimessi P, Trabanelli C, Spitali P, Neri M, Patarnello T, Angelini C, Yau SC, Abbs S, Muntoni F, Calzolari E, Ferlini A (2006). Intronic breakpoint definition and transcription analysis in DMD/BMD patients with deletion/duplication at the 5' mutation hot spot of the dystrophin gene. Gene, 370, 26 - 33.
    • Godfrey C, Mein R, Jimenez-Mallebrera C, Feng L, Brockington M, Muntoni F, Abbs S (2006). Mutation detection in a large cohort of muscular dystrophy patients widens the clinical spectrum associated with dystroglycanopathy genes.
    • Garralda ME, Muntoni F, Cunniff A, Caneja AD (2006). Knee-ankle-foot orthosis in children with duchenne muscular dystrophy: user views and adjustment. Eur J Paediatr Neurol, 10(4), 186 - 191.
    • Muntoni F, Bushby K, Manzur AY (2006). Muscular Dystrophy Campaign Funded Workshop on Management of Scoliosis in Duchenne Muscular Dystrophy 24 January 2005, London, UK. Neuromuscul.Disord, 16(3), 210 - 219.
    • Kinali M, Messina S, Mercuri E, Lehovsky J, Edge G, Manzur AY, Muntoni F (2006). Management of scoliosis in Duchenne muscular dystrophy: a large 10-year retrospective study. Dev Med Child Neurol, 48(6), 513 - 518.
    • Muntoni F, Bonne G, Goldfarb LG, Mercuri E, Piercy RJ, Burke M, Yaou RB, Richard P, Recan D, Shatunov A, Sewry CA, Brown SC (2006). Disease severity in dominant Emery Dreifuss is increased by mutations in both emerin and desmin proteins. Brain, 129(Pt 5), 1260 - 1268. doi:10.1093/brain/awl062
    • Jungbluth H, Zhou H, Treves S, Sewry C, Muntoni F (2006). Expanding range of phenotypes associated with mutations in the skeletal muscle ryanodine receptor gene. DEV MED CHILD NEUROL, 48, 7 - 8.
    • Godfrey C, Escolar D, Brockington M, Clement EM, Mein R, Jimenez-Mallebrera C, Torelli S, Feng L, Brown SC, Sewry CA, Rutherford M, Shapira Y, Abbs S, Muntoni F (2006). Fukutin gene mutations in steroid-responsive limb girdle muscular dystrophy. Ann Neurol, 60(5), 603 - 610.
    • Ducreux S, Zorzato F, Ferreiro A, Jungbluth H, Muntoni F, Monnier N, Muller CR, Treves S (2006). Functional properties of ryanodine receptors carrying three amino acid substitutions identified in patients affected by multi-minicore disease and central core disease, expressed in immortalized lymphocytes. Biochem.J, 395(2), 259 - 266.
    • Zhou H, Brockington M, Jungbluth H, Monk D, Stanier P, Sewry CA, Moore GE, Muntoni F (2006). Epigenetic allele silencing unveils recessive RYR1 mutations in core myopathies. The American Journal of Human Genetics, 79(5), 859 - 868. doi:10.1086/508500
    • Brown S, Brockington M, Kaluarachchi M, Manley J, Torelli S, Wells D, Muntoni F (2006). Evaluation of the effect of a transient up-regulation of LARGE in the mouse m.tibialis anterior.
    • Mercuri E, Brown SC, Nihoyannopoulos P, Poulton J, Kinali M, Richard P, Piercy R, Messina S, Sewry C, Burke MM, McKenna W, Bonne G, Muntoni F (2006). Extreme variability of skeletal and cardiac muscle involvement in patients with mutations in exon 11 of the lamin A/C gene. Muscle & Nerve, 31(5), 602 - 609.
    • van Reeuwijk J, Maugenre S, Van den Elzen C, Verrips A, Bertini E, Muntoni F, Merlini L, Scheffer H, Brunner HG, Guicheney P, Van Bokhoven H (2006). Glyc-O-genetics of Walker-Warburg syndrome and related disorders. doi:10.1016/j.nmd.2006.05.118
    • Nicholson C, Main M, Mercuri E, Muntoni F (2006). Is there a relationship between hamstring length and function in ambulant boys with Duchenne muscular dystrophy?. doi:10.1016/j.nmd.2006.05.238
    • Godfrey C, Mein R, Brockington M, Elson E, Topaloglu H, Smith J, Escolar D, Bertini E, Merlini I, Mercuri E, Bushby K, Straub V, North K, Abbs S, Muntoni F (2006). Molecular genetic analysis of 6 glycosyltransferases in a large population of dystroglycanopathy patients significantly widens the spectrum of phenotypes resulting from POMT1, POMGnT1 and Fukutin mutations. doi:10.1016/j.nmd.2006.05.133
    • van Reeuwijk J, Maugenre S, van den EC, Verrips A, Bertini E, Muntoni F, Merlini L, Scheffer H, Brunner HG, Guicheney P, van Bokhoven H (2006). The expanding phenotype of POMT1 mutations: from Walker-Warburg syndrome to congenital muscular dystrophy, microcephaly, and mental retardation. Hum Mutat., 27(5), 453 - 459.
    • Godfrey C, Mein R, Brockington M, Brown S, Escolar D, Abbs S, Muntoni F (2006). The identification of compound heterozygous mutations in the Fukutin gene in two non Japanese patients with Limb girdle muscular dystrphy..
    • Kaluarachchi M, Skordis L, Brockington M, Muntoni F, Brown SC (2006). The use of FRET analysis to look at the interaction of glycosyltransferases responsible for dystroglycanopathies. doi:10.1016/j.nmd.2006.05.122
    • Muntoni F (2006). Therapeutic highlights in muscular dystrophies.
    • Kinali M, Manzur AY, Mercuri E, Gibson BE, Hartley L, Simonds AK, Muntoni F (2006). UK physicians' attitudes and practices in long-term non-invasive ventilation of Duchenne Muscular Dystrophy. Pediatr Rehabil., 9(4), 351 - 364.
    • Knight R, Wilson B, Davis T, Muntoni F (2006). Ulna length in children with neuromuscular disorders: correlation with height and forced vital capacity. DEV MED CHILD NEUROL, 48, 28 - 29.
    • Kinali M, Knight RK, Main M, Mercuri E, Messina S, Manzur AY, Muntoni F (2006). Predictive factors for the development of scoliosis in Duchenne Muscular Dystrophy. DEV MED CHILD NEUROL, 48, 4 - 5.
    • Brockington M, Torelli S, Kaluarachchi M, Brown SC, Muntoni F (2006). The transient expression of Protein-O-Mannosyl Transferase 1 (POMT1) mutants retain their endoplasmic reticulum localisation.
    • Smith GC, Kinali M, Prasad SK, Bonne G, Muntoni F, Pennell DJ, Nihoyannopoulos P (2006). Primary myocardial dysfunction in autosomal dominant EDMD. A tissue doppler and cardiovascular magnetic resonance study. J Cardiovasc Magn Reson., 8(5), 723 - 730.
    • Mercuri E, Messina S, Battini R, Berardinelli A, Boffi P, Bono R, Bruno C, Carboni N, Cini C, Colitto F, D'Amico A, Minetti C, Mirabella M, Mongini T, Morandi L, Dlamini N, Orcesi S, Pelliccioni M, Pane M, Pini A, Swan AV, Villanova M, Vita G, Main M, Muntoni F, Bertini E (2006). Reliability of the Hammersmith functional motor scale for spinal muscular atrophy in a multicentric study. Neuromuscul.Disord, 16(2), 93 - 98.
    • Zhou H, Jungbluth H, Treves S, Bertini E, Straub V, Bushby K, Sewry C, Muntoni F (2006). RYR1 genotype-phenotype correlative and functional studies in a large cohort of core myopathy patients with RYR1 mutations. doi:10.1016/j.nmd.2006.05.146
    • Main M, Kinali M, Haliloglu G, Mercuri E, Baker R, Muntoni F (2006). Serial casting of the ankles in Duchenne muscular dystrophy: an alternative to surgery?. DEV MED CHILD NEUROL, 48, 5 - 5.
    • Kroos M, Manta P, Mavridou I, Muntoni F, Halley D, Van der HR, Zaifeiriou D, Van der PA, Reuser A, Michelakakis H (2006). Seven cases of Pompe disease from Greece. J Inherit Metab Dis, 29(4), 556 - 563.
    • James PA, Cader MZ, Muntoni F, Childs AM, Crow YJ, Talbot K (2006). Severe childhood SMA and axonal CMT due to anticodon binding domain mutations in the GARS gene. Neurology, 67(9), 1710 - 1712.
    • Mercuri E, Topaloglu H, Brockington M, Berardinelli A, Pichiecchio A, Santorelli F, Rutherford M, Talim B, Ricci E, Voit T, Muntoni F (2006). Spectrum of brain changes in patients with congenital muscular dystrophy and FKRP gene mutations. Arch Neurol, 63(2), 251 - 257.
    • Jungbluth H, Zhou H, Bertini E, Straub V, Bushby K, Robb S, Treves S, Sewry C, Muntoni F (2006). Autosomal centronuclear myopathy due to mutations in the skeletal muscle ryanodine receptor gene. DEV MED CHILD NEUROL, 48, 30 - 31.
    • Jimenez-Mallebrera C, Maioli MA, Kim J, Brown SC, Feng L, Lampe AK, Bushby K, Hicks D, Flanigan KM, Bonnemann C, Sewry CA, Muntoni F (2006). A comparative analysis of collagen VI production in muscle, skin and fibroblasts from 14 Ullrich congenital muscular dystrophy patients with dominant and recessive COL6A mutations. Neuromuscul.Disord, 16(9-10), 571 - 582.
    • Zhou H, Yamaguchi N, Xu L, Wang Y, Sewry C, Jungbluth H, Zorzato F, Bertini E, Muntoni F, Meissner G, Treves S (2006). Characterization of recessive RYR1 mutations in core myopathies. Hum Mol Genet, 15(18), 2791 - 2803.
    • Facer P, Atherton D, Roberts K, Misra VP, Kinali M, Manzur AY, Muntoni F, Anand P (2006). A new syndrome of congenital insensitivity to pain diagnosed by skin biopsy and contact heat evoked potentials (CHEPS).
    • Arechavala V, Bushby K, Dickson G, Graham I, Kinali M, Liu K, Morgan J, Muntoni F, Popplewell L, Partridge T, Thorogood F, Wells K, Wells N, Wood M, Yin H (2006). A phase I/II clinical trial in Duchenne muscular dystrophy using IM and IV delivered antisense oligonucleotides: The MDEX consortium. doi:10.1016/j.nmd.2006.05.138
    • Muntoni F (2006). Cardiac involvement in limb girdle muscular dystrophies.
    • Giatrakos N, Kinali M, Stephens D, Dawson D, Muntoni F, Nihoyannopoulos P (2006). Cardiac tissue velocities and strain rate in the early detection of myocardial dysfunction of asymptomatic boys with Duchenne's muscular dystrophy: relationship to clinical outcome. Heart, 92(6), 840 - 842.
    • Mercuri E, D'Amico A, Tessa A, Berardinelli A, Pane M, Messina S, van Reeuwijk J, Bertini E, Muntoni F, Santorelli FM (2006). POMT2 mutation in a patient with 'MEB-like' phenotype. Neuromuscul.Disord, 16(7), 446 - 448.
    • Kinali M, Knight RK, Main M, Mercuri E, Messina S, Manzur AY, Muntoni F (2006). Predictive factors for the development of scoliosis in Duchenne muscular dystrophy. doi:10.1016/j.nmd.2006.05.239
    • Lehtokari VL, Pelin K, Sandbacka M, Ranta S, Donner K, Muntoni F, Sewry C, Angelini C, Bushby K, Van den BP, Iannaccone S, Laing NG, Wallgren-Pettersson C (2006). Identification of 45 novel mutations in the nebulin gene associated with autosomal recessive nemaline myopathy. Hum Mutat., 27(9), 946 - 956.

    2005

    • Mercuri E, Jungbluth H, Muntoni F (2005). Muscle imaging in clinical practice: diagnostic value of muscle magnetic resonance imaging in inherited neuromuscular disorders. Curr Opin Neurol, 18(5), 526 - 537.
    • Longman C, Sellick G, Mahjneh I, Brockington M, Sagi L, Anderson L, Topaloglu H, Bushby K, Houlston R, Muntoni F (2005). A novel locus for congenital muscular dystrophy maps to chromosome 4p16.3.
    • Mercuri E, Lampe A, Allsop J, Knight R, Pane M, Kinali M, Bonnemann C, Flanigan K, Lapini I, Bushby K, Pepe G, Muntoni F (2005). Muscle MRI in Ullrich congenital muscular dystrophy and Bethlem myopathy. Neuromuscul.Disord, 15(4), 303 - 310.
    • Dolatshad NF, Brockington M, Torelli S, Skordis L, Wever U, Wells DJ, Muntoni F, Brown SC (2005). Mutated fukutin-related protein (FKRP) localises as wild type in differentiated muscle cells. Experimental Cell Research, 309(2), 370 - 378. doi:10.1016/j.yexcr.2005.06.017
    • Rimessi P, Gualandi F, Duprez L, Spitali P, Neri M, Merlini L, Calzolari E, Muntoni F, Ferlini A (2005). Genomic and transcription studies as diagnostic tools for a prenatal detection of X-linked dilated cardiomyopathy due to a dystrophin gene mutation. Am J Med Genet A, 132(4), 391 - 394.
    • Giatrakos N, Kinali M, Muntoni F, Nihoyannopoulos P (2005). Impaired endothelium independent vasodilatation of the brachial artery in patients with limb-girdle muscular dystrophy indicates smooth muscle cell dysfunction..
    • Sellick GS, Longman C, Brockington M, Mahjneh I, Sagi L, Bushby K, Topaloglu H, Muntoni F, Houlston RS (2005). Localisation of merosin-positive congenital muscular dystrophy to chromosome 4p16.3. Hum Genet, 117(2-3), 207 - 212.
    • Brockington M, Torelli S, Prandini P, Boito C, Dolatshad NF, Longman C, Brown SC, Muntoni F (2005). Localization and functional analysis of the LARGE family of glycosyltransferases: significance for muscular dystrophy. Human Molecular Genetics, 14(5), 657 - 665. doi:10.1093/hmg/ddi062
    • Jungbluth H, Zhou H, Hartley L, Halliger-Keller B, Messina S, Longman C, Brockington M, Robb SA, Straub V, Voit T, Swash M, Ferreiro A, Bydder G, Sewry CA, Muller C, Muntoni F (2005). Minicore myopathy with ophthalmoplegia caused by mutations in the ryanodine receptor type 1 gene. Neurology, 65(12), 1930 - 1935.
    • Jimenez-Mallebrera C, Brown SC, Sewry CA, Muntoni F (2005). Congenital muscular dystrophy: molecular and cellular aspects. Cell Mol Life Sci, 62(7-8), 809 - 823.
    • Lucioli S, Giusti B, Mercuri E, Vanegas OC, Lucarini L, Pietroni V, Urtizberea A, Ben Yaou R, de Visser M, van der Kooi AJ, Bonnemann C, Iannaccone ST, Merlini L, Bushby K, Muntoni F, Bertini E, Chu ML, Pepe G (2005). Detection of common and private mutations in the COL6A1 gene of patients with Bethlem myopathy. Neurology, 64(11), 1931 - 1937.
    • Muntoni F, Mercuri E, Bonne G, Goldfarb L, Richard P, Recan D, Sewry CA, Brown SC (2005). Double lamin-emerin and lamin-desmin trouble.
    • Mercuri E, Brown SC, Nihoyannopoulos P, Poulton J, Kinali M, Richard P, Piercy RJ, Messina S, Sewry C, Burke MM, McKenna W, Bonne G, Muntoni F (2005). Extreme variability of skeletal and cardiac muscle involvement in patients with mutations in exon 11 of the lamin A/C gene. Muscle Nerve, 31(5), 602 - 609.
    • Jungbluth H, Zhou H, Sewry CA, Mills KR, Rose MR, Muntoni F (2005). Multi-minicore disease with external ophthalmoplegia and periodic paralysis associated with a mutation in the skeletal muscle ryanodine receptor (RYR1) gene.
    • Senderek J, Krieger M, Stendel C, Bergmann C, Moser M, Breitbach-Faller N, Rudnik-Schoneborn S, Blaschek A, Wolf NI, Harting I, North K, Smith J, Muntoni F, Brockington M, Quijano-Roy S, Renault F, Herrmann R, Hendershot LM, Schroder JM, Lochmuller H, Topaloglu H, Voit T, Weis J, Ebinger F, Zerres K (2005). Mutations in SIL1 cause Marinesco-Sjogren syndrome, a cerebellar ataxia with cataract and myopathy. Nat Genet, 37(12), 1312 - 1314.
    • Brown SC, Torelli S, Ugo I, De Biasia F, Howman EV, Poon E, Britton J, Davies KE, Muntoni F (2005). Syncoilin upregulation in muscle of patients with neuromuscular disease. Muscle Nerve, 32(6), 715 - 725.
    • Brockington M, Muntoni F (2005). The modulation of skeletal muscle glycosylation as a potential therapeutic intervention in muscular dystrophies. Acta Myol., 24(3), 217 - 221.
    • Kirschner J, Hausser I, Zou Y, Schreiber G, Christen HJ, Brown SC, Anton-Lamprecht I, Muntoni F, Hanefeld F, Bonnemann CG (2005). Ullrich congenital muscular dystrophy: connective tissue abnormalities in the skin support overlap with Ehlers-Danlos syndromes. Am J Med Genet A, 132(3), 296 - 301.
    • Muntoni F (2005). Walker-Warburg syndrome and limb girdle muscular dystrophy; two sides of the same coin. Neuromuscul.Disord, 15(4), 269 - 270.
    • Knight RK, Muntoni F, Lampe A, Bushby K, Mercuri E, Manzur A (2005). Cutaneous abnormality as a diagnostic tool in the diagnosis of collagen VI deficient congenital muscular dystrophy.
    • Piercy RJ, Zhou H, Torelli S, Ellis J, Muntoni F, Brown SC (2005). Desmin localisation in autosomal dominant Emery Dreifuss muscular dystrophy.
    • Ip P, Knight R, Dokal I, Manzur AY, Muntoni F (2005). Peripheral neuropathy: a novel finding in dyskeratosis congenital.
    • van Reeuwijk J, Janssen M, van den EC, Beltran-Valero DB, Sabatelli P, Merlini L, Boon M, Scheffer H, Brockington M, Muntoni F, Huynen MA, Verrips A, Walsh CA, Barth PG, Brunner HG, van Bokhoven H (2005). POMT2 mutations cause alpha-dystroglycan hypoglycosylation and Walker-Warburg syndrome. J Med Genet, 42(12), 907 - 912.
    • van Reeuwijk J, Janssen M, van den Elzen C, de Bernabe DBV, Sabatelli P, Merlini L, Boon M, Scheffer H, Brockington M, Muntoni F, Huynen MA, Walsh CA, Barth PG, Brunner HG, van Bokhoven H (2005). POMT2 mutations give rise to Walker Warburg syndrome.
    • Vainzof M, Richard P, Herrmann R, Jimenez-Mallebrera C, Talim B, Yamamoto LU, Ledeuil C, Mein R, Abbs S, Brockington M, Romero N, Zatz M, Topaloglu H, Voit T, Sewry C, Muntoni F, Guicheney P, Tome FMS (2005). Prenatal diagnosis in laminin alpha-2 chain (merosin)-deficient congenital muscular dystrophy: a collective experience of 5 international centers.
    • Vainzof M, Richard P, Herrmann R, Jimenez-Mallebrera C, Talim B, Yamamoto LU, Ledeuil C, Mein R, Abbs S, Brockington M, Romero NB, Zatz M, Topaloglu H, Voit T, Sewry C, Muntoni F, Guicheney P, Tome FM (2005). Prenatal diagnosis in laminin alpha2 chain (merosin)-deficient congenital muscular dystrophy: a collective experience of five international centers. Neuromuscul.Disord, 15(9-10), 588 - 594.
    • Jimenez-Mallebrera C, Brown SC, Maioli M, Kim J, Lampe AK, Bushby K, Flanigan KM, Sewry CA, Muntoni F (2005). Production, secretion and immunolabelling of collagen VI in patients with recessive and dominant mutations in COL6 genes.
    • Dlamini N, Messina S, Padua DL, Main M, Knight R, Manzur A, Mercuri E, Muntoni F, Kinali M (2005). Quality of life outcomes following rehabilitation in knee-ankle-foot orthoses (KAFOs) in Duchenne muscular dystrophy.
    • Zhou H, Treves S, Jungbluth H, Sewry C, Muntoni F (2005). RYR1 gene genotype-phenotype and functional correlative studies in central core disease and multi-minicore disease.
    • Gonzalez V, Quijano-Roy S, Parain K, Bonnemann C, Bushby K, Castiglioni C, Ceuterick C, Chaigne D, Colomer J, Desguerre I, de Visser M, Elcioglu N, Eymard B, Fidzianska A, Goemans N, Jungbluth H, Kaindl AM, Labarre-Vila A, Leroy JP, Lochmuller H, Mayer M, Martin JJ, Muntoni F, Merlini L, Pellegrini N, Quinlivan R, Romero NB, Sewry C, Topaloglu H, Toutain A, Urtizberea A, van der Kooi A, Viollet L, Voit T, Estournet B, Richard P, Guicheney P, Ferreiro A (2005). SEPN-related myopathy: an emerging entity phenotypical and molecular analysis of 80 cases.
    • Torelli S, Brown SC, Brockington M, Dolatshad NF, Jimenez C, Skordis L, Feng LH, Merlini L, Jones DH, Romero N, Wewer U, Voit T, Sewry CA, Noguchi S, Nishino I, Muntoni F (2005). Sub-cellular localisation of fukutin related protein in different cell lines and in the muscle of patients with MDC1C and LGMD2I. Neuromuscul.Disord, 15(12), 836 - 843.
    • Lampe AK, Dunn DM, von Niederhausern AC, Hamil C, Aoyagi A, Laval SH, Marie SK, Chu ML, Swoboda K, Muntoni F, Bonnemann CG, Flanigan KM, Bushby KM, Weiss RB (2005). Automated genomic sequence analysis of the three collagen VI genes: applications to Ullrich congenital muscular dystrophy and Bethlem myopathy. J Med Genet, 42(2), 108 - 120.
    • Jungbluth H, Zhou H, Bertini E, Treves S, Sewry C, Muntoni F (2005). Autosomal dominant mutations in the human ryanodine receptor (RYR1) gene associated with centronuclear myopathy.
    • Olpin SE, Clark S, Andresen BS, Bischoff C, Olsen RK, Gregersen N, Chakrapani A, Downing M, Manning NJ, Sharrard M, Bonham JR, Muntoni F, Turnbull DN, Pourfarzam M (2005). Biochemical, clinical and molecular findings in LCHAD and general mitochondrial trifunctional protein deficiency. J Inherit Metab Dis, 28(4), 533 - 544.
    • Vasta I, Kinali M, Messina S, Guzzetta A, Kapellou O, Manzur A, Cowan F, Muntoni F, Mercuri E (2005). Can clinical signs identify newborns with neuromuscular disorders?. J Pediatr, 146(1), 73 - 79.
    • Goodwin FC, Muntoni F (2005). Cardiac involvement in muscular dystrophies: molecular mechanisms. Muscle Nerve, 32(5), 577 - 588.
    • Lucarini L, Giusti B, Zhang RZ, Pan TC, Jimenez-Mallebrera C, Mercuri E, Muntoni F, Pepe G, Chu ML (2005). A homozygous COL6A2 intron mutation causes in-frame triple-helical deletion and nonsense-mediated mRNA decay in a patient with Ullrich congenital muscular dystrophy. Hum Genet, 117(5), 460 - 466.
    • Muntoni F, Bushby K, van Ommen G (2005). 128th ENMC International Workshop on 'Preclinical optimization and Phase I/II Clinical Trials Using Antisense Oligonucleotides in Duchenne Muscular Dystrophy' 22-24 October 2004, Naarden, The Netherlands. Neuromuscul.Disord, 15(6), 450 - 457.
    • Muntoni F, Voit T (2005). 133rd ENMC International Workshop on Congenital Muscular Dystrophy (IXth International CMD Workshop) 21-23 January 2005, Naarden, The Netherlands. Neuromuscul.Disord, 15(11), 794 - 801.
    • Bertini E, Burghes A, Bushby K, Estournet-Mathiaud B, Finkel RS, Hughes RA, Iannaccone ST, Melki J, Mercuri E, Muntoni F, Voit T, Reitter B, Swoboda KJ, Tiziano D, Tizzano E, Topaloglu H, Wirth B, Zerres K (2005). 134th ENMC International Workshop: Outcome Measures and Treatment of Spinal Muscular Atrophy, 11-13 February 2005, Naarden, The Netherlands. Neuromuscul.Disord, 15(11), 802 - 816.
    • Sewry CA, Jimenez-Mallbrera C, Feng L, Quinlivan R, Muntoni F (2005). Over-expression of sarcolemmal utrophin in patients with limb-girdle muscular dystrophies.
    • Muntoni F, Zafeiriou DI, Jimenez C, Reuser A, Sewry C (2005). A case presenting with delayed motor milestones. Neuromuscul.Disord, 15(11), 817 - 818.
    • Ip P, Knight R, Dokal I, Manzur AY, Muntoni F (2005). Peripheral neuropathy--a novel finding in dyskeratosis congenita. Eur J Paediatr Neurol, 9(2), 85 - 89.
    • Fisher I, Abraham D, Bouri K, Hoffman EP, Muntoni F, Morgan J (2005). Prednisolone-induced changes in dystrophic skeletal muscle. FASEB J, 19(7), 834 - 836.
    • Main M, Haliloglu G, Kinali M, Mercuri E, Muntoni F, Baker R (2005). Rehabilitation of walking in KAFO's in Duchenne muscular dystrophy: can surgical release of the TA be avoided?.
    • Mercuri E, Topaloglu H, Brockington M, Berardinelli A, Pichiecchio A, Santorelli FM, Ricci E, Rutherford M, Voit T, Muntoni F (2005). The spectrum of brain malformations in patients with FKRP gene mutations.
    • Mercuri E, Bushby K, Ricci E, Birchall D, Pane M, Kinali M, Allsop J, Nigro V, Saenz A, Nascimbeni A, Fulizio L, Angelini C, Muntoni F (2005). Muscle MRI findings in patients with limb girdle muscular dystrophy with calpain 3 deficiency (LGMD2A) and early contractures. Neuromuscul.Disord, 15(2), 164 - 171.

    2004

    • Cohen N, Muntoni F (2004). Multiple pathogenetic mechanisms in X linked dilated cardiomyopathy. Heart, 90(8), 835 - 841.
    • Crabtree NJ, Kibirige MS, Fordham JN, Banks LM, Muntoni F, Chinn D, Boivin CM, Shaw NJ (2004). The relationship between lean body mass and bone mineral content in paediatric health and disease. Bone, 35(4), 965 - 972.
    • Beltran-Valero DB, Voit T, Longman C, Steinbrecher A, Straub V, Yuva Y, Herrmann R, Sperner J, Korenke C, Diesen C, Dobyns WB, Brunner HG, van Bokhoven H, Brockington M, Muntoni F (2004). Mutations in the FKRP gene can cause muscle-eye-brain disease and Walker-Warburg syndrome. J Med Genet, 41(5), e61 - .
    • Jimenez-Mallebrera C, Maioli M, Feng L, Brown SC, Lampe AK, Bushby K, Flanigan K, Weiss B, Bonnemann C, Mercuri E, Torelli S, Sewry CA, Muntoni F (2004). Normal collagen VI immunolabelling in Ullrich congenital muscular dystrophy with COL6 mutations.
    • Lamhonwah AM, Onizuka R, Olpin SE, Muntoni F, Tein I (2004). OCTN2 mutation (R254X) found in Saudi Arabian kindred: recurrent mutation or ancient founder mutation?. J Inherit Metab Dis, 27(4), 473 - 476.
    • Wallgren-Pettersson C, Pelin K, Nowak KJ, Muntoni F, Romero NB, Goebel HH, North KN, Beggs AH, Laing NG (2004). Genotype-phenotype correlations in nemaline myopathy caused by mutations in the genes for nebulin and skeletal muscle alpha-actin. Neuromuscul.Disord, 14(8-9), 461 - 470.
    • Kaluarachchi M, Jimenez-Mallebrera C, Torelli S, Brockington M, Muntoni F, Brown SC (2004). In situ hybridization of FKRP mRNA during mouse development.
    • Cohen N, Rimessi P, Gualandi F, Ferlini A, Muntoni F (2004). In vivo study of an aberrant dystrophin exon inclusion in X-linked dilated cardiomyopathy. Biochem.Biophys Res Commun., 317(4), 1215 - 1220.
    • Patel K, Muntoni F (2004). Inducing muscle hypertrophy as a therapeutic strategy for muscular dystrophies. 122nd ENMC International Workshop, Naarden, The Netherlands, 28-30 November 2003. Neuromuscul.Disord, 14(8-9), 519 - 525.
    • Jungbluth H, Davis MR, Muller C, Counsell S, Allsop J, Chattopadhyay A, Messina S, Mercuri E, Laing NG, Sewry CA, Bydder G, Muntoni F (2004). Magnetic resonance imaging of muscle in congenital myopathies associated with RYR1 mutations. Neuromuscul.Disord, 14(12), 785 - 790.
    • Hackman P, Juvonen V, Vihola A, Sarparanta J, Auranen M, Suominen T, Brockington M, Muntoni F, Saenz A, Kalimo H, Marchand S, Richard I, Udd B (2004). Molecular genetics of recessive limb girdle muscular dystrophies in Finland.
    • Brown SC, Torelli S, Jimenez C, Muntoni F, Sewry CA (2004). Immunopathology and molecular genetics of dystrophinopathies. Suppl Clin Neurophysiol, 57, 313 - 321.
    • Mercuri E, Messina S, Kinali M, Cini C, Longman C, Battini R, Cioni G, Muntoni F (2004). Congenital form of spinal muscular atrophy predominantly affecting the lower limbs: a clinical and muscle MRI study. Neuromuscul.Disord, 14(2), 125 - 129.
    • Muntoni F, Brockington M, Torelli S, Brown SC (2004). Defective glycosylation in congenital muscular dystrophies. Curr Opin Neurol, 17(2), 205 - 209.
    • Torelli S, Brown SC, Dolatshad N, Jimenez-Mallebrera C, Skordis L, Brockington M, Feng L, Romero N, Jones DH, Merlini L, Sewry C, Noguchi S, Nishino I, Muntoni F (2004). Developmental expression and sub-cellular localisation of fakutin related protein in cultured cell lines and the muscle of patients with MDC1C and LGMD2I.
    • Ducreux S, Zorzato F, Muller C, Sewry C, Muntoni F, Quinlivan R, Restagno G, Girard T, Treves S (2004). Effect of ryanodine receptor mutations on interleukin-6 release and intracellular calcium homeostasis in human myotubes from malignant hyperthermia-susceptible individuals and patients affected by central core disease. J Biol Chem, 279(42), 43838 - 43846.
    • Kinali M, Jungbluth H, Eunson LH, Sewry CA, Manzur AY, Mercuri E, Hanna MG, Muntoni F (2004). Expanding the phenotype of potassium channelopathy: severe neuromyotonia and skeletal deformities without prominent Episodic Ataxia. Neuromuscular Disorders, 14(10), 689 - 693. doi:10.1016/j.nmd.2004.06.007
    • Mercuri E, Poppe M, Quinlivan R, Messina S, Kinali M, Demay L, Bourke J, Richard P, Sewry C, Pike M, Bonne G, Muntoni F, Bushby K (2004). Extreme variability of phenotype in patients with an identical missense mutation in the lamin A/C gene: from congenital onset with severe phenotype to milder classic Emery-Dreifuss variant. Arch Neurol, 61(5), 690 - 694.
    • Tay SK, Akman HO, Chung WK, Pike MG, Muntoni F, Hays AP, Shanske S, Valberg SJ, Mickelson JR, Tanji K, DiMauro S (2004). Fatal infantile neuromuscular presentation of glycogen storage disease type IV. Neuromuscul.Disord, 14(4), 253 - 260.
    • Kinali M, Olpin SE, Clayton PT, Daubeney PE, Mercuri E, Manzur AY, Tein I, Leonard J, Muntoni F (2004). Diagnostic difficulties in a case of primary systemic carnitine deficiency with idiopathic dilated cardiomyopathy. Eur J Paediatr Neurol, 8(4), 217 - 219.
    • Muntoni F (2004). Duchenne Muscular dystrophy: from pathogenesis to therapeutic trials.
    • Treves S, Ducreux S, Sewry C, Muntoni F, Quinlivan R, Muller C, Restagno G, Zorzato F (2004). Effect of ryanodine receptor mutations on IL-6 release and intracellular calcium homeostasis in human myotubes from malignant hyperthermia susceptible individuals and patients affected by central core disease.
    • Muntoni F, Brockington M, Brown SC (2004). Glycosylation eases muscular dystrophy. Nat Med, 10(7), 676 - 677.
    • Muntoni F (2004). Journey into muscular dystrophies caused by abnormal glycosylation. Acta Myol., 23(2), 79 - 84.
    • Jungbluth H, Sewry CA, Counsell S, Allsop J, Chattopadhyay A, Mercuri E, North K, Laing N, Bydder G, Pelin K, Wallgren-Pettersson C, Muntoni F (2004). Magnetic resonance imaging of muscle in nemaline myopathy. Neuromuscul.Disord, 14(12), 779 - 784.
    • Kutzick C, Herrmann R, Straub V, Steinbrecher A, Cirak S, Korenke C, Guicheney P, Schara U, Wrogemann K, Muntoni F, Faurholt-Pedersen V, Wewer U, Voit T (2004). Muscle-eye-brain disease due to homozygous founder mutation in FKRP in Northern Germany and Denmark.
    • Muntoni F, Voit T (2004). The congenital muscular dystrophies in 2004: a century of exciting progress. Neuromuscul.Disord, 14(10), 635 - 649.
    • Brockington M, Torelli S, Boito C, Longman C, Brown SC, Muntoni F (2004). Transient expression of wild type but not mutant LARGE localises at the Golgi apparatus and causes increased alpha-dystroglycan biosynthesis.
    • Mercuri E, Lampe A, Straub V, Yuva Y, Longman C, Wright M, Brown S, Sewry C, Bonnemann C, Kinali M, Brockington M, Hausser I, Hilton JD, Voit T, Bushby K, Muntoni F (2004). Congenital muscular dystrophy with short stature, proximal contractures and distal laxity. Neuropediatrics, 35(4), 224 - 229.
    • Messina S, Hurtley L, Kinali M, Main M, Jungbluth H, Muntoni F, Mercuri E (2004). Pilot study of salbutamol in congenital myopathies.
    • Messina S, Hartley L, Main M, Kinali M, Jungbluth H, Muntoni F, Mercuri E (2004). Pilot trial of Salbutamol in congenital myopathies.
    • Messina S, Hartley L, Main M, Kinali M, Jungbluth H, Muntoni F, Mercuri E (2004). Pilot trial of salbutamol in central core and multi-minicore diseases. Neuropediatrics, 35(5), 262 - 266.
    • Brockington M, Brown SC, Lampe A, Yuva Y, Feng L, Jimenez-Mallebrera C, Sewry CA, Flanigan KM, Bushby K, Muntoni F (2004). Prenatal diagnosis of Ullrich congenital muscular dystrophy using haplotype analysis and collagen VI immunocytochemistry. Prenat Diagn, 24(6), 440 - 444.
    • Jimenez-Mallebrera C, Feng L, Brown SC, Barber R, Abbs S, Sewry CA, Muntoni F (2004). Primary or secondary laminin-alpha 2 deficiency?.
    • Quinlivan R, Roper H, Manzur A, Eagle M, Hill M, Davie M, Mughal Z, Shaw N, McDonagh J, Muntoni F, Bushby K (2004). Report of a Muscular Dystrophy Campaign funded workshop to review the prevalence of osteoporosis in DMD and its treatment and prevention.
    • Bushby K, Muntoni F, Urtizberea A, Hughes R, Griggs R (2004). Report on the 124th ENMC International Workshop. Treatment of Duchenne muscular dystrophy; defining the gold standards of management in the use of corticosteroids. 2-4 April 2004, Naarden, The Netherlands. Neuromuscul.Disord, 14(8-9), 526 - 534.
    • Kurian MA, Hartley L, Zolkipli Z, Little MA, Costigan D, Naughten ER, Olpin S, Muntoni F, King MD (2004). Short-chain acyl-CoA dehydrogenase deficiency associated with early onset severe axonal neuropathy. Neuropediatrics, 35(5), 312 - 316.
    • Giatrakos N, Stephens D, Kinali M, Muntoni F, Nihoyannopoulos P (2004). Strain rate can accurately predict a more aggressive cardiac involvement in asymptomatic patients with duchenne muscular dystrophy.
    • Brown SC, Torelli S, Brockington M, Yuva Y, Jimenez C, Feng L, Anderson L, Ugo I, Kroger S, Bushby K, Voit T, Sewry C, Muntoni F (2004). Abnormalities in alpha-dystroglycan expression in MDC1C and LGMD2I muscular dystrophies. American Journal Of Pathology, 164(2), 727 - 737.
    • Torelli S, Brown SC, Jimenez-Mallebrera C, Feng L, Muntoni F, Sewry CA (2004). Absence of neuronal nitric oxide synthase (nNOS) as a pathological marker for the diagnosis of Becker muscular dystrophy with rod domain deletions. Neuropathol.Appl Neurobiol., 30(5), 540 - 545.
    • Longman C, Mercuri E, Cowan F, Allsop J, Brockington M, Jimenez-Mallebrera C, Kumar S, Rutherford M, Toda T, Muntoni F (2004). Antenatal and postnatal brain magnetic resonance imaging in muscle-eye-brain disease. Arch Neurol, 61(8), 1301 - 1306.
    • Kinali M, Banks LM, Mercuri E, Manzur AY, Muntoni F (2004). Bone mineral density in a paediatric spinal muscular atrophy population. Neuropediatrics, 35(6), 325 - 328.
    • Poppe M, Bourke J, Eagle M, Frosk P, Wrogemann K, Greenberg C, Muntoni F, Voit T, Straub V, Hilton-Jones D, Shirodaria C, Bushby K (2004). Cardiac and respiratory failure in limb-girdle muscular dystrophy 2I. Ann Neurol, 56(5), 738 - 741.
    • Hu TM, Gabriel CM, Manzur AY, King RH, Muntoni F (2004). "A faint in the emergency department (due to primary systemic amyloidosis neuropathy).". Practical Neurology, 4, 104 - 109.
    • Jungbluth H, Beggs A, Bonnemann C, Bushby K, Ceuterick-de Groote C, Estournet-Mathiaud B, Goemans N, Guicheney P, Lescure A, Lunardi J, Muntoni F, Quinlivan R, Sewry C, Straub V, Treves S, Ferreiro A (2004). 111th ENMC International Workshop on Multi-minicore Disease. 2nd International MmD Workshop, 9-11 November 2002, Naarden, The Netherlands. Neuromuscul.Disord, 14(11), 754 - 766.
    • Giatrakos ND, Kinali M, Muntoni F, Nihoyannopoulos P (2004). Strain rate and strain rate-derived time to onset of relaxation can be used for the early detection of impaired myocardial function in asymptomatic boys with Duchenne muscular dystrophy.
    • Dolatshad N, Skordis LA, Torelli S, Brockington M, Muntoni F, Brown SC (2004). Cellular localisation of wild type and mutated FKRP.
    • Lampe AK, Muntoni F, Bonnemann C, Flanigan KM, Swoboda K, Jimenez-Mallebrera C, Laval S, Weiss RB, Bushby K (2004). Bethlem and Ullrich patients with splice site mutations in COL6A1, 2 and 3.
    • Majumdar A, Hartley L, Manzur AY, King RH, Orrell RW, Muntoni F (2004). A case of severe congenital chronic inflammatory demyelinating polyneuropathy with complete spontaneous remission.. Neuromuscular Disorders, 14(12), 818 - 821.
    • Treves S, Ducreux S, Sewry C, Muntoni F, Muller C, Zorzato F (2004). Ryanodine receptor mutations linked to MH and CCD: effect of mutations on intracellular calcium homeostasis of cultured primary human skeletal muscle cells.
    • Giatrakos N, Stephens D, Kinali M, Muntoni F, Nihoyannopoulos P (2004). Strain rate can be used for the prediction of the development of a more aggressive cardiomyopathy in asymptomatic patients with Duchenne muscular dystrophy. A three year follow-up study.
    • Longman C, Sewry CA, Muntoni F (2004). Muscle involvement in the cerebro-oculo-facio-skeletal syndrome. Pediatr Neurol, 30(2), 125 - 128.

    2003

    • Mercuri E, Cini C, Pichiecchio A, Allsop J, Counsell S, Zolkipli Z, Messina S, Kinali M, Brown SC, Jimenez C, Brockington M, Yuva Y, Sewry CA, Muntoni F (2003). Muscle magnetic resonance imaging in patients with congenital muscular dystrophy and Ullrich phenotype. Neuromuscul.Disord, 13(7-8), 554 - 558.
    • Lampe AK, Dunn DM, von Niederhausern AC, Aoyagi A, Hamil C, Duval B, O'Brien K, Laval S, Chu ML, Swoboda K, Muntoni F, Bonnemann C, Flanigan KM, Bushby K, Weiss RB (2003). Rapid direct sequence analysis of the three genes encoding collagen VI.
    • Hanks S, Adams S, Douglas J, Arbour L, Atherton DJ, Balci S, Bode H, Campbell ME, Feingold M, Keser G, Kleijer W, Mancini G, McGrath JA, Muntoni F, Nanda A, Teare MD, Warman M, Pope FM, Superti-Furga A, Futreal PA, Rahman N (2003). Mutations in the gene encoding capillary morphogenesis protein 2 cause juvenile hyaline fibromatosis and infantile systemic hyalinosis. Am J Hum Genet, 73(4), 791 - 800.
    • Longman CA, Brockington M, Kennedy C, Jimenez C, Torelli S, Sewry C, Brown S, Muntoni F (2003). Mutations in the human LARGE gene cause a form of congenital muscular dystrophy with severe mental retardation and abnormal glycosylation of alpha-dystroglycan (MDC1D)..
    • Longman C, Brockington M, Torelli S, Jimenez-Mallebrera C, Kennedy C, Khalil N, Feng L, Saran RK, Voit T, Merlini L, Sewry CA, Brown SC, Muntoni F (2003). Mutations in the human LARGE gene cause MDC1D, a novel form of congenital muscular dystrophy with severe mental retardation and abnormal glycosylation of alpha-dystroglycan. Human Molecular Genetics, 12(21), 2853 - 2861. doi:10.1093/hmg/ddg307
    • Treves S, Sewry C, Quinlivan R, Muntoni F, Muller CR, Girard T, Ducreux S, Zorzato F (2003). Mutations in the skeletal muscle calcium channel (ryanodine receptor) linked to central core disease. Impact on the functional properties of the endogenous calcium release channel in cultured human muscle cells.
    • Taylor MR, Fain PR, Sinagra G, Robinson ML, Robertson AD, Carniel E, Di Lenarda A, Bohlmeyer TJ, Ferguson DA, Brodsky GL, Boucek MM, Lascor J, Moss AC, Li WL, Stetler GL, Muntoni F, Bristow MR, Mestroni L (2003). Natural history of dilated cardiomyopathy due to lamin A/C gene mutations. J Am Coll.Cardiol, 41(5), 771 - 780.
    • Taylor MRG, Fain PR, Sinagra G, Robinson ML, Robertson AD, Carniel E, Di Lenarda A, Bohlmeyer TJ, Ferguson DA, Brodsky GL, Boucek MM, Lascor J, Moss AC, Li WLP, Stetler GL, Muntoni F, Bristow MR, Mestroni L, Familiar Dilated Cardiomyopathy Re (2003). Natural history of dilated cardiomyopathy due to lamin A/C gene mutations (vol 41, pg 771, 2003). J AM COLL CARDIOL, 42(3), 590 - 590. doi:10.1016/S0735-1097(03)00887-8
    • Zolkipli Z, Hartley L, Brown S, Rutherford M, Cowan F, Mercuri E, Muntoni F (2003). Occipito-temporal polymicrogyria and subclinical muscular dystrophy. Neuropediatrics, 34(2), 92 - 95.
    • Gualandi F, Rimessi P, Cardazzo B, Toffolatti L, Dunckley MG, Calzolari E, Patarnello T, Muntoni F, Ferlini A (2003). Genomic definition of a pure intronic dystrophin deletion responsible for an XLDC splicing mutation: in vitro mimicking and antisense modulation of the splicing abnormality. Gene, 311, 25 - 33.
    • Grohmann K, Varon R, Stolz P, Schuelke M, Janetzki C, Bertini E, Bushby K, Muntoni F, Ouvrier R, Van Maldergem L, Goemans NM, Lochmuller H, Eichholz S, Adams C, Bosch F, Grattan-Smith P, Navarro C, Neitzel H, Polster T, Topaloglu H, Steglich C, Guenther UP, Zerres K, Rudnik-Schoneborn S, Hubner C (2003). Infantile spinal muscular atrophy with respiratory distress type 1 (SMARD1). Ann Neurol, 54(6), 719 - 724.
    • Ben Yaou R, Richard P, Demay L, Merlini L, Muntoni F, Talim B, Toniolo D, Van der Kooi AJ, de Visser M, Voit T, Wehnert MS, Urtizberea JA, Eymard B, Recan D, Bonne G (2003). Lamin A/C gene related disorders: the EUROMEN consortium experience.
    • Nevo Y, Muntoni F, Sewry C, Legum C, Kutai M, Harel S, Dubowitz V (2003). Large in-frame deletions of the rod-shaped domain of the dystrophin gene resulting in severe phenotype. Isr.Med Assoc.J, 5(2), 94 - 97.
    • Longman C, Jimenez C, Brockington M, Torelli S, Sewry C, Brown S, Feng L, Muntoni F (2003). Novel forms of muscular dystrophy with alpha-dystroglycan deficiency and absent CNS involvement.
    • Gualandi F, Trabanelli C, Rimessi P, Calzolari E, Toffolatti L, Patarnello T, Kunz G, Muntoni F, Ferlini A (2003). Multiple exon skipping and RNA circularisation contribute to the severe phenotypic expression of exon 5 dystrophin deletion. J Med Genet, 40(8), e100 - .
    • Giatrakos N, Kinali M, Nihoyannopoulos P, Muntoni F (2003). Impaired endothelium independent vasodilatation in patients with sarcoglycan-deficient limb-girdle muscular dystrophy.
    • Muntoni F (2003). Congenital muscular dystrophies (CMD). Eur J Paediatr Neurol, 7(5), 229 - .
    • Muntoni F, Torelli S, Ferlini A (2003). Dystrophin and mutations: one gene, several proteins, multiple phenotypes. Lancet Neurol, 2(12), 731 - 740.
    • Jungbluth H, Sewry CA, Buj-Bello A, Kristiansen M, Orstavik KH, Kelsey A, Manzur AY, Mercuri E, Wallgren-Pettersson C, Muntoni F (2003). Early and severe presentation of X-linked myotubular myopathy in a girl with skewed X-inactivation. Neuromuscul.Disord, 13(1), 55 - 59.
    • Torelli S, Kunz G, Berardinelli A, Merlini L, Blake DJ, Brown SC, Muntoni F (2003). Expression and developmental regulation of dystrobrevin isoforms in fetal muscle and Duchenne and Becker muscular dystrophies.
    • Topaloglu H, Brockington M, Yuva Y, Talim B, Haliloglu G, Blake D, Torelli S, Brown SC, Muntoni F (2003). FKRP gene mutations cause congenital muscular dystrophy, mental retardation, and cerebellar cysts. Neurology, 60(6), 988 - 992.
    • Jimenez-Mallebrera C, Feng L, Brown SC, Muntoni F, Sewry CA (2003). Do alterations in laminin beta 2 localisation indicate a role of laminin-4 in congenital muscular dystrophy?.
    • Piercy RJ, Pombo A, Stewart CL, Muntoni F, Brown SC (2003). Does an association of nuclear replication and transcription sites with the nuclear matrix underlie the pathogenesis of the laminopathies?.
    • Longman C, De Bernabe DBV, Brockington M, Muntoni F, Brunner HG, van Bokhoven H (2003). FKRP mutation in a patient with Walker-Warburg syndrome.
    • Majumdar A, Kinali M, Mercuri E, Main M, Muntoni F (2003). Fracture prevalence in spinal muscular atrophy.
    • Giatrakos N, Kinali M, Koutroulis G, Muntoni F, Nihoyannopoulos P (2003). Impaired strain rate measurements in patients with Duchenne muscular dystrophy.
    • Dubowitz V, Kinali M, Mercuri E, Main M, Muntoni F (2003). Intermittent, low dosage prednisolone in the long term treatment of early Duchenne muscular dystrophy.
    • Olpin SE, Afifi A, Clark S, Manning NJ, Bonham JR, Dalton A, Leonard JV, Land JM, Andresen BS, Morris AA, Muntoni F, Turnbull D, Pourfarzam M, Rahman S, Pollitt RJ (2003). Mutation and biochemical analysis in carnitine palmitoyltransferase type II (CPT II) deficiency. Journal of Inherited Metabolic Disease, 26(6), 543 - 557.
    • Brown SC, Torelli S, Feng L, Cole GJ, Sewry CA, Muntoni F (2003). Immunocytochemical analysis of muscle agrin in MDC1C and LGDM2I.
    • Main M, Kairon H, Mercuri E, Muntoni F (2003). The Hammersmith functional motor scale for children with spinal muscular atrophy: a scale to test ability and monitor progress in children with limited ambulation. Eur J Paediatr Neurol, 7(4), 155 - 159.
    • Poppe M, Cree L, Bourke J, Eagle M, Anderson LV, Birchall D, Brockington M, Buddles M, Busby M, Muntoni F, Wills A, Bushby K (2003). The phenotype of limb-girdle muscular dystrophy type 2I. Neurology, 60(8), 1246 - 1251.
    • Kinali M, Mercuri E, Gibson BE, Hartley L, Manzur AY, Simonds AK, Muntoni F (2003). UK physicians' attitudes and practises in long term non-invasive ventilation of children with Duchenne Muscular Dystrophy.
    • Jungbluth H, Sewry CA, Muntoni F (2003). What's new in neuromuscular disorders? The congenital myopathies. Eur J Paediatr Neurol, 7(1), 23 - 30.
    • Kristiansen M, Knudsen GP, Tanner SM, McEntagart M, Jungbluth H, Muntoni F, Sewry C, Gallati S, Orstavik KH, Wallgren-Pettersson C (2003). X-inactivation patterns in carriers of X-linked myotubular myopathy. Neuromuscul.Disord, 13(6), 468 - 471.
    • Zorzato F, Yamaguchi N, Xu L, Meissner G, Muller CR, Pouliquin P, Sewry C, Muntoni F, Girard T, Treves S (2003). Clinical and functional effects of a deletion in a COOH-terminal lumenal loop of the skeletal muscle ryanodine receptor..
    • Zorzato F, Yamaguchi N, Xu L, Meissner G, Muller CR, Pouliquin P, Muntoni F, Sewry C, Girard T, Treves S (2003). Clinical and functional effects of a deletion in a COOH-terminal lumenal loop of the skeletal muscle ryanodine receptor. Hum Mol Genet, 12(4), 379 - 388.
    • Mercuri E, Brockington M, Straub V, Quijano-Roy S, Yuva Y, Herrmann R, Brown SC, Torelli S, Dubowitz V, Blake DJ, Romero NB, Estournet B, Sewry CA, Guicheney P, Voit T, Muntoni F (2003). Phenotypic spectrum associated with mutations in the fukutin-related protein gene. Ann Neurol, 53(4), 537 - 542.
    • Davis MR, Haan E, Jungbluth H, Sewry C, North K, Muntoni F, Kuntzer T, Lamont P, Bankier A, Tomlinson P, Sanchez A, Walsh P, Nagarajan L, Oley C, Colley A, Gedeon A, Quinlivan R, Dixon J, James D, Muller CR, Laing NG (2003). Principal mutation hotspot for central core disease and related myopathies in the C-terminal transmembrane region of the RYR1 gene. Neuromuscul.Disord, 13(2), 151 - 157.
    • Jimenez-Mallebrera C, Torelli S, Brown SC, Feng L, Brockington M, Sewry CA, Beltran-Valero DB, Muntoni F (2003). Profound skeletal muscle depletion of alpha-dystroglycan in Walker-Warburg syndrome. Eur J Paediatr Neurol, 7(3), 129 - 137.
    • Wells KE, Torelli S, Lu Q, Brown SC, Partridge T, Muntoni F, Wells DJ (2003). Relocalization of neuronal nitric oxide synthase (nNOS) as a marker for complete restoration of the dystrophin associated protein complex in skeletal muscle. Neuromuscul.Disord, 13(1), 21 - 31.
    • Eperon IC, Muntoni F (2003). Response to Buratti et al.: Can a 'patch' in a skipped exon make the pre-mRNA splicing machine run better?. TRENDS MOL MED, 9(6), 233 - 234. doi:10.1016/S1471-4914(03)00068-6
    • Desforges L, Stefanidis A, Koutroulis G, Kinali M, Muntoni F, Nihoyannopoulos P (2003). Role of two dimensional and Doppler echocardiography in patients with Duchenne cardiomyopathy.
    • Zolkipli Z, Longman C, Brown S, Rahman N, Holder SE, Muntoni F (2003). Skeletal muscle involvement in infantile systemic hyalinosis. Eur J Paediatr Neurol, 7(6), 401 - 406.
    • Skordis LA, Dunckley MG, Yue B, Eperon IC, Muntoni F (2003). Bifunctional antisense oligonucleotides provide a trans-acting splicing enhancer that stimulates SMN2 gene expression in patient fibroblasts. Proceedings of the National Academy of Sciences of the United States of America, 100(7), 4114 - 4119. doi:10.1073/pnas.0633863100
    • Kinali M, Messina S, Mercuri E, Stephens DA, Jaywant S, Manzur AY, Banks L, Muntoni F (2003). Bone mineral density measurement in children with Duchenne muscular dystrophy: effect of low dose intermittent prednisolone.
    • Muntoni F (2003). Cardiac complications of childhood myopathies. J Child Neurol, 18(3), 191 - 202.
    • Muntoni F (2003). Cardiomyopathy in muscular dystrophies. Curr Opin Neurol, 16(5), 577 - 583.
    • Bushby K, Muntoni F, Bourke JP (2003). 107th ENMC international workshop: the management of cardiac involvement in muscular dystrophy and myotonic dystrophy. 7th-9th June 2002, Naarden, the Netherlands. Neuromuscul.Disord, 13(2), 166 - 172.
    • Bonne G, Yaou RB, Beroud C, Boriani G, Brown S, de Visser M, Duboc D, Ellis J, Hausmanowa-Petrusewicz I, Lattanzi G, Merlini L, Morris G, Muntoni F, Opolski G, Pinto YM, Sangiuolo F, Toniolo D, Trembath R, van Berlo JH, van der Kooi AJ, Wehnert M (2003). 108th ENMC International Workshop, 3rd Workshop of the MYO-CLUSTER project: EUROMEN, 7th International Emery-Dreifuss Muscular Dystrophy (EDMD) Workshop, 13-15 September 2002, Naarden, The Netherlands. Neuromuscul.Disord, 13(6), 508 - 515.
    • Muntoni F, Valero DB, Bittner R, Blake D, van Bokhoven H, Brockington M, Brown S, Bushby K, Campbell KP, Fiszman M, Gruenewald S, Merlini L, Quijano-Roy S, Romero N, Sabatelli P, Sewry CA, Straub V, Talim B, Topaloglu H, Voit T, Yurchenco PD, Urtizberea JA, Wewer UM, Guicheney P (2003). 114th ENMC International Workshop on Congenital Muscular Dystrophy (CMD) 17-19 January 2003, Naarden, The Netherlands: (8th Workshop of the International Consortium on CMD; 3rd Workshop of the MYO-CLUSTER project GENRE). Neuromuscul.Disord, 13(7-8), 579 - 588.
    • Muntoni F, Sewry CA (2003). Central core disease: new findings in an old disease. Brain, 126(Pt 11), 2339 - 2340.
    • Saran RK, Jimenez-Malebrera C, Jungbluth H, Sewry CA, Muntoni F (2003). Central/mini core muscle disease; immunohistochemically revisited. NEUROPATH APPL NEURO, 29(5), 525 - 525.
    • Dincer P, Balci B, Yuva Y, Talim B, Brockington M, Dincel D, Torelli S, Brown S, Kale G, Haliloglu G, Gerceker FO, Atalay RC, Yakicier C, Longman C, Muntoni F, Topaloglu H (2003). A novel form of recessive limb girdle muscular dystrophy with mental retardation and abnormal expression of alpha-dystroglycan. Neuromuscul.Disord, 13(10), 771 - 778.
    • Kinali M, Banks L, Mercuri E, Manzur AY, Muntoni F (2003). Bone mineral density in paediatric spinal muscular atrophy.
    • Rimessi P, Gualandi F, Patarnello T, Muntoni F, Calzolari E, D'Agostaro G, Ferlini A (2003). Characterisation of two novel splicing enhancer sequences in the dystrophin gene, located within a LINE1 element and involved in XLDC..
    • Giatrakos N, Kinali M, Koutroulis G, Mercuri E, Desforges L, Dawson D, Stefanidis A, Nihoyannopoulos P, Muntoni F (2003). Characterization of the early cardiac phenotype in Duchenne muscular dystrophy using tissue doppler imaging derived myocardial performance index.
    • Grohmann K, Stolz P, Varon R, Schulke M, Stoltenburg G, Bertini E, Bushby K, Lochmuller H, Muntoni F, Ouvrier R, Zerres K, Rudnik-Schoneborn S, Hubner C (2003). Phenotype and genotype of spinal muscular atrophy with respiratory distress type 1.
    • Lampe AK, Dunn DM, von Niederhausern AC, Aoyagi A, Hamil C, Duval B, O'Brien K, Laval S, Chu ML, Swoboda K, Muntoni F, Bonnemann C, Flanigan KM, Bushby K, Weiss RB (2003). Rapid direct sequence analysis of the three genes encoding collagen VI.
    • Manzur AY, Muntoni F, Simonds A (2003). Muscular dystrophy campaign sponsored workshop: recommendation for respiratory care of children with spinal muscular atrophy type II and III. 13th February 2002, London, UK. Neuromuscul.Disord, 13(2), 184 - 189.

    2002

    • Mercuri E, Yuva Y, Brown SC, Brockington M, Kinali M, Jungbluth H, Feng L, Sewry CA, Muntoni F (2002). Collagen VI involvement in Ullrich syndrome: a clinical, genetic, and immunohistochemical study. Neurology, 58(9), 1354 - 1359.
    • Bastianutto C, de Visser M, Muntoni F, Klamut HJ, Patarnello T (2002). A novel muscle-specific enhancer identified within the deletion overlap region of two XLDC patients lacking muscle exon 1 of the human dystrophin gene. Genomics, 80(6), 614 - 620.
    • Cohen N, Dunckley MG, Muntoni F, Gualandi F, Rimessi P, Ferlini A (2002). An intronic rearrangement of the dystrophin gene affecting tissue specific transcription and resulting in X-linked dilated cardiomyopathy.
    • Mercuri E, Cini C, Counsell S, Allsop J, Zolkipli Z, Jungbluth H, Sewry C, Brown SC, Pepe G, Muntoni F (2002). Muscle MRI findings in a three-generation family affected by Bethlem myopathy. Eur J Paediatr Neurol, 6(6), 309 - 314.
    • Petit N, Moghadaszadeh B, Hu C, Lescure A, Quijano S, Estournet B, Merlini L, Muntoni F, Topaloglu H, Krol A, Wewer U, Guicheney P (2002). Mutations in the Selenoprotein N gene (SEPN1) cause congenital muscular dystrophy with early rigidity of the spine and restrictive respiratory syndrome.
    • Ealing J, Webster R, Brownlow S, Abdelgany A, Oosterhuis H, Muntoni F, Vaux DJ, Vincent A, Beeson D (2002). Mutations in congenital myasthenic syndromes reveal an epsilon subunit C-terminal cysteine, C470, crucial for maturation and surface expression of adult AChR. Hum Mol Genet, 11(24), 3087 - 3096.
    • Topaloglu H, Brockington M, Yuva Y, Talim B, Haliloglu G, Blake D, Muntoni F (2002). Mutations in the fukutin-related-protein gene (FKRP) in two patients with congenital muscular dystrophy 1C (MDC1C), mental retardation and cerebellar cysts.
    • Pelin K, Donner K, Holmberg M, Jungbluth H, Muntoni F, Wallgren-Pettersson C (2002). Nebulin mutations in autosomal recessive nemaline myopathy: an update. Neuromuscul.Disord, 12(7-8), 680 - 686.
    • Rimessi P, Gualandi F, Cardazzo B, Calzolari E, Muntoni F, Patarnello T, Ferlini A (2002). Occurrence of two splicing enhancers and a 5 AE cryptic splice site within a LINE1 retrotransposon (L1PMA2): a novel focus on mobile elements functioning?.
    • Deodato F, Sabatelli M, Ricci E, Mercuri E, Muntoni F, Sewry C, Naom I, Tonali P, Guzzetta F (2002). Hypermyelinating neuropathy, mental retardation and epilepsy in a case of merosin deficiency. Neuromuscul.Disord, 12(4), 392 - 398.
    • Esapa CT, Benson MA, Schroder JE, Martin-Rendon E, Brockington M, Brown SC, Muntoni F, Kroger S, Blake DJ (2002). Functional requirements for fukutin-related protein in the Golgi apparatus. Hum Mol Genet, 11(26), 3319 - 3331.
    • Pepe G, Lucioli S, Vanegas OC, Minosse C, Giusti B, Urtizberea JA, Muntoni F, Bushby K, de Visser M, Bonnemann C, Sabatelli P, Bertini E, Merlini L, Chu ML (2002). Genotype-phenotype correlation in Bethlem myopathy.
    • Wallgren-Petterson C, Pelin K, Nowak K, Muntoni F, North K, Beggs A, Laing N (2002). Genotype-phenotype correlations in nemaline myopathy.
    • Brockington M, Yuva Y, Torelli S, Sewry CA, Mercuri E, Brown SB, Muntoni F, Blake DJ, Bushby K, Voit T (2002). Limb girdle muscular dystrophy 21 is predominantly associated with a Leu276Ile mutation in the fukutin related-protein gene.
    • Toffolatti L, Cardazzo B, Nobile C, Danieli GA, Gualandi F, Muntoni F, Abbs S, Zanetti P, Angelini C, Ferlini A, Fanin M, Patarnello T (2002). Investigating the mechanism of chromosomal deletion: characterization of 39 deletion breakpoints in introns 47 and 48 of the human dystrophin gene. Genomics, 80(5), 523 - 530.
    • Sewry CA, Brown SC, Torelli S, Feng L, Quinlivan R, Muntoni F (2002). Immunolabelling of neuronal nitric oxide synthase and caveolin 3 in developing human skeletal muscle.
    • Mercuri E, Sewry C, Brown SC, Muntoni F (2002). Congenital muscular dystrophies. Semin Pediatr Neurol, 9(2), 120 - 131.
    • Muntoni F, Brockington M, Blake DJ, Torelli S, Brown SC (2002). Defective glycosylation in muscular dystrophy. Lancet, 360(9343), 1419 - 1421.
    • Cree L, Brockington M, Keers S, Poppe M, Laval S, Muntoni F, Anderson L, Bushby K (2002). Gene expression analysis of dystrophic skeletal muscle.
    • Hubner C, Varon R, Grohmann K, Schuelke M, Muntoni F, Rudnik-Schoneborn S, Zerres K, Ouvrier R, Stephani U, Bertini E (2002). Extended phenotype of SMA with respiratory distress type 1 (SMARD1).
    • Quijano-Roy S, Romero NB, Louhichi N, Brockington M, Many H, Yeliz Y, Richard P, Estournet B, Muntoni F, Fardeau M, Barois A, Guicheney P (2002). FKRP (FuKutin Related Protein) gene mutations associated with intermediate phenotype between CMD Type 1C and LGMD2I.
    • Muntoni F (2002). Gene table: congenital muscular dystrophies. Eur J Paediatr Neurol, 6(1), 79 - .
    • Muntoni F, Brockington M, Blake DJ, Torelli S, Sewry CA, Brown SC (2002). Disorders of glycosylation: an emerging group of muscular dystrophies.
    • Brown SC, Torelli S, Jimenez C, Feng L, Sewry CA, Muntoni F (2002). Dystroglycan expression during muscle development.
    • Koutroulis G, Kinali M, Dawson D, Giatrakos N, Muntoni F, Nihoyannapoulos P (2002). Evaluation of myocardial involvement in Duchenne dystrophy detected with tissue Doppler derived myocardial velocity gradients. J AM COLL CARDIOL, 39(5), 182A - 182A.
    • McDonald DG, Kinali M, Gallagher AC, Mercuri E, Muntoni F, Roper H, Jardine P, Jones DH, Pike MG (2002). Fracture prevalence in Duchenne muscular dystrophy. Dev Med Child Neurol, 44(10), 695 - 698.
    • Helbling-Leclerc A, Ben Yaou R, Demay L, Richard P, Eymard B, Urtizberea JA, Duboc D, Muntoni F, Wehnert M, Toniolo D, Merlini L, van der Kooi AJ, de Visser M, Recan D, Schwartz K, Bonne G (2002). Genetic and clinical spectrum of laminopathies.
    • Blake DJ, Benson MA, Esapa CT, Kroger S, Brockington M, Muntoni F (2002). Golgi-localization of fukutin and fukutin-related protein: Implications for muscular dystrophy.
    • Skordis LA, Dunckley MG, Eperon IC, Muntoni F (2002). Increased exon 7 inclusion during SMN2 splicing by a novel approach: antisense-mediated targeting of splicing enhancers.
    • Counsell SJ, Devile C, Mercuri E, Allsop JM, Birch R, Muntoni F (2002). Magnetic resonance imaging assessment of infantile myofibromatosis. Clin Radiol, 57(1), 67 - 70.
    • Muntoni F, Brown S, Sewry C, Patel K (2002). Muscle development genes: their relevance in neuromuscular disorders. Neuromuscul.Disord, 12(5), 438 - 446.
    • Mercuri E, Counsell S, Allsopp J, Cini C, Zolkipli Z, Kinali M, Jungbluth H, Muntoni F (2002). Muscle MRI in patients with muscular disorders with ridid spine.
    • Ferreiro A, Quijano-Roy S, Pichereau C, Moghadaszadeh B, Goemans N, Bonnemann C, Jungbluth H, Straub V, Villanova M, Leroy JP, Romero NB, Martin JJ, Muntoni F, Voit T, Estournet B, Richard P, Fardeau M, Guicheney P (2002). Mutations of the selenoprotein N gene, which is implicated in rigid spine muscular dystrophy, cause the classical phenotype of multiminicore disease: reassessing the nosology of early-onset myopathies. Am J Hum Genet, 71(4), 739 - 749.
    • Dalkilic I, Thompson TG, Brossius MA, Puca AA, Feener C, Muntoni F, Kunkel LM (2002). Obscurin interacts with skeletal muscle specific filamin.
    • Bastianutto CB, Patarnello T, De Visser M, Muntoni F, Klamut HJ (2002). Identification of a new muscle specific enhancer in the human dystrophin gene, located within the deletion overlap of two XLDC patients.
    • Greener MJ, Sewry CA, Muntoni F, Roberts RG (2002). The 3'-untranslated region of the dystrophin gene - conservation and consequences of loss. Eur J Hum Genet, 10(7), 413 - 420.
    • Brockington M, Blake DJ, Brown SC, Muntoni F (2002). The gene for a novel glycosyltransferase is mutated in congenital muscular dystrophy MDC1C and limb girdle muscular dystrophy 2I. Neuromuscul.Disord, 12(3), 233 - 234.
    • Gualandi F, Trabanelli C, Rimessi P, Calzolari E, Muntoni F, Ferlini A (2002). The phenotype associated with dystrophin exon 5 in-frame deletions relies on a splicing abnormality causing exon 6 skipping.
    • Lampe AK, Leonard N, Johnson M, Brockington M, Muntoni F, Hastings L, Bushby K (2002). Ullrich-like congenital muscular dystrophy without linkage to collagen VI.
    • Bonne G, Ben Yaou R, Demay L, Richard P, Eymard B, Urtizberea JA, Duboc D, Muntoni F, Wehnert M, Toniolo D, Merlini L, van der Kooi A, de Visser M, Recan D, Schwartz K, Bonne G (2002). Clinical analysis of 32 patients carrying R453W LMNA mutation.
    • Mercuri E, Talim B, Moghadaszadeh B, Petit N, Brockington M, Counsell S, Guicheney P, Muntoni F, Merlini L (2002). Clinical and imaging findings in six cases of congenital muscular dystrophy with rigid spine syndrome linked to chromosome 1p (RSMD1). Neuromuscul.Disord, 12(7-8), 631 - 638.
    • Mercuri E, Brockington M, Brown S, Sewry C, Yuva Y, Kinali M, Manzur A, Torelli S, Dubowitz V, Muntoni F (2002). Clinical phenotype in patients with mutations in the fukutin-related protein (FKRP) gene.
    • Romero NB, Quijano-Roy S, Estournet B, Brockington M, Many H, Ferreiro A, Barois A, Sabouraud P, Muntoni F, Richard P, Fardeau M, Guicheney P (2002). Deficiency of alpha-dystroglycan in skeletal muscle: clinical and genetic heterogeneity of 12 patients with early onset muscular dystrophy.
    • Kinali M, Mercuri E, Main M, De Biasia F, Karatza A, Higgins R, Banks LM, Manzur AY, Muntoni F (2002). Pilot trial of albuterol in spinal muscular atrophy. Neurology, 59(4), 609 - 610.
    • Dubowitz V, Kinali M, Main M, Mercuri E, Muntoni F (2002). Remission of clinical signs in early duchenne muscular dystrophy on intermittent low-dosage prednisolone therapy. Eur J Paediatr Neurol, 6(3), 153 - 159.
    • Mercuri E, Counsell S, Allsop J, Jungbluth H, Kinali M, Bonne G, Schwartz K, Bydder G, Dubowitz V, Muntoni F (2002). Selective muscle involvement on magnetic resonance imaging in autosomal dominant Emery-Dreifuss muscular dystrophy. Neuropediatrics, 33(1), 10 - 14.
    • Jimenez-Mallebrera C, Torelli S, Brown SC, Brockington M, Yuva Y, Sewry CA, Muntoni F (2002). Severe depletion of alpha-dystroglycan in Walker-Warburg syndrome.
    • Kinali M, Messina S, Mercuri E, Manzur AY, Dubowitz V, Muntoni F (2002). Spinal surgery is not always essential in management of scoliosis in Duchenne muscular dystrophy.
    • Haliloglu G, Chattopadhyay A, Skorodis L, Manzur A, Mercuri E, Talim B, Akcoren Z, Renda Y, Muntoni F, Topaloglu H (2002). Spinal muscular atrophy with progressive myoclonic epilepsy: report of new cases and review of the literature. Neuropediatrics, 33(6), 314 - 319.
    • Dincer P, Balci B, Yuva Y, Talim B, Brockington M, Dincel D, Gerceker FO, Haliloglu G, Atalay RC, Yakicier C, Muntoni F, Topaloglu H (2002). Autosomal recessive limb-girdle muscular dystrophy with severe mental retardation: a new phenotype with glycosylation defects of alpha-dystroglycan.
    • Bonne G, Ben Yaou R, Becane HM, Demay L, Richard P, Urtizberea JA, Eymard B, Cuisset JM, Ferrer X, Penisson-Besnier I, Toutain A, Wehnert M, van der Kooi A, Muntoni F, de Visser M, Merlini L, Schwartz K, Duboc D, Bonne G (2002). Cardiac sudden death in laminopathies.
    • Muntoni F, Mestroni L (2002). [Dilated cardiomyopathy: role of clinical and instrumental evaluation of the neuromuscular system]. Ital.Heart J Suppl, 3(4), 399 - 404.
    • Bonne G, Capeau J, de Visser M, Duboc D, Merlini L, Morris GE, Muntoni F, Recan D, Sewry C, Squarzoni S, Stewart C, Talim B, van der KA, Worman H, Schwartz K (2002). 82nd ENMC international workshop, 5th international Emery-Dreifuss muscular dystrophy (EDMD) workshop, 1st Workshop of the MYO-CLUSTER project EUROMEN (European muscle envelope nucleopathies), 15-16 September 2000, Naarden, The Netherlands. Neuromuscul.Disord, 12(2), 187 - 194.
    • Muntoni F, Blake D, Brockington M, Brown S, Hayashi YK, Merlini L, Sabatelli P, Topaloglu H, Voit T, Guicheney P (2002). 85th ENMC International Workshop on Congenital Muscular Dystrophy - 6th International CMD Workshop - 1st Workshop of the Myo-Cluster Project 'GENRE' - 27-28th October 2000, Naarden, The Netherlands (vol 12, pg 69, 2002). NEUROMUSCULAR DISORD, 12(4), COVER4 - COVER4.
    • Muntoni F, Guicheney P (2002). 85th ENMC International Workshop on Congenital Muscular Dystrophy. 6th International CMD Workshop. 1st Workshop of the Myo-Cluster Project 'GENRE'. 27-28th October 2000, Naarden, The Netherlands. Neuromuscul.Disord, 12(1), 69 - 78.
    • Merlini L, Estournet-Mathiaud B, Iannaccone S, Melki J, Muntoni F, Rudnik-Schoneborn S, Topaloglu H, Vita G, Voit T (2002). 90th ENMC international workshop: European Spinal Muscular Atrophy Randomised Trial (EuroSMART) 9-10 February 2001, Naarden, The Netherlands. Neuromuscul.Disord, 12(2), 201 - 210.
    • Haliloglu G, Chattopadhyay A, Skorodis L, Manzur A, Renda Y, Muntoni F, Topaloglu H (2002). A novel variant of spinal muscular atrophy with progressive myoclonic epilepsy.
    • Kinali M, Mercuri E, Main M, Muntoni F, Dubowitz V (2002). An effective, low-dosage, intermittent schedule of prednisolone in the long-term treatment of early cases of Duchenne dystrophy. Neuromuscul.Disord, 12 Suppl 1, S169 - S174.
    • Jungbluth H, Muller CR, Halliger-Keller B, Brockington M, Brown SC, Feng L, Chattopadhyay A, Mercuri E, Manzur AY, Ferreiro A, Laing NG, Davis MR, Roper HP, Dubowitz V, Bydder G, Sewry CA, Muntoni F (2002). Autosomal recessive inheritance of RYR1 mutations in a congenital myopathy with cores. Neurology, 59(2), 284 - 287.
    • Pepe G, de Visser M, Bertini E, Bushby K, Vanegas OC, Chu ML, Lattanzi G, Merlini L, Muntoni F, Urtizberea A (2002). Bethlem myopathy (BETHLEM) 86th ENMC international workshop, 10-11 November 2000, Naarden, The Netherlands. Neuromuscul.Disord, 12(3), 296 - 305.
    • Pepe G, Bertini E, Bonaldo P, Bushby K, Giusti B, de Visser M, Guicheney P, Lattanzi G, Merlini L, Muntoni F, Nishino I, Nonaka I, Yaou RB, Sabatelli P, Sewry C, Topaloglu H, van der KA (2002). Bethlem myopathy (BETHLEM) and Ullrich scleroatonic muscular dystrophy: 100th ENMC international workshop, 23-24 November 2001, Naarden, The Netherlands. Neuromuscul.Disord, 12(10), 984 - 993.
    • Van der Kooi AJ, De Voogt WG, Bertini E, Bushby K, Merlini L, Muntoni F, Talim B, Urtizberea JA, de Visser M (2002). Cardiac and pulmonary investigations in Bethlem myopathy.
    • Muntoni F, Bertini E, Bonnemann C, Brockington M, Brown S, Bushby K, Fiszman M, Korner C, Mercuri E, Merlini L, Hewitt J, Quijano-Roy S, Romero N, Squarzoni S, Sewry CA, Straub V, Topaloglu H, Haliloglu G, Voit T, Wewer U, Guicheney P (2002). 98th ENMC International Workshop on Congenital Muscular Dystrophy (CMD), 7th Workshop of the International Consortium on CMD, 2nd Workshop of the MYO CLUSTER project GENRE. 26-28th October, 2001, Naarden, The Netherlands. Neuromuscul.Disord, 12(9), 889 - 896.
    • Lampe AK, Brockington M, Johnson M, Leonard N, Hastings L, Muntoni F, Bushby K (2002). A family with Ullrich-like congenital muscular dystrophy unlinked to the collagen 6A genes.
    • Ferreiro A, Quijano-Roy S, Pichereau C, Moghadaszadeh B, Goemans NMLA, Bonnemann C, Jungbluth H, Straub V, Villanova M, Leroy JP, Romero NB, Martin JJ, Richard P, Muntoni F, Voit T, Estournet B, Fardeau M, Guicheney P (2002). SEPN1 mutations cause classical multi-minicore disease: reappraising the nosology of early-onset myopathies.
    • Muntoni F, Fisher I, Morgan JE, Abraham D (2002). Steroids in Duchenne muscular dystrophy: from clinical trials to genomic research. Neuromuscul.Disord, 12 Suppl 1, S162 - S165.
    • Brown SC, Torelli S, Brockington M, Jimenez C, Feng L, Sewry CA, Muntoni F (2002). The dystroglycan complex in patients with mutations in the gene encoding for fukutin-related protein (FKRP).

    2001

    • Moghadaszadeh B, Petit N, Jaillard C, Brockington M, Roy SQ, Merlini L, Romero N, Estournet B, Desguerre I, Chaigne D, Muntoni F, Topaloglu H, Guicheney P (2001). Mutations in SEPN1 cause congenital muscular dystrophy with spinal rigidity and restrictive respiratory syndrome. Nat Genet, 29(1), 17 - 18.
    • Brockington M, Blake DJ, Prandini P, Brown SC, Torelli S, Benson MA, Ponting CP, Estournet B, Romero NB, Mercuri E, Voit T, Sewry CA, Guicheney P, Muntoni F (2001). Mutations in the fukutin-related protein gene (FKRP) cause a form of congenital muscular dystrophy with secondary laminin alpha2 deficiency and abnormal glycosylation of alpha-dystroglycan. The American Journal of Human Genetics, 69(6), 1198 - 1209. doi:10.1086/324412
    • Grohmann K, Schuelke M, Diers A, Hoffmann K, Lucke B, Adams C, Bertini E, Leonhardt-Horti H, Muntoni F, Ouvrier R, Pfeufer A, Rossi R, Van Maldergem L, Wilmshurst JM, Wienker TF, Sendtner M, Rudnik-Schoneborn S, Zerres K, Hubner C (2001). Mutations in the gene encoding immunoglobulin mu-binding protein 2 cause spinal muscular atrophy with respiratory distress type 1. Nat Genet, 29(1), 75 - 77.
    • Brown SC, Muntoni F, Sewry CA (2001). Non-sarcolemmal muscular dystrophies. Brain Pathol, 11(2), 193 - 205.
    • Moghadaszadeh B, Petit P, Jaillard C, Brockington M, Roy SQ, Merlini L, Romero N, Estournet B, Desguerre I, Chaigne D, Muntoni F, Topaloglu H, Guicheney P (2001). Identification of the gene causing congenital muscular dystrophy with early rigidity of the spine and restrictive respiratory syndrome (RSMD1). NEUROMUSCULAR DISORD, 11(6-7), 670 - 670.
    • Ferreiro A, Estournet B, Laroche C, Cabello A, Gutierrez E, Straub V, Goemans N, Jungbluth H, Muntoni F, Merlini L, Topaloglu H, Voit T, Fardeau M, Guicheney P (2001). Genetic characterisation of multi-minicore disease: identification of a first locus and evidence for genetic heterogeneity. NEUROMUSCULAR DISORD, 11(6-7), 622 - 622.
    • Mohan U, Misra VP, Britto J, Muntoni F, King RHM, Thomas PK (2001). Inherited early onset severe axonal polyneuropathy with respiratory failure and autonomic involvement. Neuromuscular Disorders, 11(4), 395 - 399.
    • Muntoni F (2001). Is a muscle biopsy in Duchenne dystrophy really necessary?. Neurology, 57(4), 574 - 575.
    • Brodsky GL, Mestroni L, Muntoni F, Sewry C, Miocic S, Sinagra G (2001). Lamin A/C gene mutation associated with dilated cardiomyopathy with variable skeletal muscle involvement - Response. CIRCULATION, 103(4), E20 - E20.
    • Skordis LA, Dunckley MG, Muntoni F (2001). Modification of RNA splicing in the survival motor neuron 2 (SMN2) gene as a therapeutic option in spinal muscular atrophy. NEUROMUSCULAR DISORD, 11(6-7), 646 - 646.
    • Taylor MRG, Brodsky G, Moss A, Muntoni F, Sinagra G, Di Lenarda A, Carniel E, Robinson M, Fain P, Mestroni L (2001). Molecular epidemiology of lamin A/C gene mutations in dilated cardiomyopathy. CIRCULATION, 104(17), 135 - 135.
    • Ruggieri V, Lubieniecki F, Meli F, Diaz D, Ferragut E, Saito K, Brockington M, Muntoni F, Fukuyama Y, Taratuto AL (2001). Merosin-positive congenital muscular dystrophy with mental retardation, microcephaly and central nervous system abnormalities unlinked to the Fukuyama muscular dystrophy and muscular-eye-brain loci: report of three siblings. Neuromuscul.Disord, 11(6-7), 570 - 578.
    • Jungbluth H, Sewry CA, Brown SC, Nowak KJ, Laing NG, Wallgren-Pettersson C, Pelin K, Manzur AY, Mercuri E, Dubowitz V, Muntoni F (2001). Mild phenotype of nemaline myopathy with sleep hypoventilation due to a mutation in the skeletal muscle alpha-actin (ACTA1) gene. Neuromuscul.Disord, 11(1), 35 - 40.
    • Bastianutto C, Bestard JA, Broere D, de Visser M, Ferlini A, Muntoni F, Patarnello T, Klamut HJ (2001). Dystrophin muscle enhancer 1 is implicated in the activation of nonmuscle isoforms in the skeletal muscle of patients with X-linked dilated cardiomyopathy. NEUROMUSCULAR DISORD, 11(6-7), 640 - 640.
    • Bastianutto C, Bestard JA, Lahnakoski K, Broere D, de Visser M, Zaccolo M, Pozzan T, Ferlini A, Muntoni F, Patarnello T, Klamut HJ (2001). Dystrophin muscle enhancer 1 is implicated in the activation of non-muscle isoforms in the skeletal muscle of patients with X-linked dilated cardiomyopathy. Hum Mol Genet, 10(23), 2627 - 2635.
    • Mercuri E, Rutherford M, De Vile C, Counsell S, Sewry C, Brown S, Bydder G, Dubowitz V, Muntoni F (2001). Early white matter changes on brain magnetic resonance imaging in a newborn affected by merosin-deficient congenital muscular dystrophy. Neuromuscul.Disord, 11(3), 297 - 299.
    • Koutroulis G, Kinali M, Dawson D, Muntoni F, Nihoyannopoulos P (2001). Evaluation of left ventricular relaxation in patients affected with Duchenne muscular dystrophy using tissue Doppler imaging. EUR HEART J, 22, 412 - 412.
    • Fisher I, Morgan J, Abraham D, Brittan H, Dunn M, Muntoni F (2001). Glucocorticoid-induced changes in the gene expression of dystrophic mouse muscle. Neuromuscular Disorders, 11(6-7), 663 - 663.
    • Blake DJ, Brockington M, Muntoni F, Benson MA (2001). Golgi-localisation of fukutin and fukutin-related protein: implications for muscular dystrophy. MOL BIOL CELL, 12, 85A - 85A.
    • Taylor MRG, Brodsky GL, Muntoni F, Sinagra G, Di Lenarda A, Robinson M, Fain P, Mestroni L (2001). Lamin A/C gene mutations in families with dilated cardiomyopathy, conduction system defects, and skeletal muscle disease. J AM COLL CARDIOL, 37(2), 194A - 194A.
    • Afifi A, Olpin SE, Dalton A, Leonard JV, Land J, Muntoni F, Lee PJ (2001). Mutation and biochemical analysis in carnitine palmitoyl transferase type II (CPTII) deficiency suggests complex genotype/phenotype interactions. J MED GENET, 38, S69 - S69.
    • Brockington M, Yuva Y, Prandini P, Brown SC, Torelli S, Benson MA, Herrmann R, Anderson LV, Bashir R, Burgunder JM, Fallet S, Romero N, Fardeau M, Straub V, Storey G, Pollitt C, Richard I, Sewry CA, Bushby K, Voit T, Blake DJ, Muntoni F (2001). Mutations in the fukutin-related protein gene (FKRP) identify limb girdle muscular dystrophy 2I as a milder allelic variant of congenital muscular dystrophy MDC1C. Hum Mol Genet, 10(25), 2851 - 2859.
    • Philpot J, Counsell S, Bydder G, Sewry CA, Dubowitz V, Muntoni F (2001). Neonatal arthrogryposis and absent limb muscles: a muscle developmental gene defect?. Neuromuscul.Disord, 11(5), 489 - 493.
    • Tilgen N, Zorzato F, Halliger-Keller B, Muntoni F, Sewry C, Palmucci LM, Schneider C, Hauser E, Lehmann-Horn F, Muller CR, Treves S (2001). Identification of four novel mutations in the C-terminal membrane spanning domain of the ryanodine receptor 1: association with central core disease and alteration of calcium homeostasis. Hum Mol Genet, 10(25), 2879 - 2887.
    • Mercuri E, Muntoni F (2001). What's new in neuromuscular disorders? Nuclear envelope and Emery-Dreifuss muscular dystrophy. Eur J Paediatr Neurol, 5(1), 3 - 5.
    • Mercuri E, Kinali M, van der Poel LA, Jungbluth H, Brockington M, Sewry C, Brown SC, Muntoni F (2001). Clinical and muscle MRI findings in congenital muscular dystrophy with distal laxity. NEUROMUSCULAR DISORD, 11(6-7), 638 - 638.
    • Rees MI, Lewis TM, Vafa B, Ferrie C, Corry P, Muntoni F, Jungbluth H, Stephenson JB, Kerr M, Snell RG, Schofield PR, Owen MJ (2001). Compound heterozygosity and nonsense mutations in the alpha(1)-subunit of the inhibitory glycine receptor in hyperekplexia. Hum Genet, 109(3), 267 - 270.
    • Sinagra G, Di Lenarda A, Brodsky GL, Taylor MR, Muntoni F, Pinamonti B, Carniel E, Driussi M, Bristow MR, Mestroni L (2001). Current perspective new insights into the molecular basis of familial dilated cardiomyopathy. Ital.Heart J, 2(4), 280 - 286.
    • Kinali M, Koutroulis G, Dawson D, Nihoyannopoulos P, Muntoni F (2001). Detection of early cardiac involvement in Duchenne muscular dystrophy using Tissue Doppler Imaging. NEUROMUSCULAR DISORD, 11(6-7), 639 - 639.
    • Koutroulis G, Kinali M, Dawson D, Muntoni F, Nihoyannopoulos P (2001). Detection of early myocardial involvement in Duchenne muscular Dystrophy using tissue Doppler derived myocardial velocity gradients. EUR HEART J, 22, 594 - 594.
    • Kinali M, Mercuri E, Main M, Banks L, Higgins R, Manzur A, Muntoni F (2001). Pilot trial of salbutamol in spinal muscular atrophy. NEUROMUSCULAR DISORD, 11(6-7), 645 - 646.
    • Main M, Kairon H, Mercuri E, Muntoni F (2001). The Hammersmith functional motor scale for children with spinal muscular atrophy. NEUROMUSCULAR DISORD, 11(6-7), 646 - 646.
    • Sewry CA, Brown SC, Mercuri E, Bonne G, Feng L, Camici G, Morris GE, Muntoni F (2001). Skeletal muscle pathology in autosomal dominant Emery-Dreifuss muscular dystrophy with lamin A/C mutations. Neuropathol.Appl Neurobiol., 27(4), 281 - 290.
    • Pogue R, Anderson LV, Pyle A, Sewry C, Pollitt C, Johnson MA, Davison K, Moss JA, Mercuri E, Muntoni F, Bushby KM (2001). Strategy for mutation analysis in the autosomal recessive limb-girdle muscular dystrophies. Neuromuscul.Disord, 11(1), 80 - 87.
    • Jungbluth H, Sewry CA, Squier W, Newsom-Davies J, Buj-Bello A, Mercuri E, Manzur AY, Muntoni F (2001). Abnormal neuromuscular transmission in a case of myotubular (centronuclear) myopathy. NEUROMUSCULAR DISORD, 11(6-7), 625 - 625.
    • Sewry CA, Brown SC, Pelin K, Jungbluth H, Wallgren-Pettersson C, Labeit S, Manzur A, Muntoni F (2001). Abnormalities in the expression of nebulin in chromosome-2 linked nemaline myopathy. Neuromuscul.Disord, 11(2), 146 - 153.
    • Brown SC, Sewry CA, Brockington M, Muntoni F (2001). alpha-dystroglycan expression and secondary merosin deficiency. NEUROMUSCULAR DISORD, 11(6-7), 636 - 636.
    • Cohen N, Dunckley MG, Rimessi P, Gualandi F, Ferlini A, Muntoni F (2001). An intronic mutation in the dystrophin gene causing X-linked dilated cardiomyopathy may indicate the presence of splicing regulatory motifs. NEUROMUSCULAR DISORD, 11(6-7), 639 - 640.
    • Ryley S, Mountford ST, Muntoni F, Campbell CM (2001). A complex karyotype involving stable dicentric chromosomes and a jumping translocation.. J MED GENET, 38, S50 - S50.
    • Skordis LA, Dunckley MG, Burglen L, Campbell L, Talbot K, Patel S, Melki J, Davies KE, Dubowitz V, Muntoni F (2001). Characterisation of novel point mutations in the survival motor neuron gene SMN, in three patients with SMA. Hum Genet, 108(4), 356 - 357.
    • Dodds E, Dunckley MG, Roberts RG, Muntoni F, Shaw CE (2001). Overexpressed human survival motor neurone isoforms, SMNDeltaexon7 and SMN+exon7, both form intranuclear gems but differ in cytoplasmic distribution. FEBS Lett, 495(1-2), 31 - 38.
    • Brockington M, Prandini P, Brown SC, Sewry CA, Blake DJ, Muntoni F (2001). A new gene encoding a fukutin-like protein and its analysis in patients with congenital muscular dystrophy. NEUROMUSCULAR DISORD, 11(6-7), 635 - 635.
    • Torelli S, Brown SC, Howman EV, Newey SE, Poon E, Davis KE, Muntoni F (2001). Syncoilin expression in neuromuscular disorders. NEUROMUSCULAR DISORD, 11(6-7), 629 - 629.
    • Howman EV, Poon E, Newey SE, Torelli S, Brown S, Hilton-Jones D, Squier W, Muntoni F, Davies KE (2001). Syncoilin expression in neuromuscular disorders.. AM J HUM GENET, 69(4), 638 - 638.
    • Brockington M, Blake DJ, Prandini P, Brown SC, Torelli S, Benson MA, Ponting CP, Estournet B, Romero N, Voit T, Sewry CA, Guicheney P, Muntoni F (2001). A novel glycosyltransferase is mutated in a form of congenital muscular dystrophy with secondary laminin alpha 2 deficiency and abnormal glycosylation of alpha-dystroglycan.. AM J HUM GENET, 69(4), 229 - 229.

    2000

    • Naom I, D'alessandro M, Sewry CA, Jardine P, Ferlini A, Moss T, Dubowitz V, Muntoni F (2000). Mutations in the laminin alpha2-chain gene in two children with early-onset muscular dystrophy.. Brain, 123 ( Pt 1), 31 - 41.
    • Auranen M, Villanova M, Muntoni F, Fardeau M, Scherer SW, Kalino H, Minassian BA (2000). X-linked vacuolar myopathies: two separate loci and refined genetic mapping.. Ann Neurol, 47(5), 666 - 669.
    • Brodsky GL, Muntoni F, Miocic S, Sinagra G, Sewry C, Mestroni L (2000). Lamin A/C gene mutation associated with dilated cardiomyopathy with variable skeletal muscle involvement.. Circulation, 101(5), 473 - 476.
    • Crilley JG, Boehm EA, Rajagopalan B, Blamire AM, Styles P, Muntoni F, Hilton-Jones D, Clarke K (2000). Magnetic resonance spectroscopy evidence of abnormal cardiac energetics in Xp21 muscular dystrophy.. J Am Coll Cardiol, 36(6), 1953 - 1958.
    • Jungbluth H, Sewry C, Brown SC, Manzur AY, Mercuri E, Bushby K, Rowe P, Johnson MA, Hughes I, Kelsey A, Dubowitz V, Muntoni F (2000). Minicore myopathy in children: a clinical and histopathological study of 19 cases.. Neuromuscul Disord, 10(4-5), 264 - 273.
    • Villanova M, Mercuri E, Bertini E, Sabatelli P, Morandi L, Mora M, Sewry C, Brockington M, Brown SC, Ferreiro A, Maraldi NM, Toda T, Guicheney P, Merlini L, Muntoni F (2000). Congenital muscular dystrophy associated with calf hypertrophy, microcephaly and severe mental retardation in three Italian families: evidence for a novel CMD syndrome.. Neuromuscul Disord, 10(8), 541 - 547.
    • Mercuri E, Sewry CA, Brown SC, Brockington M, Jungbluth H, DeVile C, Counsell S, Manzur A, Muntoni F (2000). Congenital muscular dystrophy with secondary merosin deficiency and normal brain MRI: a novel entity?. Neuropediatrics, 31(4), 186 - 189.
    • Mercuri E, Goodwin F, Sewry C, Dubowitz V, Muntoni F (2000). Diaphragmatic spinal muscular atrophy with bulbar weakness.. Eur J Paediatr Neurol, 4(2), 69 - 72. doi:10.1053/ejpn.1999.0265
    • Banks LM, Jaywant S, Higgins RN, Manzur AY, Dubowitz V, Muntoni F (2000). Duchenne muscular dystrophy: The effect of low dose intermittent steroids and the disease on bone mineral density levels. OSTEOPOROSIS INT, 11, 22 - 22.
    • Abbs S, Smith T, MacLeod M, Bobrow M, Mathew C, Muntoni F, Yau SC (2000). Dystrophin duplications: distribution, clinical significance, and somatic mosaicism.. AM J HUM GENET, 67(4), 249 - 249.
    • Banks LM, Jayawant S, Manzur AY, Higgins R, Dubowitz V, Muntoni F (2000). Effect of low dose steroids on bone mineral density in children with muscular dystrophy. OSTEOPOROSIS INT, 11, S52 - S52.
    • Mercuri E, Manzur AY, Jungbluth H, Bonne G, Muchir A, Sewry C, Schwartz K, Muntoni F (2000). Early and severe presentation of autosomal dominant Emery-Dreifuss muscular dystrophy (EMD2).. Neurology, 54(8), 1704 - 1705.
    • Yau S, MacLeod M, Hatton Z, Muntoni F, Mathew C, Abbs S (2000). Exploring the clinical significance of dystrophin duplications. J MED GENET, 37, S80 - S80.
    • Sewry C, Ugo I, Manilal S, Feng L, Morris GE, Muntoni F, Brown SC (2000). Immunocytochemical expression of nuclear membrane proteins in skeletal muscle. BRAIN PATHOL, 10(4), 499 - 499.
    • Jin H, Gardner RJ, Viswesvaraiah R, Muntoni F, Roberts RG (2000). Two novel members of the interleukin-1 receptor gene family, one deleted in Xp22.1-Xp21.3 mental retardation.. Eur J Hum Genet, 8(2), 87 - 94. doi:10.1038/sj.ejhg.5200415
    • Lattanzi G, Muntoni F, Sabatelli P, Squarzoni S, Maraldi NM, Cenni V, Villanova M, Columbaro M, Merlini L, Marmiroli S (2000). Unusual laminin alpha2 processing in myoblasts from a patient with a novel variant of congenital muscular dystrophy.. Biochem Biophys Res Commun, 277(3), 639 - 642. doi:10.1006/bbrc.2000.3735
    • Bolland E, Manzur AY, Milward TM, Muntoni F (2000). Velocardiofacial syndrome associated with atrophy of the shoulder girdle muscles and cervicomedullary narrowing.. Eur J Paediatr Neurol, 4(2), 73 - 76. doi:10.1053/ejpn.2000.0266
    • Bonne G, Mercuri E, Muchir A, Urtizberea A, Bécane HM, Recan D, Merlini L, Wehnert M, Boor R, Reuner U, Vorgerd M, Wicklein EM, Eymard B, Duboc D, Penisson-Besnier I, Cuisset JM, Ferrer X, Desguerre I, Lacombe D, Bushby K, Pollitt C, Toniolo D, Fardeau M, Schwartz K, Muntoni F (2000). Clinical and molecular genetic spectrum of autosomal dominant Emery-Dreifuss muscular dystrophy due to mutations of the lamin A/C gene.. Ann Neurol, 48(2), 170 - 180.
    • Jungbluth H, Rees MI, Manzur AY, Mercuri E, Sewry CA, Gobbi P, Muntoni F (2000). An unusual case of hyperekplexia.. Eur J Paediatr Neurol, 4(2), 77 - 80. doi:10.1053/ejpn.1999.0267
    • Brockington M, Sewry CA, Herrmann R, Naom I, Dearlove A, Rhodes M, Topaloglu H, Dubowitz V, Voit T, Muntoni F (2000). Assignment of a form of congenital muscular dystrophy with secondary merosin deficiency to chromosome 1q42.. Am J Hum Genet, 66(2), 428 - 435. doi:10.1086/302775
    • Philpot J, Pennock J, Cowan F, Sewry CA, Dubowitz V, Bydder G, Muntoni F (2000). Brain magnetic resonance imaging abnormalities in merosin-positive congenital muscular dystrophy.. Eur J Paediatr Neurol, 4(3), 109 - 114. doi:10.1053/ejpn.2000.0277
    • Simonds AK, Ward S, Heather S, Bush A, Muntoni F (2000). Outcome of paediatric domiciliary mask ventilation in neuromuscular and skeletal disease.. Eur Respir J, 16(3), 476 - 481.
    • Brodsky GL, Muntoni F, Di Barletta MR, Miocic S, Sinagra G, Sewry C, Toniolo D, Mestroni L (2000). A lamin A/C gene mutation associated with dilated cardiomyopathy with variable skeletal muscle involvement. J AM COLL CARDIOL, 35(2), 202A - 202A.
    • Laing N, Knowak K, Durling H, North K, Nonaka I, Hutchinson D, von Kaisenberg C, Muntoni F, Pelin K, Wallgren-Pettersson C (2000). Actin and nemaline-related myopathy. BRAIN PATHOL, 10(4), 595 - 595.
    • Jungbluth H, Manzur AY, Bydder G, Muntoni F (2000). Generalized calcification in a case of dermatomyositis.. Neuromuscul Disord, 10(2), 150 - .

    1999

    • Mercuri E, Gruter-Andrew J, Philpot J, Sewry C, Counsell S, Henderson S, Jensen A, Naom I, Bydder G, Dubowitz V, Muntoni F (1999). Cognitive abilities in children with congenital muscular dystrophy: correlation with brain MRI and merosin status.. Neuromuscul Disord, 9(6-7), 383 - 387.
    • Bonne G, Di Barletta MR, Varnous S, Bécane HM, Hammouda EH, Merlini L, Muntoni F, Greenberg CR, Gary F, Urtizberea JA, Duboc D, Fardeau M, Toniolo D, Schwartz K (1999). Mutations in the gene encoding lamin A/C cause autosomal dominant Emery-Dreifuss muscular dystrophy.. Nat Genet, 21(3), 285 - 288. doi:10.1038/6799
    • Muntoni F, Goodwin F, Sewry C, Cox P, Cowan F, Airaksinen E, Patel S, Ignatius J, Dubowitz V (1999). Clinical spectrum and diagnostic difficulties of infantile ponto-cerebellar hypoplasia type 1.. Neuropediatrics, 30(5), 243 - 248. doi:10.1055/s-2007-973498
    • Philpot J, Muntoni F (1999). Limitation of eye movement in merosin-deficient congenital muscular dystrophy.. Lancet, 353(9149), 297 - 298. doi:10.1016/S0140-6736(05)74929-1
    • Wallgren-Pettersson C, Pelin K, Hilpelä P, Donner K, Porfirio B, Graziano C, Swoboda KJ, Fardeau M, Urtizberea JA, Muntoni F, Sewry C, Dubowitz V, Iannaccone S, Minetti C, Pedemonte M, Seri M, Cusano R, Lammens M, Castagna-Sloane A, Beggs AH, Laing NG, de la Chapelle A (1999). Clinical and genetic heterogeneity in autosomal recessive nemaline myopathy.. Neuromuscul Disord, 9(8), 564 - 572.
    • Muntoni F, Ferlini A, Sewry C, Mateddu A, Marrosu G, Porcu M, Di Lenarda A, Sinagra G, Mestroni L (1999). Dilated cardiomyopathy and muscular dystrophies: which lesson can be learned?. Cardiologia, 44 Suppl 1(Pt 1), 209 - 211.
    • Ferlini A, Sewry C, Melis MA, Mateddu A, Muntoni F (1999). X-linked dilated cardiomyopathy and the dystrophin gene.. Neuromuscul Disord, 9(5), 339 - 346.
    • Fatkin D, MacRae C, Sasaki T, Wolff MR, Porcu M, Frenneaux M, Atherton J, Vidaillet HJ, Spudich S, De Girolami U, Seidman JG, Seidman C, Muntoni F, Müehle G, Johnson W, McDonough B (1999). Missense mutations in the rod domain of the lamin A/C gene as causes of dilated cardiomyopathy and conduction-system disease.. N Engl J Med, 341(23), 1715 - 1724. doi:10.1056/NEJM199912023412302
    • Mahjneh I, Bushby K, Anderson L, Muntoni F, Tolvanen-Mahjneh H, Bashir R, Pizzi A, Brockington M, Marconi G (1999). Merosin-positive congenital muscular dystrophy: a large inbred family.. Neuropediatrics, 30(1), 22 - 28. doi:10.1055/s-2007-973452
    • Philpot J, Cowan F, Pennock J, Sewry C, Dubowitz V, Bydder G, Muntoni F (1999). Merosin-deficient congenital muscular dystrophy: the spectrum of brain involvement on magnetic resonance imaging.. Neuromuscul Disord, 9(2), 81 - 85.
    • Wehnert M, Muntoni F (1999). 60th ENMC International Workshop: non X-linked Emery-Dreifuss Muscular Dystrophy 5-7 June 1998, Naarden, The Netherlands.. Neuromuscul Disord, 9(2), 115 - 121.
    • D'Alessandro M, Naom I, Ferlini A, Sewry C, Dubowitz V, Muntoni F (1999). Is there selection in favour of heterozygotes in families with merosin-deficient congenital muscular dystrophy?. Hum Genet, 105(4), 308 - 313.
    • Sewry CA, Muntoni F (1999). Inherited disorders of the extracellular matrix.. Curr Opin Neurol, 12(5), 519 - 526.
    • Ferlini A, Patarnello T, Dunckley M, Muntoni F (1999). LINE1 element tails: a possible role in alternative splicing relevant for primates genome evolution?. AM J HUM GENET, 65(4), A186 - A186.
    • Moghadaszadeh B, Topaloglu H, Merlini L, Muntoni F, Estournet B, Sewry C, Naom I, Barois A, Fardeau M, Tomé FM, Guicheney P (1999). Genetic heterogeneity of congenital muscular dystrophy with rigid spine syndrome.. Neuromuscul Disord, 9(6-7), 376 - 382.
    • Manzati E, Bigoni S, Gualandi F, Scapoli C, Guarna M, Pini G, Zappella M, Muntoni F, Hajek G, Calzolari E, Ferlini A (1999). Genetic and transcription analysis in Rett syndrome.. AM J HUM GENET, 65(4), A478 - A478.
    • Mercuri E, Poulton J, Buck J, Broadbent V, Bamford M, Jungbluth H, Manzur AY, Muntoni F (1999). Vincristine treatment revealing asymptomatic hereditary motor sensory neuropathy type 1A.. Arch Dis Child, 81(5), 442 - 443.
    • Beckmann JS, Brown RH, Muntoni F, Urtizberea A, Bonnemann C, Bushby KM (1999). 66th/67th ENMC sponsored international workshop: The limb-girdle muscular dystrophies, 26-28 March 1999, Naarden, The Netherlands.. Neuromuscul Disord, 9(6-7), 436 - 445.
    • Marrosu MG, Vaccargiu S, Marrosu G, Vannelli A, Cianchetti C, Muntoni F (1999). Charcot-Marie-Tooth disease type 2 and P0 gene mutations - Reply. NEUROLOGY, 52(5), 1111 - 1111.
    • Nowak KJ, Wattanasirichaigoon D, Goebel HH, Wilce M, Pelin K, Donner K, Jacob RL, Hübner C, Oexle K, Anderson JR, Verity CM, North KN, Iannaccone ST, Müller CR, Nürnberg P, Muntoni F, Sewry C, Hughes I, Sutphen R, Lacson AG, Swoboda KJ, Vigneron J, Wallgren-Pettersson C, Beggs AH, Laing NG (1999). Mutations in the skeletal muscle alpha-actin gene in patients with actin myopathy and nemaline myopathy.. Nat Genet, 23(2), 208 - 212. doi:10.1038/13837
    • Pelin K, Hilpelä P, Donner K, Sewry C, Akkari PA, Wilton SD, Wattanasirichaigoon D, Bang ML, Centner T, Hanefeld F, Odent S, Fardeau M, Urtizberea JA, Muntoni F, Dubowitz V, Beggs AH, Laing NG, Labeit S, de la Chapelle A, Wallgren-Pettersson C (1999). Mutations in the nebulin gene associated with autosomal recessive nemaline myopathy.. Proc Natl Acad Sci U S A, 96(5), 2305 - 2310.
    • Torelli S, Ferlini A, Obici L, Sewry C, Muntoni F (1999). Expression, regulation and localisation of dystrophin isoforms in human foetal skeletal and cardiac muscle.. Neuromuscul Disord, 9(8), 541 - 551.
    • Lodi R, Kemp GJ, Muntoni F, Thompson CH, Rae C, Taylor J, Styles P, Taylor DJ (1999). Reduced cytosolic acidification during exercise suggests defective glycolytic activity in skeletal muscle of patients with Becker muscular dystrophy. An in vivo 31P magnetic resonance spectroscopy study.. Brain, 122 ( Pt 1), 121 - 130.
    • Minassian BA, Auranen MP, Scherer SW, Villanova M, Muntoni F, Fardeau M, Kalimo H (1999). The gene for X-linked Vacuolated Myopathy (XVM), is located in a 14 cM span of Xq28.. AM J HUM GENET, 65(4), A436 - A436.
    • Bonne G, Muchir A, Recan D, Becane HM, Urtizberea JA, Penisson-Besnier I, Muntoni F, Merlini L, Toniolo D, Duboc D, Fardeau M, Schwartz K (1999). Spectrum of mutations in lamin A/C gene implicated in a new form of dilated cardiomyopathy with conduction defects and muscular dystrophy. CIRCULATION, 100(18), 617 - 617.
    • Mestroni L, Rocco C, Gregori D, Sinagra G, Di Lenarda A, Miocic S, Vatta M, Pinamonti B, Muntoni F, Caforio A, McKenna WJ, Falaschi A, Giacca M, Camerini F, and HMDSG (1999). Familial dilated cardiomyopathy: evidence for genetic and phenotypic heterogeneity.. Journal of the American College of Cardiology, 34, 181 - 190.
    • Mestroni L, Rocco C, Gregori D, Sinagra G, Di Lenarda A, Miocic S, Vatta M, Pinamonti B, Muntoni F, Caforio AL, McKenna WJ, Falaschi A, Giacca M, Camerini (1999). Familial dilated cardiomyopathy: evidence for genetic and phenotypic heterogeneity. Heart Muscle Disease Study Group.. J Am Coll Cardiol, 34(1), 181 - 190.
    • Muntoni F, Ferlini A (1999). Paola Gobbi - 9 November 1966 23 February 1999 - Obituary. NEUROMUSCULAR DISORD, 9(6-7), 455 - 455.
    • Haddad F, Noordeen MHH, Muntoni F (1999). Blood Loss in Duchenne Muscular Dystrophy: A Vascular Smooth Muscle Phenomenon. Journal of Pediatric Orthopaedics, 9, 58 - 61.
    • Noordeen MH, Haddad FS, Muntoni F, Gobbi P, Hollyer JS, Bentley G (1999). Blood loss in Duchenne muscular dystrophy: vascular smooth muscle dysfunction?. J Pediatr Orthop B, 8(3), 212 - 215.
    • Gnecchi-Ruscone T, Taylor J, Mercuri E, Paternostro G, Pogue R, Bushby K, Sewry C, Muntoni F, Camici PG (1999). Cardiomyopathy in duchenne, becker, and sarcoglycanopathies: a role for coronary dysfunction?. Muscle Nerve, 22(11), 1549 - 1556.
    • Mestroni L, Miocic S, Sinagra G, Brodsky GL, Di Barletta MR, Mateddu A, Toniolo D, Muntoni F (1999). Autosomal dominant dilated cardiomyopathy with subclinical skeletal muscle involvement.. AM J HUM GENET, 65(4), A335 - A335.
    • Philpot J, Bagnall A, King C, Dubowitz V, Muntoni F (1999). Feeding problems in merosin deficient congenital muscular dystrophy.. Arch Dis Child, 80(6), 542 - 547.

    1998

    • Marrosu MG, Murru MR, Costa G, Murru R, Muntoni F, Cucca F (1998). DRB1-DQA1-DQB1 loci and multiple sclerosis predisposition in the Sardinian population.. Hum Mol Genet, 7(8), 1235 - 1237.
    • Melis MA, Cau M, Muntoni F, Mateddu A, Galanello R, Boccone L, Deidda F, Loi D, Cao A (1998). Elevation of serum creatine kinase as the only manifestation of an intragenic deletion of the dystrophin gene in three unrelated families.. Eur J Paediatr Neurol, 2(5), 255 - 261.
    • Muntoni F, Lichtarowicz-Krynska EJ, Sewry CA, Manilal S, Recan D, Llense S, Taylor J, Morris GE, Dubowitz V (1998). Early presentation of X-linked Emery-Dreifuss muscular dystrophy resembling limb-girdle muscular dystrophy.. Neuromuscul Disord, 8(2), 72 - 76.
    • Simonds AK, Muntoni F, Heather S, Fielding S (1998). Impact of nasal ventilation on survival in hypercapnic Duchenne muscular dystrophy.. Thorax, 53(11), 949 - 952.
    • Naom I, D'Alessandro M, Sewry CA, Philpot J, Manzur AY, Dubowitz V, Muntoni F (1998). Laminin alpha 2-chain gene mutations in two siblings presenting with limb-girdle muscular dystrophy.. Neuromuscul Disord, 8(7), 495 - 501.
    • Moghadaszadeh B, Desguerre I, Topaloglu H, Muntoni F, Pavek S, Mayer M, Sewry C, Fardeau M, Tome FMS, Guicheney P (1998). Identification of a new locus for congenital muscular dystrophy with rigid spine syndrome to chromosome 1p35-36. EUR J HUM GENET, 6, 39 - 39.
    • Moghadaszadeh B, Desguerre I, Topaloglu H, Muntoni F, Pavek S, Sewry C, Mayer M, Fardeau M, Tomé FM, Guicheney P (1998). Identification of a new locus for a peculiar form of congenital muscular dystrophy with early rigidity of the spine, on chromosome 1p35-36.. Am J Hum Genet, 62(6), 1439 - 1445. doi:10.1086/301882
    • Melis MA, Muntoni F, Cau M, Loi D, Puddu A, Boccone L, Mateddu A, Cianchetti C, Cao A (1998). Novel nonsense mutation (C-->A nt 10512) in exon 72 of dystrophin gene leading to exon skipping in a patient with a mild dystrophinopathy.. Hum Mutat, Suppl 1, S137 - S138.
    • Manilal S, Recan D, Sewry CA, Hoeltzenbein M, Llense S, Leturcq F, Deburgrave N, Barbot J, Man N, Muntoni F, Wehnert M, Kaplan J, Morris GE (1998). Mutations in Emery-Dreifuss muscular dystrophy and their effects on emerin protein expression.. Hum Mol Genet, 7(5), 855 - 864.
    • Taylor J, Sewry CA, Dubowitz V, Muntoni F (1998). Early onset, autosomal recessive muscular dystrophy with Emery-Dreifuss phenotype and normal emerin expression.. Neurology, 51(4), 1116 - 1120.
    • Bushby K, Anderson LV, Pollitt C, Naom I, Muntoni F, Bindoff L (1998). Abnormal merosin in adults. A new form of late onset muscular dystrophy not linked to chromosome 6q2.. Brain, 121 ( Pt 4), 581 - 588.
    • Manzur AY, Sewry CA, Ziprin J, Dubowitz V, Muntoni F (1998). A severe clinical and pathological variant of central core disease with possible autosomal recessive inheritance.. Neuromuscul Disord, 8(7), 467 - 473.
    • Muntoni F, Sewry CA (1998). Congenital muscular dystrophy: from rags to riches.. Neurology, 51(1), 14 - 16.
    • Mercuri E, Philpot J, Anker S, Sewry C, Dubowitz L, Muntoni F (1998). Visual function in children with merosin-deficient and merosin-positive congenital muscular dystrophy. Pediatric Neurology, 18(5), 399 - 401.
    • Cau M, Cao A, Loi D, Puddu A, Muntoni F, Mateddu A, Melis MA (1998). Two novel mutations (10410 T-->G; 10296 del C) at carboxy-terminus of the dystrophin gene associated with mental retardation. Mutations in brief no. 149. Online.. Hum Mutat, 12(1), 70 - . doi:10.1002/(SICI)1098-1004(1998)12:1<70::AID-HUMU13>3.0.CO;2-G
    • Lagae L, Muntoni F (1998). The Second Congress of the European Paediatric Neurology Society: Maastricht 8-11 October 1997.. Eur J Paediatr Neurol, 2(1), 61 - 64.
    • Ferlini A, Muntoni F (1998). The 5' region of intron 11 of the dystrophin gene contains target sequences for mobile elements and three overlapping ORFs.. Biochem Biophys Res Commun, 242(2), 401 - 406. doi:10.1006/bbrc.1997.7976
    • Cianchetti C, Marrosu MG, Muntoni F, Fratta A, Zuddas A (1998). Intraventricular alpha-interferon in subacute sclerosing panencephalitis.. Neurology, 50(1), 315 - 316.
    • Spyrou N, Philpot J, Foale R, Camici PG, Muntoni F (1998). Evidence of left ventricular dysfunction in children with merosin-deficient congenital muscular dystrophy.. Am Heart J, 136(3), 474 - 476.
    • Ferlini A, Galié N, Merlini L, Sewry C, Branzi A, Muntoni F (1998). A novel Alu-like element rearranged in the dystrophin gene causes a splicing mutation in a family with X-linked dilated cardiomyopathy.. Am J Hum Genet, 63(2), 436 - 446. doi:10.1086/301952
    • Marrosu MG, Vaccargiu S, Marrosu G, Vannelli A, Cianchetti C, Muntoni F (1998). Charcot-Marie-Tooth disease type 2 associated with mutation of the myelin protein zero gene.. Neurology, 50(5), 1397 - 1401.
    • Muntoni F, Taylor J, Sewry CA, Naom I, Dubowitz V (1998). An early onset muscular dystrophy with diaphragmatic involvement, early respiratory failure and secondary alpha2 laminin deficiency unlinked to the LAMA2 locus on 6q22.. Eur J Paediatr Neurol, 2(1), 19 - 26.

    1997

    • Nigro G, Muntoni F (1997). 42nd ENMC Sponsored International Workshop: X-linked cardiomyopathies. 21-23 June 1996, Naarden, The Netherlands.. Neuromuscul Disord, 7(6-7), 397 - 403.
    • Marrosu MG, Vaccargiu S, Marrosu G, Vannelli A, Cianchetti C, Muntoni F (1997). A novel point mutation in the peripheral myelin protein 22 (PMP22) gene associated with Charcot-Marie-Tooth disease type 1A.. Neurology, 48(2), 489 - 493.
    • Talbot K, Rodrigues NR, Ignatius J, Muntoni F, Davies KE (1997). Gene conversion at the SMN locus in autosomal recessive spinal muscular atrophy does not predict a mild phenotype.. Neuromuscul Disord, 7(3), 198 - 201.
    • Tyson J, Ellis D, Fairbrother U, King RH, Muntoni F, Jacobs J, Malcolm S, Harding AE, Thomas PK (1997). Hereditary demyelinating neuropathy of infancy. A genetically complex syndrome.. Brain, 120(1), 47 - 63.
    • Villanova M, Malandrini A, Sabatelli P, Sewry CA, Toti P, Torelli S, Six J, Scarfó G, Palma L, Muntoni F, Squarzoni S, Tosi P, Maraldi NM, Guazzi GC (1997). Localization of laminin alpha 2 chain in normal human central nervous system: an immunofluorescence and ultrastructural study.. Acta Neuropathol, 94(6), 567 - 571.
    • Taylor J, Muntoni F, Dubowitz V, Sewry CA (1997). The abnormal expression of utrophin in Duchenne and Becker muscular dystrophy is age related.. Neuropathol Appl Neurobiol, 23(5), 399 - 405.
    • Ferlini A, Muntoni F (1997). The dystrophin gene intron 11 has target sequences for mobile elements and one ORF transcribed in skeletal and heart muscle. AM J HUM GENET, 61(4), A170 - A170.
    • Naom I, D'Alessandro M, Sewry C, Ferlini A, Topaloglu H, Helbling-Leclerc A, Guicheney P, Schwartz K, Akcoren Z, Dubowitz V, Muntoni F (1997). The role of immunocytochemistry and linkage analysis in the prenatal diagnosis of merosin-deficient congenital muscular dystrophy.. Hum Genet, 99(4), 535 - 540.
    • Sewry CA, Naom I, D'Alessandro M, Sorokin L, Bruno S, Wilson LA, Dubowitz V, Muntoni F (1997). Variable clinical phenotype in merosin-deficient congenital muscular dystrophy associated with differential immunolabelling of two fragments of the laminin alpha 2 chain.. Neuromuscul Disord, 7(3), 169 - 175.
    • GnecchiRuscone T, Paternostro G, Taylor J, Muntoni F, Camici PG (1997). Coronary flow reserve in muscle dystrophies.. CIRCULATION, 96(8), 540 - 540.
    • Naom I, Sewry C, D'Alessandro M, Topaloglu H, Ferlini A, Wilson L, Dubowitz V, Muntoni F (1997). Prenatal diagnosis in merosin-deficient congenital muscular dystrophy.. Neuromuscul Disord, 7(3), 176 - 179.
    • Naom IS, D'Alessandro M, Topaloglu H, Sewry C, Ferlini A, Helbling-Leclerc A, Guicheney P, Weissenbach J, Schwartz K, Bushby K, Philpot J, Dubowitz V, Muntoni F (1997). Refinement of the laminin alpha2 chain locus to human chromosome 6q2 in severe and mild merosin deficient congenital muscular dystrophy.. J Med Genet, 34(2), 99 - 104.
    • Paternostro G, Pagano D, Bonser RS, Muntoni F, Camici PG (1997). The GLUT-4 glucose transporter protein is reduced in the failing human heart. CIRCULATION, 96(8), 3510 - 3510.
    • Brockington M, Sewry C, Philpot J, Topaloglu H, Manheim I, Bushby K, Dubowitz V, Muntoni F (1997). Search for the defective gene(s) responsible for merosin-positive Congenital Muscular Dystrophy.. AM J HUM GENET, 61(4), A269 - A269.
    • Marrosu MG, Murru MR, Costa G, Cucca F, Sotgiu S, Rosati G, Muntoni F (1997). Multiple sclerosis in Sardinia is associated and in linkage disequilibrium with HLA-DR3 and -DR4 alleles.. Am J Hum Genet, 61(2), 454 - 457. doi:10.1016/S0002-9297(07)64074-9
    • Campbell L, Potter A, Ignatius J, Muntoni F, Dubowitz V, Davies KE (1997). Genotype/phenotype correlation in childhood autosomal recessive spinal muscular atrophy (SMA) by pulsed field gel analysis.. AM J HUM GENET, 61(4), A330 - A330.
    • Tan E, Topaloglu H, Sewry C, Zorlu Y, Naom I, Erdem S, D'Alessandro M, Muntoni F, Dubowitz V (1997). Late onset muscular dystrophy with cerebral white matter changes due to partial merosin deficiency.. Neuromuscul Disord, 7(2), 85 - 89.
    • Villanova M, Sewry C, Malandrini A, Toti P, Muntoni F, Merlini L, Torelli S, Tosi P, Maraldi NM, Guazzi GC (1997). Immunolocalization of several laminin chains in the normal human central and peripheral nervous system.. J Submicrosc Cytol Pathol, 29(3), 409 - 413.
    • Lodi R, Muntoni F, Taylor J, Kumar S, Sewry CA, Blamire A, Styles P, Taylor DJ (1997). Correlative MR imaging and 31P-MR spectroscopy study in sarcoglycan deficient limb girdle muscular dystrophy.. Neuromuscul Disord, 7(8), 505 - 511.
    • Manilal S, Sewry CA, Man N, Muntoni F, Morris GE (1997). Diagnosis of X-linked Emery-Dreifuss muscular dystrophy by protein analysis of leucocytes and skin with monoclonal antibodies.. Neuromuscul Disord, 7(1), 63 - 66.
    • Taylor J, Muntoni F, Robb S, Dubowitz V, Sewry C (1997). Early onset autosomal dominant myopathy with rigidity of the spine: a possible role for laminin beta 1?. Neuromuscul Disord, 7(4), 211 - 216.
    • Topaloglu H, Muntoni F, Dubowitz V, Sewry C (1997). Expression of HLA class I antigens in skeletal muscle is a diagnostic marker in juvenile dermatomyositis.. J Child Neurol, 12(1), 60 - 63.
    • Sewry CA, D'Alessandro M, Wilson LA, Sorokin LM, Naom I, Bruno S, Ferlini A, Dubowitz V, Muntoni F (1997). Expression of laminin chains in skin in merosin-deficient congenital muscular dystrophy.. Neuropediatrics, 28(4), 217 - 222. doi:10.1055/s-2007-973703
    • Muntoni F, Di Lenarda A, Porcu M, Sinagra G, Mateddu A, Marrosu G, Ferlini A, Cau M, Milasin J, Melis MA, Marrosu MG, Cianchetti C, Sanna A, Falaschi A, Camerini F, Giacca M, Mestroni L (1997). Dystrophin gene abnormalities in two patients with idiopathic dilated cardiomyopathy.. Heart, 78(6), 608 - 612.
    • Bushby K, Anderson LVB, Sewry C, Pogue R, Taylor J, Pollitt C, Muntoni F (1997). Dystrophinopathy or sarcoglycanopathy - the importance of a full diagnostic assessment in suspected manifesting carriers of Duchenne and Becker muscular dystrophy.. J MED GENET, 34, 522 - 522.
    • Goodwin F, Muntoni F, Dubowitz V (1997). Epilepsy in Duchenne and Becker muscular dystrophies.. Eur J Paediatr Neurol, 1(4), 115 - 119.

    1996

    • WallgrenPettersson C, Avela R, Marchand S, Kolehmainen J, Tahvanainen E, Hansen FJ, Muntoni F, Dubowitz V, deVisser M, vanLangen IM, Laing NG, Faure S, delaChapelle A (1996). A gene for autosomal recessive nemaline myopathy assigned to chromosome 2q by linkage analysis. CYTOGENET CELL GENET, 73(4), 13 - 13.
    • Serra G, Piccinnu R, Tondi M, Muntoni F, Zeviani M, Mastropaolo C (1996). Clinical and EEG findings in eleven patients affected by mitochondrial encephalomyopathy with MERRF-MELAS overlap.. Brain Dev, 18(3), 185 - 191.
    • Murru MR, Costa G, Murru R, Muntoni F, Marrosu MG (1996). A new allelic variant of HLA-DRB1*1101 (DRB1*11013) segregating in a Sardinian family.. Tissue Antigens, 48(5), 604 - 606.
    • Milasin J, Muntoni F, Severini GM, Bartoloni L, Vatta M, Krajinovic M, Mateddu A, Angelini C, Camerini F, Falaschi A, Mestroni L, Giacca M (1996). A point mutation in the 5' splice site of the dystrophin gene first intron responsible for X-linked dilated cardiomyopathy.. Hum Mol Genet, 5(1), 73 - 79.
    • Sewry CA, Naom I, D'Alessandro M, Ferlini A, Philpot J, Mercuri E, Dubowitz V, Muntoni F (1996). The protein defect in congenital muscular dystrophy.. Biochem Soc Trans, 24(2), 281S - .
    • Mestroni L, Muntoni F, Milasin J, DiLenarda A, Sinagra G, Rocco C, Vatta M, Matulic M, Falaschi A, Camerini F, Giacca M (1996). Familial dilated cardiomyopathy with subclinical skeletal muscle involvement. CIRCULATION, 94(8), 1582 - 1582.
    • Sewry CA, Taylor J, Anderson LV, Ozawa E, Pogue R, Piccolo F, Bushby K, Dubowitz V, Muntoni F (1996). Abnormalities in alpha-, beta- and gamma-sarcoglycan in patients with limb-girdle muscular dystrophy.. Neuromuscul Disord, 6(6), 467 - 474.
    • Torelli S, Muntoni F (1996). Alternative splicing of dystrophin exon 4 in normal human muscle.. Hum Genet, 97(4), 521 - 523.
    • Rodrigues NR, Owen N, Talbot K, Patel S, Muntoni F, Ignatius J, Dubowitz V, Davies KE (1996). Gene deletions in spinal muscular atrophy.. J Med Genet, 33(2), 93 - 96.
    • Sewry CA, Philpot J, Sorokin LM, Wilson LA, Naom I, Goodwin F, D'Alessandro M, Dubowitz V, Muntoni F (1996). Diagnosis of merosin (laminin-2) deficient congenital muscular dystrophy by skin biopsy.. Lancet, 347(9001), 582 - 584.
    • Mercuri E, Pennock J, Goodwin F, Sewry C, Cowan F, Dubowitz L, Dubowitz V, Muntoni F (1996). Sequential study of central and peripheral nervous system involvement in an infant with merosin-deficient congenital muscular dystrophy.. Neuromuscul Disord, 6(6), 425 - 429.

    1995

    • BREWSTER BS, HARLEY HG, MUNTONI F, DUBOWITZ V, HARPER PS, STRONG PN (1995). CHANGES IN THE LEVEL OF EXPRESSION OF A PROTEIN RELATED TO THE MYOTONIC-DYSTROPHY GENE AND THE CORRELATION OF EXPRESSION WITH THE SIZE OR CTG REPEAT EXPANSION. AM J HUM GENET, 57(4), 1367 - 1367.
    • Rapisarda R, Muntoni F, Gobbi P, Dubowitz V (1995). Duchenne muscular dystrophy presenting with failure to thrive.. Arch Dis Child, 72(5), 437 - 438.
    • Muntoni F, Sewry C, Wilson L, Angelini C, Trevisan CP, Brambati B, Dubowitz V (1995). Prenatal diagnosis in congenital muscular dystrophy.. Lancet, 345(8949), 591 - .
    • Muntoni F, Wilson L, Marrosu G, Marrosu MG, Cianchetti C, Mestroni L, Ganau A, Dubowitz V, Sewry C (1995). A mutation in the dystrophin gene selectively affecting dystrophin expression in the heart.. J Clin Invest, 96(2), 693 - 699. doi:10.1172/JCI118112
    • Sewry CA, Philpot J, Mahony D, Wilson LA, Muntoni F, Dubowitz V (1995). Expression of laminin subunits in congenital muscular dystrophy.. Neuromuscul Disord, 5(4), 307 - 316.
    • Muntoni F, Melis MA, Ganau A, Dubowitz V (1995). Transcription of the dystrophin gene in normal tissues and in skeletal muscle of a family with X-linked dilated cardiomyopathy.. Am J Hum Genet, 56(1), 151 - 157.
    • Philpot J, Muntoni F, Skellett S, Dubowitz V (1995). Congenital symmetrical weakness of the upper limbs resembling brachial plexus palsy: a possible sequel of drug toxicity in first trimester of pregnancy?. Neuromuscul Disord, 5(1), 67 - 69.
    • DUBOWITZ V, MERCURI E, MUNTONI F, PHILPOT J, SEWRY CA, SHORER Z (1995). PERIPHERAL AND CENTRAL-NERVOUS-SYSTEM INVOLVEMENT IN MEROSIN-DEFICIENT CONGENITAL MUSCULAR-DYSTROPHY. NEUROLOGY, 45(4), A407 - A407.
    • Voit T, Sewry CA, Meyer K, Hermann R, Straub V, Muntoni F, Kahn T, Unsöld R, Helliwell TR, Appleton R (1995). Preserved merosin M-chain (or laminin-alpha 2) expression in skeletal muscle distinguishes Walker-Warburg syndrome from Fukuyama muscular dystrophy and merosin-deficient congenital muscular dystrophy.. Neuropediatrics, 26(3), 148 - 155. doi:10.1055/s-2007-979745
    • Helbling-Leclerc A, Topaloglu H, Tomé FM, Sewry C, Gyapay G, Naom I, Muntoni F, Dubowitz V, Barois A, Estournet B (1995). Readjusting the localization of merosin (laminin alpha 2-chain) deficient congenital muscular dystrophy locus on chromosome 6q2.. C R Acad Sci III, 318(12), 1245 - 1252.
    • Mercuri E, Muntoni F, Berardinelli A, Pennock J, Sewry C, Philpot J, Dubowitz V (1995). Somatosensory and visual evoked potentials in congenital muscular dystrophy: correlation with MRI changes and muscle merosin status.. Neuropediatrics, 26(1), 3 - 7. doi:10.1055/s-2007-979711
    • WALLGRENPETERSSON C, AVELA K, MARCHAND S, HANSEN FJ, MUNTONI F, DEVISSER M, FAURE S, DELACHAPELLE A (1995). GENETIC NONALLELIC HETEROGENITY CONFIRMED IN NEMALINE (ROD) MYOPATHY. AM J HUM GENET, 57(4), 1177 - 1177.
    • THEODOSIOU AM, RODRIGUES NR, TALBOT K, CAMPBELL L, NESBIT MA, OWEN N, AMBROSE H, MUNTONI F, PATEL S, IGNATIUS J, DUBOWITZ V, DAVIES KE (1995). MOLECULAR ANALYSIS OF CHILDHOOD-ONSET SPINAL MUSCULAR-ATROPHY. AM J HUM GENET, 57(4), 106 - 106.
    • Mercuri E, Dubowitz L, Berardinelli A, Pennock J, Jongmans M, Henderson S, Muntoni F, Sewry C, Philpot J, Dubowitz V (1995). Minor neurological and perceptuo-motor deficits in children with congenital muscular dystrophy: correlation with brain MRI changes.. Neuropediatrics, 26(3), 156 - 162. doi:10.1055/s-2007-979746
    • Shorer Z, Philpot J, Muntoni F, Sewry C, Dubowitz V (1995). Demyelinating peripheral neuropathy in merosin-deficient congenital muscular dystrophy.. J Child Neurol, 10(6), 472 - 475.
    • MUNTONI F, FERLINI A, TORELLI S, SEWRY C (1995). DP71 CARDIAC EXPRESSION IN 2 FAMILIES WITH X-LINKED DILATED CARDIOMYOPATHY AND A DYSTROPHIN GENE MUTATION. AM J HUM GENET, 57(4), 1429 - 1429.
    • Wallgren-Pettersson C, Avela K, Marchand S, Kolehmainen J, Tahvanainen E, Hansen FJ, Muntoni F, Dubowitz V, De Visser M, Van Langen IM (1995). A gene for autosomal recessive nemaline myopathy assigned to chromosome 2q by linkage analysis.. Neuromuscul Disord, 5(6), 441 - 443.

    1994

    • Cianchetti C, Fratta AL, Muntoni F, Marrosu G, Marrosu MG (1994). Toxic effect of intraventricular interferon-alpha in subacute sclerosing panencephalitis.. Ital J Neurol Sci, 15(3), 153 - 155.
    • MUNTONI F (1994). X-LINKED DILATED CARDIOMYOPATHY (VOL 329, PG 921, 1993). NEW ENGL J MED, 330(5), 370 - 370.
    • Muntoni F, Hird M, Simonds AK (1994). Preventive nasal ventilation in Duchenne muscular dystrophy.. Lancet, 344(8918), 340 - .
    • Muntoni F, Catani G, Mateddu A, Rimoldi M, Congiu T, Faa G, Marrosu MG, Cianchetti C, Porcu M (1994). Familial cardiomyopathy, mental retardation and myopathy associated with desmin-type intermediate filaments.. Neuromuscul Disord, 4(3), 233 - 241.
    • Muntoni F, Gobbi P, Sewry C, Sherratt T, Taylor J, Sandhu SK, Abbs S, Roberts R, Hodgson SV, Bobrow M (1994). Deletions in the 5' region of dystrophin and resulting phenotypes.. J Med Genet, 31(11), 843 - 847.
    • Porcu M, Muntoni F, Catani G, Mereu D (1994). Familial cardiac and skeletal myopathy associated with desmin accumulation.. Clin Cardiol, 17(5), 277 - 279.
    • CONGIA M, MUNTONI F, CUCCA F, FRAU F, LAMPIS R, PORCU S, SONGINI M, MUNTONI S (1994). HLA-DQB1, DQA1 AND DPB1 ALLELES IN SARDINIAN PATIENTS WITH INSULIN-DEPENDENT DIABETES-MELLITUS.

    1993

    • Zeviani M, Muntoni F, Savarese N, Serra G, Tiranti V, Carrara F, Mariotti C, DiDonato S (1993). A MERRF/MELAS overlap syndrome associated with a new point mutation in the mitochondrial DNA tRNA(Lys) gene.. Eur J Hum Genet, 1(1), 80 - 87.
    • Muntoni F, Mateddu A, Cianchetti C, Marrosu MG, Clerk A, Cau M, Congiu R, Cao A, Melis MA (1993). Dystrophin analysis using a panel of anti-dystrophin antibodies in Duchenne and Becker muscular dystrophy.. J Neurol Neurosurg Psychiatry, 56(1), 26 - 31.
    • MUNTONI F (1993). THE USE OF MULTIPLE ANTI-DYSTROPHIN ANTIBODIES IN DUCHENNE AND BECKER MUSCULAR-DYSTROPHY - REPLY. J NEUROL NEUROSUR PS, 56(10), 1137 - 1138.
    • Cucca F, Muntoni F, Lampis R, Frau F, Cao A, De Virgiliis S, Congia M (1993). A novel HLA-DQB1 allele: evidence for gene conversion event promoted by chi-like sequence at DQB1 locus.. Tissue Antigens, 41(5), 263 - 266.
    • Muntoni F, Cau M, Congiu R, Congia M, Cao A, Melis MA (1993). Identification of a novel T-insertion polymorphism at the DMD locus.. Hum Genet, 92(1), 103 - .
    • Marrosu MG, Muntoni F, Murru MR, Costa G, Congia M, Marrosu G, Aiello I, Pirastu M, Cianchetti C (1993). Role of predisposing and protective HLA-DQA and HLA-DQB alleles in Sardinian multiple sclerosis.. Arch Neurol, 50(3), 256 - 260.
    • Muntoni F, Cau M, Ganau A, Congiu R, Arvedi G, Mateddu A, Marrosu MG, Cianchetti C, Realdi G, Cao A (1993). Brief report: deletion of the dystrophin muscle-promoter region associated with X-linked dilated cardiomyopathy.. N Engl J Med, 329(13), 921 - 925. doi:10.1056/NEJM199309233291304
    • Muntoni F, Mateddu A, Marchei F, Clerk A, Serra G (1993). Muscular weakness in the mdx mouse.. J Neurol Sci, 120(1), 71 - 77.
    • CONGIA M, CUCCA F, FRAU F, LAMPIS R, CLEMENTE MG, MUNTONI F, FLORIS M, DEVIRGILIIS S, CAO A (1993). GENE-FREQUENCY AND MECHANISM OF GENERATION OF A NOVEL HLA-DQB1 ALLELE. AM J HUM GENET, 53(3), 1611 - 1611.
    • Melis MA, Cau M, Congiu R, Puddu R, Muntoni F, Cao A (1993). Germinal mosaicism in a Duchenne muscular dystrophy family: implications for genetic counselling.. Clin Genet, 43(5), 247 - 249.
    • HAEGERT DG, MUNTONI F, MURRU MR, COSTA G, MARROSU MG, FRANCIS GS (1993). HLA AND MS - REPLY. NEUROLOGY, 43(11), 2427 - 2427.
    • CUCCA F, CONGIA M, MUNTONI F, FRAU F, LAMPIS R, CLEMENTE MG, SILVETTI M, ANGIUS E, DEVIRGILIIS S, CAO A (1993). HLA CLASS-II GENES AND INSULIN-DEPENDENT DIABETES-MELLITUS (IDDM) IN SARDINIA. AM J HUM GENET, 53(3), 789 - 789.
    • Haegert DG, Muntoni F, Murru MR, Costa G, Francis GS, Marrosu MG (1993). HLA-DQA1 and -DQB1 associations with multiple sclerosis in Sardinia and French Canada: evidence for immunogenetically distinct patient groups.. Neurology, 43(3 Pt 1), 548 - 552.
    • Cucca F, Muntoni F, Lampis R, Frau F, Argiolas L, Silvetti M, Angius E, Cao A, De Virgiliis S, Congia M (1993). Combinations of specific DRB1, DQA1, DQB1 haplotypes are associated with insulin-dependent diabetes mellitus in Sardinia.. Hum Immunol, 37(2), 85 - 94.
    • Muntoni F, Mateddu A, Cau M, Congiu R, Puddu R, Cossu P, Cao A, Melis MA (1993). Diagnosis of DMD carrier status in a family with no known affected males.. Dev Med Child Neurol, 35(1), 70 - 73.
    • Clerk A, Muntoni F, Strong PN (1993). A dystrophin-immunoreactive protein in mammalian brain.. J Neurochem, 60(2), 435 - 441.

    1992

    • Congia M, Frau F, Lampis R, Frau R, Mele R, Cucca F, Muntoni F, Porcu S, Boi F, Contu L (1992). A high frequency of the A30, B18, DR3, DRw52, DQw2 extended haplotype in Sardinian celiac disease patients: further evidence that disease susceptibility is conferred by DQ A1*0501, B1*0201.. Tissue Antigens, 39(2), 78 - 83.
    • Muntoni F, Congia M, Cucca F, Cossu P, Porcu S, Frau F, Arnone M, Songini M, Muntoni S, Cao A (1992). The HLA DQB1*0502 allele is neutrally associated with insulin-dependent diabetes mellitus in the Sardinian population.. Tissue Antigens, 39(5), 262 - 265.
    • Muntoni F, Mateddu A, Marrosu MG, Cau M, Congiu R, Melis MA, Cao A, Cianchetti C (1992). Variable dystrophin expression in different muscles of a Duchenne muscular dystrophy carrier.. Clin Genet, 42(1), 35 - 38.
    • Torelli S, Sogos V, Ennas MG, Muntoni F, Clerk A, Strong PN, Gremo F (1992). Dystrophin immunoreactivity in normal and Duchenne human fetal neurons in culture.. J Neurosci Res, 32(1), 116 - 125. doi:10.1002/jnr.490320114
    • Marrosu MG, Mazzoleni AP, Galantuomo S, Melis A, Muntoni F, Lai E (1992). Polymerase chain reaction analysis for specific HTLV-1 sequences from cerebrospinal fluid and peripheral blood cells in Sardinian multiple sclerosis patients.. Eur Neurol, 32(4), 195 - 198.
    • Marrosu MG, Muntoni F, Murru MR, Costa G, Pischedda MP, Pirastu M, Sotgiu S, Rosati G, Cianchetti C (1992). HLA-DQB1 genotype in Sardinian multiple sclerosis: evidence for a key role of DQB1 *0201 and *0302 alleles.. Neurology, 42(4), 883 - 886.
    • MARROSU MG, MUNTONI F, MURRU MR, COSTA G, PISCHEDDA MP, PIRASTU M, SOTGIU S, ROSATI G, CIANCHETTI C (1992). HLA-DQB1 GENOTYPE IN SARDINIAN MULTIPLE-SCLEROSIS - EVIDENCE FOR A KEY ROLE OF DQB1 ASTERISK-0201 AND ASTERISK-0302 ALLELES. NEUROLOGY, 42(4), 883 - 886.
    • Cianchetti C, Muntoni F, Falchi AM, Nucaro A, Sannio-Fancello G, Cao A, Marrosu MG (1992). X-linked mental retardation and characteristic physical features in two brothers with duplication Xp22-Xpter.. Am J Med Genet, 43(1-2), 475 - 478.

    1991

    • Muntoni F, Mateddu A, Serra G (1991). Passive avoidance behaviour deficit in the mdx mouse.. Neuromuscul Disord, 1(2), 121 - 123.
    • Muntoni F, Murru MR, Costa G, Congia M, Cucca F, Cossu P, Cao A, Dessalvi L, Pirastu M, Marrosu MG (1991). Different HLA DR2-DQw1 haplotypes in Sardinian and northern Italian populations: implications for multiple sclerosis susceptibility.. Tissue Antigens, 38(1), 34 - 36.
    • Muntoni F, Lampis R, Frau F, Argiolas L, Murru MR, Costa G, Congia M (1991). A PvuII RFLP at D6S114E locus in the HLA region (RING4 locus).. Nucleic Acids Res, 19(24), 6974 - .

    1990

    • Clerk A, Muntoni F, Strong P (1990). Dystrophin and dystrophin-like proteins in muscle and brain of normal and mdx mice.. Biochem Soc Trans, 18(3), 388 - 389.
    • CIANCHETTI C, MUNTONI F, FRATTA A, MARROSU MG (1990). IMMUNOLOGICAL PARAMETERS IN SUBACUTE SCLEROSING PANENCEPHALITIS AND THE EFFECT OF INTRAVENTRICULAR INTERFERON.

    1989

    • Rodillo E, Noble-Jamieson CM, Aber V, Heckmatt JZ, Muntoni F, Dubowitz V (1989). Respiratory muscle training in Duchenne muscular dystrophy.. Arch Dis Child, 64(5), 736 - 738.
    • Muntoni F, Strong PN (1989). Transcription of the dystrophin gene in Duchenne muscular dystrophy muscle.. FEBS Lett, 252(1-2), 95 - 98.

    1988

    • Marrosu MG, Muntoni F, Murru MR, Spinicci G, Pischedda MP, Goddi F, Cossu P, Pirastu M (1988). Sardinian multiple sclerosis is associated with HLA-DR4: a serologic and molecular analysis.. Neurology, 38(11), 1749 - 1753.

    1987

    • Fratta W, Collu M, Martellotta MC, Pichiri M, Muntoni F, Gessa GL (1987). Stress-induced insomnia: opioid-dopamine interactions.. Eur J Pharmacol, 142(3), 437 - 440.

    1986

    • Mereu G, Muntoni F, Calabresi P, Romani F, Boi V, Gessa GL (1986). Responsiveness to 'autoreceptor' doses of apomorphine inversely correlated with the firing rate of dopaminergic A9 neurons: action of baclofen.. Neurosci Lett, 65(2), 161 - 166.

    1985

    • Gessa GL, Muntoni F, Collu M, Vargiu L, Mereu G (1985). Low doses of ethanol activate dopaminergic neurons in the ventral tegmental area.. Brain Res, 348(1), 201 - 203.

    • Jaffer F, Reilly MM, Quinlivan R , Muntoni F, Orrell R, Wraige E, Radunovic A, Mummery C, Hanna MG (). Avoiding unplanned admissions in patients with neuromuscular diseases: a regional collaborative audit of hospital admissions 2009-2011.